	<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
	<channel rdf:about="https://biorxiv.org">
	<admin:errorReportsTo rdf:resource="mailto:biorxiv@cshlpress.edu"/>
	<title>bioRxiv Channel: Babraham Institute </title>
	<link>https://biorxiv.org</link>
	<description>
	This feed contains articles for bioRxiv Channel "Babraham Institute "
	</description>

		<items>
	<rdf:Seq>
		</rdf:Seq>
	</items>
	<prism:eIssn/>
	<prism:publicationName>bioRxiv</prism:publicationName>
	<prism:issn/>

	<image rdf:resource=""/>
	</channel>
	<image rdf:about="">
	<title>bioRxiv</title>
	<url/>
	<link>https://biorxiv.org</link>
	</image>
	<item rdf:about="https://biorxiv.org/content/10.64898/2026.04.29.721300?rss=1">
<title>
<![CDATA[
Phosphoproteomics identifies the DYRK1B protein kinase as a regulator of processing bodies 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.04.29.721300?rss=1</link>
<description><![CDATA[
Dual-specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B) modulates the cell cycle, cell fate during development, and is deregulated in cancer and metabolic syndrome. However, only a few DYRK1B substrates have been defined, so we undertook a phosphoproteomics screen in cells that exhibit inducible DYRK1B expression. Motif analysis revealed enrichment for proline-directed serine or threonine phosphorylation sites (pSer/pThr-Pro), consistent with the consensus motif of class I DYRKs. Gene ontology analysis revealed enrichment of proteins involved in mRNA binding, mRNA processing and ribonucleoprotein complexes. Several processing body (PB) components, including DCP1A, PATL1(PAT1B), EDC3 and 4E-T, were identified as DYRK1B-inducible phosphoproteins. DYRK1B also co-immunoprecipitated with DCP1A, PAT1B, EDC3, EDC4, DDX6 and XRN1. Super-resolution microscopy demonstrated that DYRK1B co-localised with DCP1A, DCP1B and DDX6 in PBs. Activation of DYRK1B increased PB abundance, whereas inhibition, depletion or knockout of DYRK1B reduced phosphorylation of DCP1A and 4E-T and decreased PB number. Re-expression of wild type, but not kinase-dead, DYRK1B restored PB numbers in knockout cells. These findings reveal novel DYRK1B targets and establish DYRK1B as a regulator of processing body abundance.

HighlightsO_LIDYRK1B induces phosphorylation of a cluster of RNA binding and processing body associated proteins.
C_LIO_LIDYRK1B localises to PBs and associates with multiple PB components.
C_LIO_LIDYRK1B controls P-body abundance in a kinase-dependent manner.
C_LI
]]></description>
<dc:creator>Ashford, A. L.</dc:creator>
<dc:creator>Ber, S.</dc:creator>
<dc:creator>Ems, M. S.</dc:creator>
<dc:creator>Duncan, E.</dc:creator>
<dc:creator>Balmanno, K.</dc:creator>
<dc:creator>Reeves, H.</dc:creator>
<dc:creator>Huntly, R.</dc:creator>
<dc:creator>Cassidy, M. A.</dc:creator>
<dc:creator>Johnston, H. E.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Nthiga, T. M.</dc:creator>
<dc:creator>Johansen, T.</dc:creator>
<dc:creator>Kluge, M.</dc:creator>
<dc:creator>Jacob, R.</dc:creator>
<dc:creator>Lauth, M.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:date>2026-05-01</dc:date>
<dc:identifier>doi:10.64898/2026.04.29.721300</dc:identifier>
<dc:title><![CDATA[Phosphoproteomics identifies the DYRK1B protein kinase as a regulator of processing bodies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-05-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.04.18.719387?rss=1">
<title>
<![CDATA[
Booster vaccination improves the durability of antibody-secreting plasma cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.04.18.719387?rss=1</link>
<description><![CDATA[
Booster vaccination can restore antibody titres and protection, but whether it improves long-term durability by expanding plasma cell (PC) numbers or also by shifting PC fate toward intrinsically longer-lived states remains unclear. Here we established longitudinal in vivo ground truth for PC persistence by combining PC-specific genetic timestamping, clonal tracking, and multi-timepoint single-cell profiling across spleen and bone marrow. We resolved PC longevity as a layered, non-binary architecture comprising short-, intermediate-, and long-lived programs, and showed that program identity is specified early in secondary lymphoid tissues and largely maintained as PCs populate bone marrow niches. Primary vaccine responses initiated from naive B-cells generated a prominent intermediate-lived wave, whereas memory B-cell recall during boosting redistributed output toward long-lived programs rather than recreating the intermediate-lived compartment characteristic of priming. Conserved longevity signatures projected onto early circulating PCs provide a cross-species framework to infer durability programs, supporting benchmarking of vaccine regimens by predicted persistence rather than peak titres.

HighlightsO_LIGenetic timestamping resolves short-, intermediate-, and long-lived PC programs
C_LIO_LILongevity programs are imprinted early and maintained from lymphoid organs to bone marrow
C_LIO_LICross-species signatures stratify human blood and bone marrow PCs by persistence
C_LIO_LIBoosting via MBC recall enriches long-lived PC and contracts the intermediate-lived tier
C_LI
]]></description>
<dc:creator>Xu, A. Q.</dc:creator>
<dc:creator>Hung, M. S.</dc:creator>
<dc:creator>Chen, B.</dc:creator>
<dc:creator>Sopena, M. L.</dc:creator>
<dc:creator>Chakravarty, P.</dc:creator>
<dc:creator>Camara, A.</dc:creator>
<dc:creator>Calado, D. P.</dc:creator>
<dc:date>2026-04-22</dc:date>
<dc:identifier>doi:10.64898/2026.04.18.719387</dc:identifier>
<dc:title><![CDATA[Booster vaccination improves the durability of antibody-secreting plasma cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.04.20.719651?rss=1">
<title>
<![CDATA[
Extrafollicular plasma cells disable dendritic cell-T-cell priming in tumor-draining lymph nodes 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.04.20.719651?rss=1</link>
<description><![CDATA[
How plasma cells (PCs) shape anti-tumor immunity is unclear. We hypothesized that conflicting prognostic associations reflect differences in immune context and PC ontogeny. We identify extrafollicular (EF)-PCs as an antibody-independent checkpoint that aborts priming by disabling the cDC1[-&gt;]CD8+ T-cell axis in tumor-draining lymph nodes (td-LNs). EF-PCs blunt cDC1 activation and CCR7-guided repositioning into T-cell zones, precluding formation of TCF1 stem-like CD8 T-cells. Depleting EF-PCs in vivo restores cDC1 trafficking, expands the stem-like reservoir, increases intratumoral CD8 infiltration, and restrains tumor growth; benefit is lost with CD8 T-cell ablation. Neither serum transfer nor Fc{gamma} receptor blockade reverses tumor control, supporting a non-canonical, antibody-independent mechanism. Across independent triple-negative breast cancer cohorts, we find EF-PC hyperplasia in td-LNs and tumors; and within immune-cold cases, EF-PC burden stratifies poor prognosis and metastatic risk. A cross-species EF-PC signature maps to a conserved PC-state across cancer types that is linked to poor outcome and immune-checkpoint blockade resistance. EF-PCs thus relocate the dominant failure point to td-LNs and offer a tractable upstream target to convert immune-cold tumors into immune-responsive disease.
]]></description>
<dc:creator>Alberts, E.</dc:creator>
<dc:creator>Boulat, V.</dc:creator>
<dc:creator>Hung, M. S.</dc:creator>
<dc:creator>Xu, A. Q.</dc:creator>
<dc:creator>Quist, J.</dc:creator>
<dc:creator>Li, M.</dc:creator>
<dc:creator>Liu, F.</dc:creator>
<dc:creator>Wall, I.</dc:creator>
<dc:creator>Verghese, G.</dc:creator>
<dc:creator>Brundin, C. A.</dc:creator>
<dc:creator>Bhalla, A.</dc:creator>
<dc:creator>Jonsson, M.</dc:creator>
<dc:creator>Castellanos, C.</dc:creator>
<dc:creator>Rosekilly, J.</dc:creator>
<dc:creator>GILLETT, C.</dc:creator>
<dc:creator>Staaf, J.</dc:creator>
<dc:creator>e Sousa, C. R.</dc:creator>
<dc:creator>Karagiannis, S.</dc:creator>
<dc:creator>Grigoriadis, A.</dc:creator>
<dc:creator>Calado, D. P.</dc:creator>
<dc:date>2026-04-22</dc:date>
<dc:identifier>doi:10.64898/2026.04.20.719651</dc:identifier>
<dc:title><![CDATA[Extrafollicular plasma cells disable dendritic cell-T-cell priming in tumor-draining lymph nodes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.17.712327?rss=1">
<title>
<![CDATA[
A GABARAP-PtdIns3K-C1 positive feedback loop at the heart of the phagophore nucleation 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.17.712327?rss=1</link>
<description><![CDATA[
Macroautophagy/autophagy is a cellular process enabling degradation of intracellular components during starvation. In mammalian cells, autophagosomes can reach diameters of over 1000 nm within 30 min after triggering starvation, but how such substantial amounts of membranes can be synthesized within a brief time remains elusive. A protein complex central to the phagophore initiation is the lipid kinase PIK3C3-Complex 1 (PtdIns3K-C1), which produces phosphatidylinositol-3-phosphate (PtdIns3P). PtdIns3P recruits a variety of downstream proteins, among which is PtdIns3P-binding WIPI2 that facilitates lipidation of mammalian ATG8 (mATG8) family proteins on phagophores. Here we show that upon inhibition of mATG8 lipidation in cells, there is a decreased accumulation of WIPI2, suggesting a feedback loop between mATG8s and PtdIns3P production. The role of PtdIns3K-C1 in this feedback was demonstrated by in vitro experiments where recombinant membrane-coupled mATG8s bind to and potently activate PtdIns3K-C1, with GABARAP being the most potent activator among all mATG8s. By a combination of cryo-electron microscopy, structural mass spectrometry, activity assays and mutagenesis, we show that GABARAP binds two sites in PtdIns3K-C1, with one site showing an atypical bipartite interaction with the mATG8. We also confirm both sites are essential for GABARAP to activate PtdIns3K-C1. We propose that once GABARAP is indirectly recruited by PtdIns3P generated by basal activity of PtdIns3K-C1, a positive feedback loop is formed where PtdIns3K-C1 interacts with GABARAP and becomes activated to produce more PtdIns3P, thereby further stimulating GABARAP lipidation. This mechanism would be central for autophagosome biogenesis, where enlarged membranes need to be synthesized within a brief period.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/712327v1_ufig1.gif" ALT="Figure 1">
View larger version (25K):
org.highwire.dtl.DTLVardef@1dc398eorg.highwire.dtl.DTLVardef@146a2cborg.highwire.dtl.DTLVardef@69c649org.highwire.dtl.DTLVardef@58fd81_HPS_FORMAT_FIGEXP  M_FIG The GABARAP-PtdIns3K-C1 positive feedback loop.

Model for the GABARAP-PtdIns3K-C1 positive feedback loop. GABARAP is indirectly recruited to the growing phagophore by PtdIns3P and activates PtdIns3K-C1, leading to an increased PtdIns3P production. The E1 (ATG7), E2 (ATG3) and E3 (ATG5-ATG12-ATG16L1) enzymes and WIPI2 are involved in the lipidation (covalent coupling) of GABARAP to membranes.

C_FIG
]]></description>
<dc:creator>Dessus, A. N.</dc:creator>
<dc:creator>Ohashi, Y.</dc:creator>
<dc:creator>Bourguet, M.</dc:creator>
<dc:creator>Morgan, T. E.</dc:creator>
<dc:creator>Nunez, A.</dc:creator>
<dc:creator>Manifava, M.</dc:creator>
<dc:creator>Ktistakis, N. T.</dc:creator>
<dc:creator>Williams, R. L.</dc:creator>
<dc:date>2026-03-18</dc:date>
<dc:identifier>doi:10.64898/2026.03.17.712327</dc:identifier>
<dc:title><![CDATA[A GABARAP-PtdIns3K-C1 positive feedback loop at the heart of the phagophore nucleation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.25.708054?rss=1">
<title>
<![CDATA[
Epigenomic profiling of cerebrospinal fluid cells identifies immune regulatory alterations and implicates protocadherins in multiple sclerosis 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.25.708054?rss=1</link>
<description><![CDATA[
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), where DNA methylation may play a role by connecting genetic and environmental risk factors. We performed whole-genome DNA methylation profiling of cerebrospinal fluid (CSF) cells from relapsing-remitting MS patients and matched controls, identifying 2,710 differentially methylated positions (DMPs) and 4,330 regions (DMRs). These changes were enriched in immune signaling, adhesion and migration processes, and were accompanied by corresponding RNA expression changes. MS-associated methylation changes enriched in the cohesin chromatin regulation pathway mapped to enhancers of T helper 17 (Th17) cells, whereas in other T cell types they were mapping to bivalent enhancers and repressed chromatin. Notably, this pathway comprised multiple Protocadherin (PCDH) genes, typically expressed in neuronal cells, that displayed consistent methylation and expression changes in CSF cells. Expression of shared intracellular domain of PCDH{gamma} cluster proteins was confirmed in peripheral blood T cells by flow cytometry as well as expression of PCDH{gamma} cluster genes in memory CD4+ T cell subsets. Moreover, co-expression analysis suggests a role of PCDH genes in aryl hydrocarbon receptor (AHR) signaling. In summary, DNA methylation changes in CSF resident cells reflect dysregulated T cell activation and migration in MS and suggest a novel role of protocadherin molecules in MS pathogenesis.
]]></description>
<dc:creator>Han, Y.</dc:creator>
<dc:creator>Zheleznyakova, G. Y.</dc:creator>
<dc:creator>Sorini, C.</dc:creator>
<dc:creator>Pahlevan Kakhki, M.</dc:creator>
<dc:creator>Ruffin, N.</dc:creator>
<dc:creator>Liang, H.</dc:creator>
<dc:creator>Hallen, N.</dc:creator>
<dc:creator>Rao Prakash, C.</dc:creator>
<dc:creator>Beckers, V.</dc:creator>
<dc:creator>Ivanova, E.</dc:creator>
<dc:creator>Khademi, M.</dc:creator>
<dc:creator>Karlsson, M. C. I.</dc:creator>
<dc:creator>Piehl, F.</dc:creator>
<dc:creator>Olsson, T.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:creator>Kular, L.</dc:creator>
<dc:creator>Needhamsen, M.</dc:creator>
<dc:creator>Jagodic, M.</dc:creator>
<dc:date>2026-02-27</dc:date>
<dc:identifier>doi:10.64898/2026.02.25.708054</dc:identifier>
<dc:title><![CDATA[Epigenomic profiling of cerebrospinal fluid cells identifies immune regulatory alterations and implicates protocadherins in multiple sclerosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.13.703496?rss=1">
<title>
<![CDATA[
Ubi-SCAPE enables deep exploration of the poly-ubiquitylome 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.13.703496?rss=1</link>
<description><![CDATA[
Post-translational modification with chains of the 76-amino-acid protein ubiquitin ( poly-ubiquitylation) confers diverse fates to the targeted protein and non-protein substrates, including degradation, intracellular trafficking, and signal transduction. Despite being one of the most frequent modifications, the complexity of poly-ubiquitin chains adds methodological challenges to their characterization. Trypsin-resistant tandem-ubiquitin-binding entities (trTUBEs), engineered from natural ubiquitin-binding domains, can capture intact poly-ubiquitylated proteins with high cumulative avidity. However, such approaches have suffered from considerable co-eluting contaminants in proteomics applications. Here, we introduce an optimized trTUBE-based method for poly-ubiquitylated proteome purification, drastically depleting non-ubiquitylated protein contaminants and mono-ubiquitylated proteins. The method, termed Ubiquitylomics by Stringent, Cleavable, Affinity-based Proteome Extraction (Ubi-SCAPE), offers a streamlined and reproducible (median R2 > 0.98; CV < 8%) means of characterizing the poly-ubiquitylome. Over 7,800 poly-ubiquitylated proteins and 8,500 ubiquitin-modified peptides (diGly) were quantified with Ubi-SCAPE at a throughput of 40 samples per day, as well as over 6,000 from an equivalent of 33 g unstressed cell lysate. Upon acute stress by heat-shock, we identified 2,700 proteins and 8,000 diGly peptides with increased poly-ubiquitylation--offering similar biological insight as with far more material-, labor-, and cost-intensive peptide-based ubiquitin enrichment methods. Ubi-SCAPE therefore provides a simple and effective means of comprehensively quantifying a selective-enriched poly-ubiquitylome.

GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/703496v1_ufig1.gif" ALT="Figure 1">
View larger version (51K):
org.highwire.dtl.DTLVardef@a28120org.highwire.dtl.DTLVardef@cb801aorg.highwire.dtl.DTLVardef@47577aorg.highwire.dtl.DTLVardef@1c030af_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Johnston, H. E.</dc:creator>
<dc:creator>Frey, A.</dc:creator>
<dc:creator>Barve, G.</dc:creator>
<dc:creator>Carling, S.</dc:creator>
<dc:creator>Trost, M.</dc:creator>
<dc:creator>Samant, R. S.</dc:creator>
<dc:date>2026-02-15</dc:date>
<dc:identifier>doi:10.64898/2026.02.13.703496</dc:identifier>
<dc:title><![CDATA[Ubi-SCAPE enables deep exploration of the poly-ubiquitylome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.02.703435?rss=1">
<title>
<![CDATA[
Expression and role of the RNA-binding protein, ZFP36L1, in mouse T follicular helper cell differentiation and function 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.02.703435?rss=1</link>
<description><![CDATA[
T follicular helper (Tfh) cells are critical for germinal centers (GC), the specialised microenvironment where long-lived humoral immunity is generated in response to vaccination or infection. Within the GC, B cells engage with Tfh cells and elicit their help in the form of cytokines and cell-surface co-stimulator molecules. Tfh helper activity must be rapidly available in response to B cell engagement, yet the mechanisms controlling this helper activity remain poorly characterized. Post-transcriptional regulation of mRNA decay and translation offer one way to rapidly and temporally tune Tfh cell activity. ZFP36L1, a member of the ZFP family of RNA-binding proteins, is a candidate modulator of Tfh cell helper activity as it controls cytokine production and responses in other T cell lineages, modulating their differentiation and function. We sought to determine if ZFP36L1 is also important for Tfh cell biology. In this study, we show expression of ZFP36L1 by Tfh cells. We selectively delete ZFP36L1 from Tfh cells and analyze the effect this has on the GCs. Surprisingly, we find the GC response and affinity maturation is resilient to deletion of ZFP36L1 from Tfh cells.
]]></description>
<dc:creator>Carslaw, H. A.</dc:creator>
<dc:creator>Woolliscroft, S.</dc:creator>
<dc:creator>Watson, E. M.</dc:creator>
<dc:creator>Bell, S. E.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:creator>Webb, L. M. C.</dc:creator>
<dc:date>2026-02-05</dc:date>
<dc:identifier>doi:10.64898/2026.02.02.703435</dc:identifier>
<dc:title><![CDATA[Expression and role of the RNA-binding protein, ZFP36L1, in mouse T follicular helper cell differentiation and function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.30.702770?rss=1">
<title>
<![CDATA[
Antigen accumulation in the B cell follicle is impaired in aged mice 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.30.702770?rss=1</link>
<description><![CDATA[
Vaccine responses are impaired in aged mice and older people. An essential early step in mounting successful responses to vaccines is the delivery of antigens from the site of injection to the draining lymph node. This study tested the hypothesis that particle drainage to the lymph node is impaired in older mice after intramuscular injection. We observed fewer 20nm nanoparticles in the B cell follicle of the draining lymph node in aged mice after intramuscular injection. However, there was no significant difference in the abundance of larger 1000nm particles in the lymph nodes of aged mice, which are typically transported to the lymph node by antigen presenting cells. This data suggests that access of smaller antigens to the B cell follicle is impaired in ageing and may have implications for the initiation of T and B cell responses after vaccination.
]]></description>
<dc:creator>Ge, X.</dc:creator>
<dc:creator>Fra-Bido, S.</dc:creator>
<dc:creator>Innocentin, S.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:creator>Webb, L. M.</dc:creator>
<dc:date>2026-02-02</dc:date>
<dc:identifier>doi:10.64898/2026.01.30.702770</dc:identifier>
<dc:title><![CDATA[Antigen accumulation in the B cell follicle is impaired in aged mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.21.700774?rss=1">
<title>
<![CDATA[
CASM potentiates STING-driven NFκB signaling in immune cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.21.700774?rss=1</link>
<description><![CDATA[
Stimulator of Interferon Gene (STING), a key player of antimicrobial immune responses, has emerged as a promising target to mitigate inflammation and cancer. Following STING activation, proinflammatory molecules and type I Interferons (IFN) are released thus favoring the establishment of effective immune responses and adaptive immunity. Autophagy has been proposed to negatively regulate STING signaling. While STING activation drives microtubule-associated proteins 1A/1B light chain 3B (hereafter referred to as LC3) lipidation, the underlying mechanisms and functional consequences remain however incompletely defined. Especially, the consequences of STING-associated Conjugation of autophagy related (ATG) 8 to Single Membranes (CASM) in the control of immune responses remain elusive. Using innate and adaptive cells specifically inactivated for autophagy or CASM, we found that STING agonists primarily trigger CASM over autophagy. While STING-associated autophagy exerts negative feedback on the STING pathway and downstream type I IFN and pro-inflammatory responses, with different underlying molecular mechanisms between immune cells, STING-driven CASM potentiates NF{kappa}B-associated TNF production. These results overall uncover a new function of CASM and underscore the relevance of both CASM and autophagy in shaping STING signaling
]]></description>
<dc:creator>Benoit-Lizon, I.</dc:creator>
<dc:creator>Pignol, C.</dc:creator>
<dc:creator>Hooper, K.</dc:creator>
<dc:creator>Truntzer, C.</dc:creator>
<dc:creator>Radoua, A.</dc:creator>
<dc:creator>Dal Zuffo, L.</dc:creator>
<dc:creator>Lucas, J.</dc:creator>
<dc:creator>Frenger, Q.</dc:creator>
<dc:creator>Ponsardin, E.</dc:creator>
<dc:creator>Cornebise, C.</dc:creator>
<dc:creator>Cantaloube, I.</dc:creator>
<dc:creator>Ratier, A.</dc:creator>
<dc:creator>Aucagne, R.</dc:creator>
<dc:creator>Hermetet, F.</dc:creator>
<dc:creator>Shahoei, S. H.</dc:creator>
<dc:creator>Nelson, E. R.</dc:creator>
<dc:creator>Limagne, E.</dc:creator>
<dc:creator>Poüs, C.</dc:creator>
<dc:creator>Delomenie, C.</dc:creator>
<dc:creator>Soulas-Sprauel, P.</dc:creator>
<dc:creator>Gros, F.</dc:creator>
<dc:creator>Vegran, F.</dc:creator>
<dc:creator>Garrido, C.</dc:creator>
<dc:creator>Ghiringhelli, F.</dc:creator>
<dc:creator>Paul, C.</dc:creator>
<dc:creator>Florey, O.</dc:creator>
<dc:creator>Jacquin, E.</dc:creator>
<dc:creator>Apetoh, L.</dc:creator>
<dc:date>2026-01-24</dc:date>
<dc:identifier>doi:10.64898/2026.01.21.700774</dc:identifier>
<dc:title><![CDATA[CASM potentiates STING-driven NFκB signaling in immune cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.02.679816?rss=1">
<title>
<![CDATA[
Poising and connectivity of emergent human developmental enhancers in the transition from naive to primed pluripotency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.02.679816?rss=1</link>
<description><![CDATA[
In primed human pluripotent stem cells (hPSCs) resembling post-implantation epiblast, numerous lineage-specific enhancers assume the poised chromatin state, co-marked by H3K4me1 and Polycomb-associated H3K27me3 histone modifications. In contrast, poised enhancers (PEs) are scarce in naive hPSCs that model pre-implantation epiblast. PEs form abundant chromosomal contacts with developmental genes, but when these contacts emerge, how their formation relates to enhancer poising and their functional significance remains incompletely understood. Here, we devise high-resolution, PE-targeted Capture Hi-C to generate a comprehensive atlas of PE chromosomal contacts in the time course of hPSC transition from the naive to primed state. We find that enhancer poising emerges early in the transition, while the contacts show diverse dynamics that is only partially coupled to poising. PROTAC-induced degradation of Polycomb Repressive Complex 2 (PRC2) early in the transition weakens PE connectivity, while inhibition of its H3K27 methyltransferase activity does not, suggesting a non-catalytic role of Polycomb in supporting PE contacts. Notably, PE contacts persist after developmental activation or ectopic CRISPRa targeting and can mediate long-range gene induction. Together, these findings reveal the temporal and mechanistic principles of PE connectivity, highlighting a potential role of PE contacts in establishing gene expression patterns in human development.
]]></description>
<dc:creator>Nocente, M. C.</dc:creator>
<dc:creator>Della Rosa, M.</dc:creator>
<dc:creator>Malcom, A. A.</dc:creator>
<dc:creator>Lister, G.</dc:creator>
<dc:creator>Savin, I.</dc:creator>
<dc:creator>Ray-Jones, H.</dc:creator>
<dc:creator>Elderkin, S.</dc:creator>
<dc:creator>Tian, R.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Bendall, A.</dc:creator>
<dc:creator>Semprich, C. I.</dc:creator>
<dc:creator>Kampmann, M.</dc:creator>
<dc:creator>Malysheva, V.</dc:creator>
<dc:creator>Rostovskaya, M.</dc:creator>
<dc:creator>Rugg-Gunn, P.</dc:creator>
<dc:creator>Spivakov, M.</dc:creator>
<dc:date>2025-10-03</dc:date>
<dc:identifier>doi:10.1101/2025.10.02.679816</dc:identifier>
<dc:title><![CDATA[Poising and connectivity of emergent human developmental enhancers in the transition from naive to primed pluripotency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.24.678222?rss=1">
<title>
<![CDATA[
Differential regulation of TCR-induced ZFP36 and ZFP36L1 expression by cyclosporin A in CD8+ T cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.24.678222?rss=1</link>
<description><![CDATA[
CD8+ T cells target infected or malignant cells via the production of pro-inflammatory cytokines and direct target cell killing. Members of the ZFP36-family of RNA binding proteins, ZFP36 and ZFP36L1 regulate these functions in T cells via the regulation of mRNA stability and protein translation. We investigate the regulation of ZFP36 and ZFP36L1 expression using in vitro differentiated OT1 TCR transgenic memory-like T cells. We characterise the differential kinetics and sensitivity of ZFP36 and ZFP36L1 to antigen affinity and PMA versus ionomycin stimulation. By selectively inhibiting TCR-induced signalling pathways, we find that p38 MAPK, MEK1/2 and PKC contribute to inducing both ZFP36 and ZFP36L1 expression. By contrast, inhibition of calcineurin using cyclosporin A potently inhibits ZFP36L1 expression while increasing and prolonging ZFP36 expression. The Zfp36 promoter contains many binding sites for the transcription factors ELK-1/4 and few binding sites for NFAT, while the Zfp36l1 promoter contains many NFAT binding sites and few ELK1/4 binding sites. Our findings suggest that regulation of divergent transcription factors enable calcineurin to act as a signalling node that mediates the differential regulation of ZFP36 and ZFP36L1 during T cell activation.
]]></description>
<dc:creator>Turner, M.</dc:creator>
<dc:creator>Petkau, G.</dc:creator>
<dc:creator>Mitchell, T.</dc:creator>
<dc:creator>Zaucha, M.</dc:creator>
<dc:creator>Jones Evans, M.</dc:creator>
<dc:date>2025-09-29</dc:date>
<dc:identifier>doi:10.1101/2025.09.24.678222</dc:identifier>
<dc:title><![CDATA[Differential regulation of TCR-induced ZFP36 and ZFP36L1 expression by cyclosporin A in CD8+ T cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.09.675154?rss=1">
<title>
<![CDATA[
A post-transcriptional regulatory checkpoint controls the response of tumor-infiltrating cytotoxic CD4+ T cells to immunotherapy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.09.675154?rss=1</link>
<description><![CDATA[
Acquisition of cytotoxic activity in CD4+ T cells (TCTX) can promote potent anti-tumor activity thus holding promise as a therapeutic approach. However, how this activity is regulated remains poorly understood. Here, we demonstrate that tumor-infiltrating CD4+ TCTX activity is restrained by a post-transcriptional regulatory checkpoint. In untreated tumors, CD4+ TCTX exist in a poised state, characterized by abundant Gzmb mRNA but limited Granzyme B (GzmB) protein. Differentiation into poised TCTX is regulated by the Blimp-1-Bcl6 axis and requires type-I interferon signaling. Treatment with anti-CTLA-4 or anti-LAG-3 plus anti-PD-1 removed the block to GzmB protein production by repressing expression of the post-transcriptional regulator Zfp36l1. Constitutive Zfp36l1 expression abrogated the effects of anti-CTLA-4 while deletion of Zfp36l1 and its paralog Zfp36 triggered GzmB protein production and promoted tumor control. These data identify ZFP36/ZFP36L1 as a key post-transcriptional regulatory checkpoint of CD4+ TCTX activity and a potential immunotherapy target in cancer.
]]></description>
<dc:creator>Vila de Mucha, M.</dc:creator>
<dc:creator>Hlond, J.</dc:creator>
<dc:creator>Costoya, C.</dc:creator>
<dc:creator>Lau, C.-I.</dc:creator>
<dc:creator>Sledzinska, A.</dc:creator>
<dc:creator>Uddin, I.</dc:creator>
<dc:creator>Navarrete, M.</dc:creator>
<dc:creator>Shah, M.</dc:creator>
<dc:creator>Mastrokalos, G.</dc:creator>
<dc:creator>Karagianni, D.</dc:creator>
<dc:creator>Bell, S. E.</dc:creator>
<dc:creator>Nattress, C.</dc:creator>
<dc:creator>Beattie, G.</dc:creator>
<dc:creator>Tape, C. J.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:creator>Quezada, S. A.</dc:creator>
<dc:creator>Jenner, R. G.</dc:creator>
<dc:date>2025-09-12</dc:date>
<dc:identifier>doi:10.1101/2025.09.09.675154</dc:identifier>
<dc:title><![CDATA[A post-transcriptional regulatory checkpoint controls the response of tumor-infiltrating cytotoxic CD4+ T cells to immunotherapy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.07.674107?rss=1">
<title>
<![CDATA[
Declining intracellular proteostasis capacity drives misfolded protein secretion in senescent human cells. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.07.674107?rss=1</link>
<description><![CDATA[
Healthy protein homeostasis ( proteostasis) relies on tightly-regulated protein quality-control (PQC) circuits that co-ordinate sequestration and clearance of potentially toxic aggregation-prone proteins, arising from various internal or external stress throughout an organisms lifespan. At the protein level, proteotoxic stress responses typically involve extensive poly-ubiquitylation and sequestration of aggregation-prone proteins and PQC factors into various protective cytoplasmic and nuclear granules. However, much of our current understanding regarding this aspect of stress responses in humans stems from research in proliferating cells--despite growing evidence that stress responses vary considerably at the transcriptional level across cell proliferation states. Here, we show that the senescent cellular state--considered a major contributor to ageing-associated degeneration due to a chronic inflammatory phenotype--re-wires PQC and expels the misfolded protein load to mitigate proteotoxic stresses. Starting with a multi-dimensional transcriptomics and proteomics approach for measuring levels of total, poly-ubiquitylated, and granule-forming proteins, we have discovered a clear point of divergence between senescent and proliferating or quiescent human cell states in their responses to proteotoxic stress. Although the proteins that were poly-ubiquitylated and degraded during stress were largely conserved across states, the stress-induced sedimentation of a large number of disease-associated RNA-binding proteins (including TDP-43) was impaired only in the senescent state. Strikingly, TDP-43, as well as several other misfolded proteins, were actively secreted through the endo-lysosomal system by a diverse range of senescent cells during acute or chronic stress, through a process that requires the vesicle-associated HSP70 co-chaperone DNAJC5--an established risk factor for several neurodegenerative diseases. Misfolded protein secretion could be rescued by increasing intracellular HSP levels in  shallow but not  deep senescence, suggesting that secretion is a proteostatic adaptation that becomes less reversible over time. Our findings reveal an unappreciated aspect of the senescent-cell secretory phenotype, which may have important consequences for the non-cell-autonomous impact of senescence at the level of tissue resilience and frailty.
]]></description>
<dc:creator>Watts, T.</dc:creator>
<dc:creator>Johnston, H. E.</dc:creator>
<dc:creator>Al-Mufti, Y.</dc:creator>
<dc:creator>Odle, R. I.</dc:creator>
<dc:creator>Hodgson, R.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Carr, H.</dc:creator>
<dc:creator>Cranwell, S.</dc:creator>
<dc:creator>Wu, E.</dc:creator>
<dc:creator>Walker, S.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Shelkovnikova, T.</dc:creator>
<dc:creator>Samant, R. S.</dc:creator>
<dc:date>2025-09-08</dc:date>
<dc:identifier>doi:10.1101/2025.09.07.674107</dc:identifier>
<dc:title><![CDATA[Declining intracellular proteostasis capacity drives misfolded protein secretion in senescent human cells.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.30.673054?rss=1">
<title>
<![CDATA[
Lactate Blocks Tertiary Lymphoid Structure Formation by Inhibiting B Cell Chemotaxis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.30.673054?rss=1</link>
<description><![CDATA[
Tertiary lymphoid structures (TLS) and B cell infiltration are strong predictors of immunotherapy success across cancers, including triple-negative breast cancer (TNBC). However, immune-cold TNBCs often lack both features. Here, we identify a tumor-intrinsic mechanism that actively suppresses B cell recruitment. Despite evidence of B cell responses in cancer-associated lymph nodes (cLNs), B cells fail to infiltrate TNBC tumors or form TLS. This exclusion is not simply due to chemokine deficiency as exogenous chemokine addition fails to restore B cell migration. Using fractionation and metabolic profiling, we identify lactate as a dominant tumor-secreted metabolite that directly impairs B cell chemotaxis by disrupting mitochondrial metabolism. In vivo, combining lactate inhibition with engineered chemokine secretion promotes cLN-derived B cell infiltration and enables TLS formation, particularly when coupled with CD40 stimulation. Transcriptomics analyses across several human cancer datasets strengthen the association between high glycolytic activity with poor B-cell infiltration in chemokine-rich tumors. Together, our findings reveal lactate as a key metabolic barrier to B cell trafficking and TLS induction, suggesting that metabolic reprogramming may provide an avenue to convert "immune-cold" tumors into TLS-rich, immunologically responsive microenvironments.
]]></description>
<dc:creator>Calado, D. P.</dc:creator>
<dc:creator>Boulat, V.</dc:creator>
<dc:creator>Alberts, E.</dc:creator>
<dc:creator>Driscoll, P. C.</dc:creator>
<dc:creator>Hung, M. S.</dc:creator>
<dc:creator>Cunha, A.</dc:creator>
<dc:creator>Quist, J.</dc:creator>
<dc:creator>Liu, F.</dc:creator>
<dc:creator>Brundin, C. A.</dc:creator>
<dc:creator>Bhalla, A.</dc:creator>
<dc:creator>Avalle, L.</dc:creator>
<dc:creator>Rosekilly, J.</dc:creator>
<dc:creator>Ryan, L.</dc:creator>
<dc:creator>Gillett, C.</dc:creator>
<dc:creator>Strom, M.</dc:creator>
<dc:creator>Poli, V.</dc:creator>
<dc:creator>MacRae, J. I.</dc:creator>
<dc:creator>Grigoriadis, A.</dc:creator>
<dc:date>2025-09-04</dc:date>
<dc:identifier>doi:10.1101/2025.08.30.673054</dc:identifier>
<dc:title><![CDATA[Lactate Blocks Tertiary Lymphoid Structure Formation by Inhibiting B Cell Chemotaxis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.28.672833?rss=1">
<title>
<![CDATA[
Towards active vaccination against tumour endothelial marker Robo4 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.28.672833?rss=1</link>
<description><![CDATA[
Targeting tumour antigens is a major challenge in cancer-immunotherapy. We use active vaccination to induce antibodies targeting self-antigen Robo4, which is selectively expressed on tumour vascular endothelium, supporting vascular development. Our previous work showed that a conjugate of Robo4 with a foreign carrier protein can induce autoantibodies specific to Robo4, which inhibited angiogenesis and tumour growth. The current project aims to translate the vaccine protocol to exploit a carrier protein used in routine human vaccination schedules. The well-characterised, non-toxic fragment C of tetanus toxin (TTc) was selected as the carrier protein. Here we show that priming with the carrier TTc followed by boost with Robo4-TTc (R4-TTc) efficiently induces strong antibody responses to Robo4 and inhibits tumour growth in LLC1 and 4T1 tumour models. The growth inhibition was correlated with anti-Robo4 IgG1 titres. Furthermore, we observed decreased vessel formation and increased immune cell infiltration in tumours from R4-TTc vaccinated mice in the absence of detectable adverse effects on health. The data indicate that this vaccination strategy remodels tumour vessels and probably promotes immunogenic pathway activation, therefore repressing tumour growth.

One Sentence SummaryA conjugate vaccine inducing antibody responses to tumour endothelial markers Robo4 can inhibit tumour growth.
]]></description>
<dc:creator>Escobar-Riquelme, F. N.</dc:creator>
<dc:creator>Kara, M. A.</dc:creator>
<dc:creator>Price, M.</dc:creator>
<dc:creator>Hidalgo-Gajardo, A.</dc:creator>
<dc:creator>Carr, H.</dc:creator>
<dc:creator>Bending, D.</dc:creator>
<dc:creator>Bicknell, R.</dc:creator>
<dc:creator>Savelyeva, N.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Toellner, K.-M.</dc:creator>
<dc:date>2025-09-02</dc:date>
<dc:identifier>doi:10.1101/2025.08.28.672833</dc:identifier>
<dc:title><![CDATA[Towards active vaccination against tumour endothelial marker Robo4]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.18.660429?rss=1">
<title>
<![CDATA[
Tissue-specific consequences of tag fusions on protein expression in transgenic mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.18.660429?rss=1</link>
<description><![CDATA[
Genetic fusion of protein tags is widely used to study protein functions in vivo. It is well known that tag fusion can cause unwanted changes in protein stability, but whether this is an inherent property of the tagged protein, or can be influenced by the cell and tissue environment, is unclear. Using a series of genome edited mouse models, we show that tag-dependent changes in protein expression can vary across different primary cell and tissue contexts. In one case (Ncaph2), a C-terminal auxin-inducible degron fusion strongly increased protein stability in some tissues but decreased it in others. Destabilisation resulted from tissue-specific  leakage of the auxin-inducible degron, which depended on TIR1 expression, and occurred selectively in the small intestine where basal concentrations of auxin / indole-3-acetic acid can reach levels that are sufficient to trigger protein degradation in cultured cells. Stabilisation occurred in post-mitotic cells via an endogenous degradation signal situated at the Ncaph2 C-terminus, which normally undergoes activation upon cell cycle exit, but is inactivated by C-terminal tag fusion. Our results highlight the underappreciated importance of cell and tissue environment in determining the consequences of tag fusions on protein expression, which may be particularly important in animal models that contain diverse cell types.
]]></description>
<dc:creator>Taylor, G. C.</dc:creator>
<dc:creator>Macdonald, L.</dc:creator>
<dc:creator>Szulc, N. A.</dc:creator>
<dc:creator>Gudauskaite, E.</dc:creator>
<dc:creator>Moran, B. H.</dc:creator>
<dc:creator>Brisbane, J. M.</dc:creator>
<dc:creator>Donald, M.</dc:creator>
<dc:creator>Taylor, E.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Gu, B.</dc:creator>
<dc:creator>Mill, P.</dc:creator>
<dc:creator>Yeyati, P. L.</dc:creator>
<dc:creator>Pokrzywa, W.</dc:creator>
<dc:creator>de Almeida, C. R.</dc:creator>
<dc:creator>Wood, A. J.</dc:creator>
<dc:date>2025-06-18</dc:date>
<dc:identifier>doi:10.1101/2025.06.18.660429</dc:identifier>
<dc:title><![CDATA[Tissue-specific consequences of tag fusions on protein expression in transgenic mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.09.658559?rss=1">
<title>
<![CDATA[
TrAEL-seq captures DNA replication dynamics in mammalian cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.09.658559?rss=1</link>
<description><![CDATA[
Precise DNA replication is critical to the maintenance of genome stability, and the DNA replication machinery is a focal point of many current and upcoming chemotherapeutics. TrAEL-seq is a robust method for profiling DNA replication genome-wide that works in unsynchronised cells and does not require treatment with drugs or nucleotide analogues. Here, we provide an updated method for TrAEL-seq including multiplexing of up to 6 samples that dramatically improves sample quality and throughput, and we validate TrAEL-seq in multiple mammalian cell lines. The updated protocol is straightforward and robust yet provides excellent resolution comparable to OK-seq in mammalian cell samples. High resolution replication profiles can be obtained across large panels of samples and in dynamic systems, for example during the progressive onset of oncogene induced senescence. In addition to mapping zones where replication initiates and terminates, TrAEL-seq is sensitive to replication fork speed, revealing effects of both transcription and proximity to replication Initiation Zones on fork progression. Although forks move more slowly through transcribed regions, this does not have a significant impact on the broader dynamics of replication fork progression, which is dominated by rapid fork movement in long replication regions (>1Mb). Short and long replication regions are not intrinsically different, and instead replication forks accelerate across the first [~]1 Mb of travel such that forks progress faster in the middle of regions lying between widely spaced Initiation Zones. We propose that this is a natural consequence of fewer replication forks being active later in S phase when these distal regions are replicated and there being less competition for replication factors.
]]></description>
<dc:creator>Kara, N.</dc:creator>
<dc:creator>Biggins, L.</dc:creator>
<dc:creator>Grinkevich, V.</dc:creator>
<dc:creator>Whale, A.</dc:creator>
<dc:creator>Garran Garcia, P.</dc:creator>
<dc:creator>Srinivasan, J.</dc:creator>
<dc:creator>Rugg-Gunn, P.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Parry, A.</dc:creator>
<dc:creator>Robinson, H. M. R.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:date>2025-06-11</dc:date>
<dc:identifier>doi:10.1101/2025.06.09.658559</dc:identifier>
<dc:title><![CDATA[TrAEL-seq captures DNA replication dynamics in mammalian cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.01.657118?rss=1">
<title>
<![CDATA[
Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.01.657118?rss=1</link>
<description><![CDATA[
Enhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programmes. However recent findings indicate that approaches to identify enhancers may not capture the full repertoire of active enhancers in mammalian genomes. Here, we combine massively parallel enhancer assays with chromatin structure and transcriptome profiling to functionally annotate enhancers genome-wide in human induced pluripotent stem cells. We find that a substantial fraction ([~]40%) of accessible chromatin regions with enhancer function lack key features associated with active enhancers, including the active enhancer mark histone H3 lysine 27 acetylation and enhancer-associated RNAs. Perturbation of this class of non-canonical enhancers by CRISPR-mediated epigenome editing results in decreased levels of target gene expression and, in one instance, loss of pluripotent stem cell characteristics. Collectively, our data demonstrate enhancer activity for a class of gene regulatory elements that had until now only been associated with a neutral or inactive status, challenging current models of enhancer function.
]]></description>
<dc:creator>Cao, Y.</dc:creator>
<dc:creator>Dovgusha, O.</dc:creator>
<dc:creator>Ebrahimi, A.</dc:creator>
<dc:creator>Bevan, S.</dc:creator>
<dc:creator>Widmer, L.</dc:creator>
<dc:creator>Torabi, F.</dc:creator>
<dc:creator>Kurlovich, J.</dc:creator>
<dc:creator>Rodriguez-Polo, I.</dc:creator>
<dc:creator>Khan, S.</dc:creator>
<dc:creator>Patel, M.</dc:creator>
<dc:creator>Pradeepa, M. M.</dc:creator>
<dc:creator>Guenesdogan, U.</dc:creator>
<dc:creator>Schoenfelder, S.</dc:creator>
<dc:date>2025-06-01</dc:date>
<dc:identifier>doi:10.1101/2025.06.01.657118</dc:identifier>
<dc:title><![CDATA[Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.30.651421?rss=1">
<title>
<![CDATA[
Mucosal B cell memory selection integrates tissue-specific microbial cues via the IgA BCR 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.30.651421?rss=1</link>
<description><![CDATA[
B cells engender plasma cells (PCs) and memory B cells (MBCs) to combat recurrent pathogens. While B cell receptor (BCR) affinity dictates fate decisions in clonally-restricted set-ups, the driving factors in more complex systems remain unknown. Here, we show that memory selection during mucosal infection is imprinted by inherent cues from barrier tissues: lungs skew selection towards MBCs while the gut favors PC entry, even in response to the same pathogen. This divergence is linked to differential BCR isotype usage across barrier tissues rather than to affinity. In the gut, the commensal-induced TGF-{beta}-rich milieu promotes B cell class-switching to IgA. Consequently, the IgA BCR bias selection towards PCs, a process that is counteracted by its cytosolic tail domain. Overall, mucosal B cell selection integrates tissue-specific cues by strongly relying on BCR isotype usage rather than affinity, with implications for nasal and oral vaccine development.

One sentence summaryDivergent B cell memory strategies evolved in lung and gut mucosa to counteract recurrent pathogens.
]]></description>
<dc:creator>Holgado, M. P.</dc:creator>
<dc:creator>Origlio, S.</dc:creator>
<dc:creator>Bertoia, L.</dc:creator>
<dc:creator>Moussa, M.</dc:creator>
<dc:creator>Trivedi, A.</dc:creator>
<dc:creator>Fiore, F.</dc:creator>
<dc:creator>Zarubica, A.</dc:creator>
<dc:creator>Slack, E.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:creator>Cogne, M.</dc:creator>
<dc:creator>Gregoire, C.</dc:creator>
<dc:creator>GAYA, M.</dc:creator>
<dc:date>2025-05-05</dc:date>
<dc:identifier>doi:10.1101/2025.04.30.651421</dc:identifier>
<dc:title><![CDATA[Mucosal B cell memory selection integrates tissue-specific microbial cues via the IgA BCR]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.27.650842?rss=1">
<title>
<![CDATA[
Pervanadate-induced oxidation relieves autoinhibition of SRC protein tyrosine kinase 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.27.650842?rss=1</link>
<description><![CDATA[
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by phosphatases (PTPs) and kinases enables cells to sense and respond to environmental changes. The widely used chemical probe Pervanadate (PV) induces accumulation of high levels of pTyr in cells, an effect primarily attributed to its properties as a PTP inhibitor. This led to the assertion that PTPs are the master gatekeeper of intracellular pTyr homeostasis. Here, we use diverse approaches to reveal that PV disrupts cellular redox homeostasis and directly activates SRC family tyrosine kinases via oxidation of specific cysteine residues. Using mass spectrometry and biophysical approaches, we show that oxidation activates SRC by disrupting autoinhibition and altering phosphopeptide binding by its SH2 domain. We further establish that redox-sensitive cysteine residues are essential for SRC to promote cellular overgrowth. Our findings call for a re-evaluation of PV-based experiments and provide compelling evidence that oxidation is a crucial mechanism in controlling the oncogenic properties of SRC.
]]></description>
<dc:creator>Mulholland, K. E.</dc:creator>
<dc:creator>Bourguet, M.</dc:creator>
<dc:creator>Cheng, N.</dc:creator>
<dc:creator>Rahman, O.</dc:creator>
<dc:creator>Ezerina, D.</dc:creator>
<dc:creator>Daly, L. A.</dc:creator>
<dc:creator>Lai, T.</dc:creator>
<dc:creator>Casanova, S. A.</dc:creator>
<dc:creator>Creixell, P.</dc:creator>
<dc:creator>Eyers, C.</dc:creator>
<dc:creator>Eyers, P.</dc:creator>
<dc:creator>Messens, J.</dc:creator>
<dc:creator>Byrne, D.</dc:creator>
<dc:creator>Sharpe, H.</dc:creator>
<dc:date>2025-04-27</dc:date>
<dc:identifier>doi:10.1101/2025.04.27.650842</dc:identifier>
<dc:title><![CDATA[Pervanadate-induced oxidation relieves autoinhibition of SRC protein tyrosine kinase]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.07.647564?rss=1">
<title>
<![CDATA[
VH-replacement shapes the antibody repertoire by targeting non-pairing heavy-chains 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.07.647564?rss=1</link>
<description><![CDATA[
The diversity of antibodies underpins robust immune responses. During the formation of the antibody repertoire in early bone marrow B-cells, random antibody heavy-chain proteins are generated from recombined V, D and J gene-segments. Many are non- functional and are negatively selected. Critically, this phase of development is impacted by ageing and inflammation. To understand this process in normal mice we have undertaken the first in-depth analysis of heavy-chain selection at this  pre-B cell transition. We find independent selection acting on three regions of the CDR3 antigen binding site, with particularly heavy counter-selection of certain productive VH/JH combinations. This led us to hypothesise that VH-replacement is targeting productive VDJ rearrangements that cannot pair with the surrogate light-chain (SLC). We detect VH-replacement recombination products that closely follow the pattern of counter- selection of productive VDJ. This reveals a physiological role for VH-replacement: the developmental release of B-cells that are stalled, with a productive but not SLC-pairing VDJ, leading to re-modelling of the early VDJ repertoire toward locus-distal VH that we show are more tolerant of CDR3 composition.
]]></description>
<dc:creator>White, H. N.</dc:creator>
<dc:creator>Chovanec, P.</dc:creator>
<dc:creator>Biggins, L.</dc:creator>
<dc:creator>French, E. C.</dc:creator>
<dc:creator>Bullen, G.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Corcoran, A. E.</dc:creator>
<dc:date>2025-04-11</dc:date>
<dc:identifier>doi:10.1101/2025.04.07.647564</dc:identifier>
<dc:title><![CDATA[VH-replacement shapes the antibody repertoire by targeting non-pairing heavy-chains]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.25.645097?rss=1">
<title>
<![CDATA[
RAB5c controls the assembly of non-canonical autophagy machinery to promote phagosome maturation and microbicidal function of macrophages 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.25.645097?rss=1</link>
<description><![CDATA[
Non-canonical conjugation of ATG8 proteins, including LC3, to single membranes implicates the autophagy machinery in cell functions unrelated to metabolic stress. One such pathway is LC3-associated phagocytosis (LAP), which aids in phagosome maturation and subsequent signaling upon cargo uptake mediated by certain innate immunity-associated receptors. Here, we show that a specific isoform of RAB5 GTPases, the molecular switches controlling early endosome traffic, is necessary for LAP. We demonstrate that RAB5c regulates phagosome recruitment and function of complexes required for phosphatidylinositol-3-phosphate [PI(3)P] and reactive oxygen species (ROS) generation by macrophages. RAB5c facilitates phagosome translocation of the V-ATPase transmembrane core, which is needed for ATG16L1 binding and consequent LC3 conjugation. RAB5c depletion impaired macrophage elimination of the fungal pathogen Aspergillus fumigatus and disruption of the V-ATPase-ATG16L1 axis increased susceptibility in vivo. Therefore, early endosome-to-phagosome traffic is differentially regulated to promote LAP and ROS contributes to resistance against A. fumigatus by effecting LAP.

HIGHLIGHTSO_LIRAB5c is required for LC3-associated phagocytosis
C_LIO_LIRAB5c finetunes NAPDH oxidase assembly and ROS generation in the phagosome
C_LIO_LIRAB5c regulates V-ATPase assembly on the phagosome
C_LIO_LIRAB5c and V-ATPase-ATG16L1 axis are required for the killing of A. fumigatus
C_LI
]]></description>
<dc:creator>Freitas-Filho, E. G.</dc:creator>
<dc:creator>Zaidan, I.</dc:creator>
<dc:creator>Fortes-Rocha, M.</dc:creator>
<dc:creator>Alzamora-Terrel, D. L.</dc:creator>
<dc:creator>Bifano, C.</dc:creator>
<dc:creator>Castro, P. A.</dc:creator>
<dc:creator>Piraine, R. E. A.</dc:creator>
<dc:creator>Pinzan, C. F.</dc:creator>
<dc:creator>Rezende, C. P.</dc:creator>
<dc:creator>Boada-Romero, E.</dc:creator>
<dc:creator>Almeida, F. B. R.</dc:creator>
<dc:creator>Goldman, G.</dc:creator>
<dc:creator>Florey, O.</dc:creator>
<dc:creator>Cunha, L. D.</dc:creator>
<dc:date>2025-03-28</dc:date>
<dc:identifier>doi:10.1101/2025.03.25.645097</dc:identifier>
<dc:title><![CDATA[RAB5c controls the assembly of non-canonical autophagy machinery to promote phagosome maturation and microbicidal function of macrophages]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.27.645766?rss=1">
<title>
<![CDATA[
Re-engineering of acetyl coenzyme A metabolism prevents senescence in budding yeast 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.27.645766?rss=1</link>
<description><![CDATA[
Although lifespan has long been the focus of ageing research, preventing functional decline late in life is a more pressing societal need. Here, we investigate the basis of senescence and declining fitness during replicative ageing in budding yeast, and describe a metabolic perturbation that preserves late-life fitness even on an unrestricted glucose diet. We show that senescence can be prevented by constitutive activation of AMPK, though only for approximately half the ageing population, and use genetic and functional assays to link this heterogeneous response with differences in cytosolic acetyl coenzyme A (Acetyl-CoA) metabolism. In one class of ageing cell, AMPK activity maintains fitness late-in-life through pathways that transport cytosolic Acetyl-CoA into mitochondria, but AMPK also inhibits fatty acid synthesis which leads to lipid starvation in the other class of ageing cell. Therefore, AMPK activity has both positive and negative effects, but we show that constitutive AMPK activity uncoupled from fatty acid synthesis inhibition (the A2A mutant) suppresses senescence and maintains fitness in both classes of ageing cell. Our findings support a model in which lipid starvation and excess acetyl coenzyme A availability are major drivers of senescence in replicatively aged wild-type yeast. This work shows that ageing is not intrinsically associated with declining fitness, at least in yeast, and that re-engineering highly conserved metabolic pathways allows fitness to be preserved very late in life.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=150 SRC="FIGDIR/small/645766v3_ufig1.gif" ALT="Figure 1">
View larger version (84K):
org.highwire.dtl.DTLVardef@1766b7dorg.highwire.dtl.DTLVardef@18af0cforg.highwire.dtl.DTLVardef@c7b530org.highwire.dtl.DTLVardef@14868de_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Hadj-Moussa, H.</dc:creator>
<dc:creator>Ulusan, M.</dc:creator>
<dc:creator>Horkai, D.</dc:creator>
<dc:creator>Mirza, M. K. A.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:date>2025-03-27</dc:date>
<dc:identifier>doi:10.1101/2025.03.27.645766</dc:identifier>
<dc:title><![CDATA[Re-engineering of acetyl coenzyme A metabolism prevents senescence in budding yeast]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.13.643129?rss=1">
<title>
<![CDATA[
A transcriptional clock of the human pluripotency transition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.13.643129?rss=1</link>
<description><![CDATA[
Developmental timing differs strikingly between mammals. All embryonic and some placental lineages emerge from the pluripotent epiblast in a temporally defined sequence, lasting about two weeks in the human embryo, but only two days in mice. Moreover, the order of lineage segregation and gene expression differ between the species. We used human pluripotent stem cells to recapitulate this window of epiblast development in vitro. Simultaneous profiling of gene expression and chromatin accessibility in single cells revealed a robust, autonomous switch between cell states during this process. We reconstructed the integrative gene regulatory network (GRN) of transcription factors (TFs) and signalling molecules. Notably, this revealed a transcriptional cascade including temporally close positive and distant inhibitory connections. We suggest that this cascade acts as a transcriptional clock and governs the directionality, timing and intrinsic decisions during epiblast development. From individual gene interactions, we derived a mechanistic mathematical model of the transcriptional clock of pluripotency that closely reproduced gene expression dynamics and identified key regulatory connections. Moreover, our model revealed a bistable switch governing the transition, thus translating the GRN inference into an interpretable mechanism. Strikingly, the GRN model derived for humans predicted the acceleration of developmental timing in mice when initialised with mouse-specific expression patterns, yet still leading to a human-like expression state. Therefore, TF levels explain developmental timing, whereas the architecture of the network defines its trajectory. Together, our work provides novel conceptual insights into the intrinsic mechanisms of developmental transitions in the human embryo.

HIGHLIGHTSO_LIThe human pluripotency transition is guided by an intrinsic developmental programme
C_LIO_LIA cascade of transcription factors defines directionality and timing of the pluripotency transition through positive and negative interactions
C_LIO_LITranscription factor levels explain developmental timing
C_LIO_LIThe architecture of the gene regulatory network defines its trajectory
C_LI

GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/643129v1_ufig1.gif" ALT="Figure 1">
View larger version (37K):
org.highwire.dtl.DTLVardef@1faf1aaorg.highwire.dtl.DTLVardef@10053borg.highwire.dtl.DTLVardef@1c76aacorg.highwire.dtl.DTLVardef@12c7b89_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Coussement, L.</dc:creator>
<dc:creator>Ciarchi, M.</dc:creator>
<dc:creator>Kolmogorova, A.</dc:creator>
<dc:creator>De Meyer, T.</dc:creator>
<dc:creator>Rulands, S.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Rostovskaya, M.</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:identifier>doi:10.1101/2025.03.13.643129</dc:identifier>
<dc:title><![CDATA[A transcriptional clock of the human pluripotency transition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.27.640173?rss=1">
<title>
<![CDATA[
Distinct chromatin regulators downmodulate meiotic axis formation and DNA break induction at chromosome ends 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.27.640173?rss=1</link>
<description><![CDATA[
In many organisms, meiotic crossover recombination is suppressed near the extreme ends of chromosomes. Here we show that multiple, often chromosome-specific, suppressive mechanisms with differing ranges contribute to the consistently low enrichment of recombination-promoting axis proteins and downregulation of DNA double-strand breaks (DSBs) within 20 kb of telomeres in Saccharomyces cerevisiae. Suppression of axis proteins is associated with cis-encoded signals and correlates with reduced coding density, although whether this sequence feature actively drives suppression remains to be determined. In addition, axis protein suppression requires the histone methyltransferase Dot1 and the Sir silencing complex. We show that Dot1 suppresses Sir complex activity at least in part independently of its canonical target, H3K79, to downmodulate axis protein deposition near chromosome ends. In parallel, the Sir complex, but not Dot1, suppresses the induction of DSBs at a small number of cryptic hotspots by limiting the openness of promoters, the preferred sites of meiotic DSB formation. Much of the reduced DSB induction near chromosome ends persists in dot1 and sir3 mutants, indicating that additional layers of regulation contribute to the robust reduction of meiotic recombination effectors near chromosome ends.
]]></description>
<dc:creator>Raghavan, A. R.</dc:creator>
<dc:creator>May, K.</dc:creator>
<dc:creator>Subramanian, V. V.</dc:creator>
<dc:creator>Blitzblau, H. G.</dc:creator>
<dc:creator>Patel, N. J.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:creator>Hochwagen, A.</dc:creator>
<dc:date>2025-03-03</dc:date>
<dc:identifier>doi:10.1101/2025.02.27.640173</dc:identifier>
<dc:title><![CDATA[Distinct chromatin regulators downmodulate meiotic axis formation and DNA break induction at chromosome ends]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.20.639225?rss=1">
<title>
<![CDATA[
An Nlrp5-null mutation leads to attenuated de novo methylation in oocytes, accompanied by a significant reduction in DNMT3L 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.20.639225?rss=1</link>
<description><![CDATA[
Nlrp5 encodes a core component of the subcortical maternal complex (SCMC) a cytoplasmic protein structure unique to the mammalian oocyte and cleavage-stage embryo. NLRP5 mutations have been identified in patients presenting with early embryo arrest, recurrent molar pregnancies and imprinting disorders. Correct patterning of DNA methylation over imprinted domains during oogenesis is necessary for faithful imprinting of genes. It was previously shown that oocytes with mutation in the human SCMC gene KHDC3L had globally impaired methylation, indicating that integrity of the SCMC is essential for correct establishment of DNA methylation at imprinted regions. Here, we present a multi-omic analysis of an Nlrp5- null mouse model, which in GV oocytes displays a misregulation of a broad range of maternal proteins, including proteins involved in several key developmental processes. This misregulation likely underlies impaired oocyte developmental competence. Amongst impacted proteins are several epigenetic modifiers, including a substantial reduction in DNMT3L; we show that de novo DNA methylation is attenuated in Nlrp5-null oocytes. This provides evidence for mechanisms leading to downstream misregulation of imprinted genes, which in turn, may result in imprinting syndromes, multi-locus imprinting disturbances (MLID) and hydatidiform moles.
]]></description>
<dc:creator>Nic Aodha, L.</dc:creator>
<dc:creator>Pokhilko, A.</dc:creator>
<dc:creator>Rosen, L. U.</dc:creator>
<dc:creator>Galatidou, S.</dc:creator>
<dc:creator>Walewska, E.</dc:creator>
<dc:creator>Belton, C.</dc:creator>
<dc:creator>Galvao, A.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Nakhuda, A.</dc:creator>
<dc:creator>Mansfield, B.</dc:creator>
<dc:creator>Khan, S.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Barragan, M.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:date>2025-02-23</dc:date>
<dc:identifier>doi:10.1101/2025.02.20.639225</dc:identifier>
<dc:title><![CDATA[An Nlrp5-null mutation leads to attenuated de novo methylation in oocytes, accompanied by a significant reduction in DNMT3L]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.30.635440?rss=1">
<title>
<![CDATA[
The KRAB-Zinc Finger protein ZKSCAN3 represses enhancers via embedded retrotransposons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.30.635440?rss=1</link>
<description><![CDATA[
Gene cis-regulatory sequences are increasingly recognised as containing "domesticated" transposable elements that impact their function. The KRAB Zinc Finger Protein (KZFP) family of transcription factors is typically associated with transposable element silencing through establishment of heterochromatin. Here, using acute protein depletion in embryonic stem cells, we reveal that the KZFP ZKSCAN3 represses enhancer activity through targeting enhancer-embedded retrotransposons and that ZKSCAN3-mediated repression does not rely on the induction of heterochromatin. ZKSCAN3, which exhibits strong genetic association with the neurodevelopmental disorder schizophrenia, operates during neural differentiation and is necessary for proper cell specification and expression of genes that regulate axon guidance, neuronal motility and pathfinding. These findings define ZKSCAN3 as an enhancer regulator and uncover a heterochromatin-independent KZFP. Additionally, they exemplify how a KZFP epigenetically regulates enhancers in a native setting and highlight how transposable elements and their KZFP binders have shaped gene expression networks.
]]></description>
<dc:creator>Moore, D.</dc:creator>
<dc:creator>Wong, E.</dc:creator>
<dc:creator>Arnal, C.</dc:creator>
<dc:creator>Schoenfelder, S. W.</dc:creator>
<dc:creator>Spivakov, M.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Christophorou, M. A.</dc:creator>
<dc:date>2025-01-31</dc:date>
<dc:identifier>doi:10.1101/2025.01.30.635440</dc:identifier>
<dc:title><![CDATA[The KRAB-Zinc Finger protein ZKSCAN3 represses enhancers via embedded retrotransposons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.10.632317?rss=1">
<title>
<![CDATA[
RNA helicase DDX1 regulates germinal centre selection and affinity maturation by promoting tRNA ligase activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.10.632317?rss=1</link>
<description><![CDATA[
Clonal expansion of antigen-specific B-cells defines effective germinal centre responses and is key for the generation of high-affinity antibodies. While positive selection in germinal centres has been associated with anabolic metabolism and cell growth, the downstream drivers of B-cell proliferation are not well understood. Here we report that the RNA helicase DDX1 is required for germinal centre maturation and accrual of dark-zone cellularity. Upon interaction with T-follicular helper cells, DDX1-deficient B-cells upregulate c-MYC but do not clonally expand. We show that positive selection is coupled with an increase in mRNA translation, that is dependent on DDX1. DDX1 endows B-cells with the protein biosynthetic capability that is required for rapid cell proliferation. It does so by modulating the activity of the tRNA ligase complex and tRNA splicing. Our data reveal that mRNA translation efficiency is a key determinant of B-cell fitness during germinal centre responses.
]]></description>
<dc:creator>Kimber, R.</dc:creator>
<dc:creator>Ingelsfield, S.</dc:creator>
<dc:creator>Screen, M.</dc:creator>
<dc:creator>Salerno, F.</dc:creator>
<dc:creator>Matheson, L. S.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Whale, A.</dc:creator>
<dc:creator>Assalaarachchi, J.</dc:creator>
<dc:creator>Stammers, M.</dc:creator>
<dc:creator>Akdeniz, D.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Ribeiro de Almeida, C.</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:identifier>doi:10.1101/2025.01.10.632317</dc:identifier>
<dc:title><![CDATA[RNA helicase DDX1 regulates germinal centre selection and affinity maturation by promoting tRNA ligase activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.08.631917?rss=1">
<title>
<![CDATA[
NF-κB is a Central Regulator of Hypoxia-Induced Gene Expression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.08.631917?rss=1</link>
<description><![CDATA[
Hypoxia is both a physiological and pathological signal in cells. Changes in gene expression play a critical role in the cellular response to hypoxia, enabling cells to adapt to reduced oxygen availability. These changes are primarily mediated by the HIF family of transcription factors, however other transcription factors such as NF-{kappa}B, are also activated by hypoxia. Although NF-{kappa}B is known to be activated by hypoxia, the extent to which NF-{kappa}B contributes to the hypoxic response remains poorly understood. Here, we analysed hypoxia-induced, NF-{kappa}B-dependent gene expression, to define the NF-{kappa}B-dependent hypoxic signature. Our analysis reveals that most genes downregulated by hypoxia require NF-{kappa}B for their repression. We show that although the NF-{kappa}B-mediated hypoxic response may vary between cell types, a core subset of hypoxia-inducible genes requires NF-{kappa}B across multiple cell backgrounds. We demonstrate that NF-{kappa}B is critical for reactive oxygen species (ROS) generation and regulation of genes involved in oxidative phosphorylation under hypoxia. This work highlights NF-{kappa}Bs central role in the hypoxia response and offering new insights into gene expression regulation by hypoxia and NF-{kappa}B.
]]></description>
<dc:creator>Shakir, D.</dc:creator>
<dc:creator>Batie, M.</dc:creator>
<dc:creator>Kwok, C.-S.</dc:creator>
<dc:creator>Kenneth, N. S.</dc:creator>
<dc:creator>Rocha, S.</dc:creator>
<dc:date>2025-01-09</dc:date>
<dc:identifier>doi:10.1101/2025.01.08.631917</dc:identifier>
<dc:title><![CDATA[NF-κB is a Central Regulator of Hypoxia-Induced Gene Expression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.09.627617?rss=1">
<title>
<![CDATA[
H3.1K27M-induced misregulation of the TSK/TONSL-H3.1 pathway causes genomic instability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.09.627617?rss=1</link>
<description><![CDATA[
The oncomutation lysine 27-to-methionine in histone H3 (H3K27M) is frequently identified in tumors of patients with diffuse midline glioma-H3K27 altered (DMG-H3K27a). H3K27M inhibits the deposition of the histone mark H3K27me3, which affects the maintenance of transcriptional programs and cell identity. Cells expressing H3K27M are also characterized by defects in genome integrity, but the mechanisms linking expression of the oncohistone to DNA damage remain mostly unknown. In this study, we demonstrate that expression of H3.1K27M in the model plant Arabidopsis thaliana interferes with post-replicative chromatin maturation mediated by the H3.1K27 methyltransferases ATXR5 and ATXR6. As a result, H3.1 variants on nascent chromatin remain unmethylated at K27 (H3.1K27me0), leading to ectopic activity of TONSOKU (TSK), which induces DNA damage and genomic alterations. Elimination of TSK activity suppresses the genome stability defects associated with H3.1K27M expression, while inactivation of specific DNA repair pathways prevents survival of H3.1K27M-expressing plants. Overall, our results suggest that H3.1K27M disrupts the chromatin-based mechanisms regulating TSK/TONSL activity, which causes genomic instability and may contribute to the etiology of DMG-H3K27a.
]]></description>
<dc:creator>Yuan, W.</dc:creator>
<dc:creator>Huang, Y.-C.</dc:creator>
<dc:creator>LeBlanc, C.</dc:creator>
<dc:creator>Poulet, A.</dc:creator>
<dc:creator>Valsakumar, D.</dc:creator>
<dc:creator>van Wolfswinkel, J. C.</dc:creator>
<dc:creator>Voigt, P.</dc:creator>
<dc:creator>Jacob, Y.</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:identifier>doi:10.1101/2024.12.09.627617</dc:identifier>
<dc:title><![CDATA[H3.1K27M-induced misregulation of the TSK/TONSL-H3.1 pathway causes genomic instability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.01.626220?rss=1">
<title>
<![CDATA[
RNA-binding proteins control the G2-M checkpoint of the germinal centre B cell 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.01.626220?rss=1</link>
<description><![CDATA[
How germinal centre (GC) B cells undergo rapid cell division while maintaining genome stability is poorly understood. Here, we show that the RNA-binding proteins ZFP36L1 and ZFP36L2 act downstream of antigen-sensing and protect GC B cells from replication stress by controlling a cell cycle-related RNA post-transcriptional regulon. ZFP36L1 and ZFP36L2 safeguard faithful completion of mitosis by restraining the expression of CDK1 and cyclin B1, whilst controlling their activity through regulation of a p21-mediated negative feedback loop. In the absence of ZFP36L1 and ZFP36L2, GC B cells arrest in G2-M and die by apoptosis, resulting in curtailed GC responses. This is associated with stalling of the DNA replication fork at active replication initiation zones, which causes replication stress and increased activity of the ATR/CHK1 DNA damage response. Our findings reveal that gene regulation by RNA-binding proteins is essential for a functional G2-M checkpoint to operate in GC B cells.
]]></description>
<dc:creator>Salerno, F.</dc:creator>
<dc:creator>Whale, A.</dc:creator>
<dc:creator>Matheson, L. S.</dc:creator>
<dc:creator>Foster, W.</dc:creator>
<dc:creator>Stammers, M.</dc:creator>
<dc:creator>Bell, S. E.</dc:creator>
<dc:creator>Hidson, D. J.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:creator>Houseley, J. A.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:date>2024-12-05</dc:date>
<dc:identifier>doi:10.1101/2024.12.01.626220</dc:identifier>
<dc:title><![CDATA[RNA-binding proteins control the G2-M checkpoint of the germinal centre B cell]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.08.622602?rss=1">
<title>
<![CDATA[
Pathogenesis and immune response to respiratory coronaviruses in their natural porcine host 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.08.622602?rss=1</link>
<description><![CDATA[
Porcine respiratory coronavirus (PRCV) is a naturally occurring pneumotropic coronavirus in the pig, providing a valuable large animal model to study acute respiratory disease. PRCV pathogenesis and the resulting immune response was investigated in pigs, the natural large animal host. We compared two strains, ISU-1 and 135, which induced differing levels of pathology in the respiratory tract to elucidate the mechanisms leading to mild or severe disease. The 135 strain induced greater pathology which was associated with higher viral load and stronger spike-specific antibody and T cell responses. In contrast, the ISU-1 strain triggered mild pathology with a more balanced immune response and greater abundance of T regulatory cells. A higher frequency of putative T follicular helper cells was observed in animals infected with strain 135 at 11 days post-infection. Single-cell RNA-sequencing of bronchoalveolar lavage revealed differential gene expression in B and T cells between animals infected with 135 and ISU-1 at 1 day post infection. These genes were associated with cell adhesion, migration, and immune regulation. Along with increased IL-6 and IL-12 production, these data suggest that heightened inflammatory responses to the 135 strain may contribute to pronounced pneumonia. Among BAL immune cell populations, B cells and plasma cells exhibited the most gene expression divergence between pigs infected with different PRCV strains, highlighting their potential role in maintaining immune homeostasis in the respiratory tract. These findings indicate the potential of the PRCV model for studying coronavirus induced respiratory disease and identifying mechanisms that determine infection outcomes.

Author summaryUnderstanding how our immune system reacts to respiratory viruses, like SARS-CoV-2, is crucial to developing better treatments. While most COVID-19 infections are mild, some cases lead to severe lung damage, but we do not fully understand why. To study this, we used pigs, which respond more like humans compared to small animals, to explore how the immune system deals with respiratory coronaviruses. We tested two porcine respiratory coronavirus strains that caused different levels of lung damage. The more severe strain triggered a strong immune response and high inflammation, leading to lung pathology similar to that seen in severe COVID-19 cases. By contrast, the milder strain caused a balanced immune response, including more regulatory T cells that help control inflammation. We also found changes in genes related to antibody-producing cells, which may be important for controlling respiratory pathology. Interestingly, changes in immune responses and gene expression lasted long after the virus was cleared, potentially making individuals more vulnerable to future infections - similar to the "long COVID" symptoms seen in people. We propose that this pig model could help us study coronavirus-induced lung damage and test new therapies to prevent severe disease.
]]></description>
<dc:creator>Sedaghat-Rostami, E.</dc:creator>
<dc:creator>Carr, B. V.</dc:creator>
<dc:creator>Yang, L.</dc:creator>
<dc:creator>Keep, S.</dc:creator>
<dc:creator>Lean, F. Z. X.</dc:creator>
<dc:creator>Atkinson, I.</dc:creator>
<dc:creator>Fones, A.</dc:creator>
<dc:creator>Paudyal, B.</dc:creator>
<dc:creator>Kirk, J.</dc:creator>
<dc:creator>Vatzia, E.</dc:creator>
<dc:creator>Gubbins, S.</dc:creator>
<dc:creator>Bickerton, E.</dc:creator>
<dc:creator>Briggs, E.</dc:creator>
<dc:creator>Nunez, A. Z. X.</dc:creator>
<dc:creator>MacNee, A.</dc:creator>
<dc:creator>Moffat, K.</dc:creator>
<dc:creator>Freimanis, G.</dc:creator>
<dc:creator>Rollier, C.</dc:creator>
<dc:creator>Muir, A.</dc:creator>
<dc:creator>Richard, A. C.</dc:creator>
<dc:creator>Angelopoulos, N.</dc:creator>
<dc:creator>Gerner, W.</dc:creator>
<dc:creator>Tchilian, E.</dc:creator>
<dc:date>2024-11-09</dc:date>
<dc:identifier>doi:10.1101/2024.11.08.622602</dc:identifier>
<dc:title><![CDATA[Pathogenesis and immune response to respiratory coronaviruses in their natural porcine host]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.22.619613?rss=1">
<title>
<![CDATA[
A distinctive PI(4,5)P2 compartment forms during entosis and related engulfment processes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.22.619613?rss=1</link>
<description><![CDATA[
Entosis is a form of cell cannibalism prevalent in human tumours. During entosis, one live and viable epithelial cell is completely internalised by another, then housed inside a large, single-membrane, endolysosomal vacuole in the host cytosol. The composition and maturation of this specialised, macroendocytic compartment has not been fully defined, but ultimately, the inner cell is killed and digested by host lysosomes. Here, we investigate the molecular characteristics and maturation profile of the entotic vacuole. Like phagosomes and macropinosomes, this vacuole undergoes a series of phospholipid modifications, but its maturation profile bears distinctive dynamics. While PI(4,5)P2 is lost rapidly during phagosome maturation, entosis yields an unusual, intracellular PI(4,5)P2-positive compartment, that can persist for hours, suggesting vacuole maturation is uncoupled from membrane scission. Loss of PI(4,5)P2 is eventually triggered, a requisite step for lysosomal killing of the internalised cell. More broadly, PI(4,5)P2-positive vacuoles also form during T-cell engulfment by thymic nurse cells, dependent on ROCK activity, suggesting this distinctive compartment represents a shared feature of entosis-like cell engulfments.
]]></description>
<dc:creator>Durgan, J.</dc:creator>
<dc:creator>Sloan, K.</dc:creator>
<dc:creator>Domart, M.-C.</dc:creator>
<dc:creator>Collinson, L.</dc:creator>
<dc:creator>Florey, O.</dc:creator>
<dc:date>2024-10-22</dc:date>
<dc:identifier>doi:10.1101/2024.10.22.619613</dc:identifier>
<dc:title><![CDATA[A distinctive PI(4,5)P2 compartment forms during entosis and related engulfment processes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.19.618135?rss=1">
<title>
<![CDATA[
KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.19.618135?rss=1</link>
<description><![CDATA[
Mutations in KRAS, particularly at codon 12, are frequent in adenocarcinomas of the colon, lungs and pancreas, driving carcinogenesis by altering cell signalling and reprogramming metabolism. However, the specific mechanisms by which different KRAS G12 alleles initiate distinctive patterns of metabolic reprogramming is unclear. Using isogenic panels of colorectal cell lines harbouring the G12A, G12C, G12D and G12V heterozygous mutations and employing transcriptomics, metabolomics, and extensive biochemical validation, we demonstrate distinctive features of each allele. We also demonstrate that cells harbouring the common G12D and G12V oncogenic mutations significantly alter glutamine metabolism and nitrogen recycling through FOXO1-mediated regulation compared to parental lines. Moreover, with a combination of small molecule inhibitors targeting glutamine and glutamate metabolism, we also identify a common vulnerability that eliminates mutant cells selectively. These results highlight a previously unreported mutant-specific effect of KRAS alleles on metabolism and signalling that could be potentially harnessed for cancer therapy.

In briefBer et al. reveal common and distinct features of oncogenic KRAS mutant isogenic cell lines. Mutant lines upregulate different nitrogen-recycling metabolic pathways and show sensitivity to combinatorial drugging of glutamine metabolism.



O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/618135v1_ufig1.gif" ALT="Figure 1">
View larger version (101K):
org.highwire.dtl.DTLVardef@1459558org.highwire.dtl.DTLVardef@14fcd43org.highwire.dtl.DTLVardef@2d22ccorg.highwire.dtl.DTLVardef@147b068_HPS_FORMAT_FIGEXP  M_FIG C_FIG HighlightsO_LIDifferent KRAS mutations trigger distinct metabolic phenotypes in colorectal cell lines
C_LIO_LIGlutamine metabolism and nitrogen recycling are upregulated in KRAS mutant cells
C_LIO_LIFOXO1 is a key regulator of KRAS-induced rewiring of glutamine and nitrogen metabolism
C_LIO_LIInhibition of glutamine synthetase and glutaminase selectively kills mutant KRAS lines
C_LI
]]></description>
<dc:creator>Ber, S.</dc:creator>
<dc:creator>Yang, M.</dc:creator>
<dc:creator>Sciacovelli, M.</dc:creator>
<dc:creator>Samarajiwa, S.</dc:creator>
<dc:creator>Patel, K.</dc:creator>
<dc:creator>Nikitopoulou, E.</dc:creator>
<dc:creator>Howitt, A.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Venkitaraman, A. R.</dc:creator>
<dc:creator>Frezza, C.</dc:creator>
<dc:creator>Esposito, A.</dc:creator>
<dc:date>2024-10-22</dc:date>
<dc:identifier>doi:10.1101/2024.10.19.618135</dc:identifier>
<dc:title><![CDATA[KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.09.611867?rss=1">
<title>
<![CDATA[
Epigenetic priming of embryonic enhancer elements coordinates developmental gene networks 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.09.611867?rss=1</link>
<description><![CDATA[
Embryonic development requires the accurate spatiotemporal execution of cell lineage-specific gene expression programs, which are controlled by transcriptional enhancers. Developmental enhancers adopt a primed chromatin state prior to their activation; however how this primed enhancer state is established, maintained, and how it affects the regulation of developmental gene networks remains poorly understood. Here, we use comparative multi-omic analyses of human and mouse early embryonic development to identify subsets of post-gastrulation lineage-specific enhancers which are epigenetically primed ahead of their activation, marked by the histone modification H3K4me1 within the epiblast. We show that epigenetic priming occurs at lineage-specific enhancers for all three germ layers, and that epigenetic priming of enhancers confers lineage-specific regulation of key developmental gene networks. Surprisingly in some cases, lineage-specific enhancers are epigenetically marked already in the zygote, weeks before their activation during lineage specification. Moreover, we outline a generalisable strategy to use naturally occurring human genetic variation to delineate important sequence determinants of primed enhancer function. Our findings identify an evolutionarily conserved program of enhancer priming and begin to dissect the temporal dynamics and mechanisms of its establishment and maintenance during early mammalian development.
]]></description>
<dc:creator>Todd, C. D.</dc:creator>
<dc:creator>Ijaz, J.</dc:creator>
<dc:creator>Torabi, F.</dc:creator>
<dc:creator>Dovgusha, O.</dc:creator>
<dc:creator>Bevan, S.</dc:creator>
<dc:creator>Cracknell, O.</dc:creator>
<dc:creator>Lohoff, T.</dc:creator>
<dc:creator>Clark, S.</dc:creator>
<dc:creator>Argelaguet, R.</dc:creator>
<dc:creator>Pearce, J.</dc:creator>
<dc:creator>Kafetzopoulos, I.</dc:creator>
<dc:creator>Santambrogio, A.</dc:creator>
<dc:creator>Nichols, J.</dc:creator>
<dc:creator>von Meyenn, F.</dc:creator>
<dc:creator>Guenesdogan, U.</dc:creator>
<dc:creator>Schoenfelder, S.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2024-09-10</dc:date>
<dc:identifier>doi:10.1101/2024.09.09.611867</dc:identifier>
<dc:title><![CDATA[Epigenetic priming of embryonic enhancer elements coordinates developmental gene networks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.19.608560?rss=1">
<title>
<![CDATA[
The consequences of mismatched buffers in spectral cell sorting 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.19.608560?rss=1</link>
<description><![CDATA[
Although spectral flow cytometry has become a ubiquitous tool for cell analysis, the use of spectral cytometry on cell sorters requires additional considerations arising from the unique requirements of sorting workflows. Here, we show that care should be taken when ascertaining the purity of a sort on a spectral cell sorter, as the mismatch of buffers used for initial sample suspension and the buffers used for sort collection can affect the unmixing of the data, potentially giving rise to erroneous purity check results.
]]></description>
<dc:creator>Dapaah, R. A. S.</dc:creator>
<dc:creator>Ferrer Font, L.</dc:creator>
<dc:creator>Shi, X.</dc:creator>
<dc:creator>Hall, C.</dc:creator>
<dc:creator>Thompson, S.</dc:creator>
<dc:creator>Catharina Costa, L.</dc:creator>
<dc:creator>Mage, P. L.</dc:creator>
<dc:creator>Tyznik, A. J.</dc:creator>
<dc:creator>Lundsten, K.</dc:creator>
<dc:creator>Walker, R. V.</dc:creator>
<dc:date>2024-08-19</dc:date>
<dc:identifier>doi:10.1101/2024.08.19.608560</dc:identifier>
<dc:title><![CDATA[The consequences of mismatched buffers in spectral cell sorting]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.15.607884?rss=1">
<title>
<![CDATA[
RAF inhibitors activate the integrated stress response by direct activation of GCN2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.15.607884?rss=1</link>
<description><![CDATA[
Paradoxical RAF activation by chemical RAF inhibitors (RAFi) is a well-understood  on-target biological and clinical response. In this study, we show that a range of RAFi drive ERK1/2-independent activation of the Unfolded Protein Response (UPR), including expression of ATF4 and CHOP, that required the translation initiation factor eIF2. RAFi-induced ATF4 and CHOP expression was not reversed by inhibition of PERK, a known upstream activator of the eIF2-dependent Integrated Stress Response (ISR). Rather, we found that RAFi exposure activated GCN2, an alternate eIF2 kinase, leading to eIF2-dependent (and ERK1/2-independent) ATF4 and CHOP expression. The GCN2 kinase inhibitor A-92, GCN2 RNAi, GCN2 knock-out or ISRIB (an eIF2 antagonist) all reversed RAFi-induced expression of ATF4 and CHOP indicating that RAFi require GCN2 to activate the ISR. RAFi also activated full-length recombinant GCN2 in vitro and in cells, generating a characteristic  bell-shaped concentration-response curve, reminiscent of RAFi-driven paradoxical activation of WT RAF dimers. Activation of the ISR by RAFi was abolished by GCN2 kinase dead mutations and M802A or M802G gatekeeper mutations, suggesting that RAFi bind directly to the GCN2 kinase domain; this was supported by mechanistic structural models of RAFi interaction with GCN2. Since the ISR is a critical pathway for determining cell survival or death, our observations may be relevant to the clinical use of RAFi, where paradoxical GCN2 activation may be a previously unappreciated off-target effect that may modulate tumour cell responses.
]]></description>
<dc:creator>Gilley, R.</dc:creator>
<dc:creator>Kidger, A. M.</dc:creator>
<dc:creator>Neill, G.</dc:creator>
<dc:creator>Severson, P.</dc:creator>
<dc:creator>Byrne, D. P.</dc:creator>
<dc:creator>Kenneth, N. S.</dc:creator>
<dc:creator>Bollag, G.</dc:creator>
<dc:creator>Zhang, C.</dc:creator>
<dc:creator>de Oliveira, T. M.</dc:creator>
<dc:creator>Eyers, P.</dc:creator>
<dc:creator>Bayliss, R.</dc:creator>
<dc:creator>Masson, G. R.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:date>2024-08-16</dc:date>
<dc:identifier>doi:10.1101/2024.08.15.607884</dc:identifier>
<dc:title><![CDATA[RAF inhibitors activate the integrated stress response by direct activation of GCN2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.13.607790?rss=1">
<title>
<![CDATA[
Eomes directs the formation of spatially and functionally diverse extra-embryonic hematovascular tissues 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.13.607790?rss=1</link>
<description><![CDATA[
During mouse gastrulation, extraembryonic mesoderm (ExEM) contributes to the extraembryonic yolk sac (YS) and allantois, both of which are essential for successful gestation. Although the genetic networks coordinating intra-embryonic mesodermal subtype specification are well-studied, the mechanisms driving ExEM diversification are poorly understood. Here, we reveal that embryoid body in vitro differentiation generates two distinct lineages of mesodermal cells matching YS and allantois respectively. Combining in vitro models with in vivo chimeric embryo analysis, we discover that Eomesodermin (Eomes) regulates the formation of a subset of YS-fated ExEM but is dispensable for allantois formation. Furthermore, simultaneous disruption of Eomes and T impedes the specification of any YS or allantois mesoderm, indicating compensatory roles for T during allantois formation when Eomes is disrupted. Our study highlights previously unrecognized functional and mechanistic diversity in ExEM diversification and endothelial development and introduces a tractable EB model to dissect the signaling pathways and transcriptional networks driving the formation of key extraembryonic tissues.
]]></description>
<dc:creator>Theeuwes, B.</dc:creator>
<dc:creator>Harland, L. T.</dc:creator>
<dc:creator>Bisia, A.</dc:creator>
<dc:creator>Costello, I.</dc:creator>
<dc:creator>Ton, M.-L.</dc:creator>
<dc:creator>Lohoff, T.</dc:creator>
<dc:creator>Clark, S. J.</dc:creator>
<dc:creator>Argelaguet, R.</dc:creator>
<dc:creator>Wilson, N. K.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Bikoff, E.</dc:creator>
<dc:creator>Robertson, E. J.</dc:creator>
<dc:creator>Gottgens, B.</dc:creator>
<dc:date>2024-08-16</dc:date>
<dc:identifier>doi:10.1101/2024.08.13.607790</dc:identifier>
<dc:title><![CDATA[Eomes directs the formation of spatially and functionally diverse extra-embryonic hematovascular tissues]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.14.606984?rss=1">
<title>
<![CDATA[
Paradoxical Activation of GCN2 by ATP-competitive inhibitors via allosteric activation and autophosphorylation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.14.606984?rss=1</link>
<description><![CDATA[
Recently it has been found that General Control Non-derepressible 2 (GCN2) can be activated by an array of small molecule ATP-competitive inhibitors, including clinically relevant compounds such as Ponatinib, and compounds specifically designed to be GCN2 inhibitors, such as GCN2iB. Furthermore, we recently showed that GCN2 can be activated in cells by clinically approved small molecule RAF inhibitors. GCN2 is a drug target, specifically in cancers such as mesothelioma, and a better understanding of this paradoxical activation is required to develop drugs which truly inhibit the enzyme. Using biochemical assays and structural mass spectrometry, we present a model for how GCN2 is activated by these compounds by promoting an active conformation in the HisRS domain while competitively inhibiting the kinase domain. This conformation promotes activating phosphorylation of GCN2, potentially through phosphorylation of other activated GCN2 molecules which are not bound to compound. Together this model suggests that efforts to inhibit GCN2 would benefit from exploring allosteric routes rather than targeting the ATP-binding pocket of the kinase domain.
]]></description>
<dc:creator>Masson, G. R.</dc:creator>
<dc:creator>Neill, G.</dc:creator>
<dc:creator>Vinciauskaite, V.</dc:creator>
<dc:creator>Paul, M.</dc:creator>
<dc:creator>Gilley, R.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:date>2024-08-14</dc:date>
<dc:identifier>doi:10.1101/2024.08.14.606984</dc:identifier>
<dc:title><![CDATA[Paradoxical Activation of GCN2 by ATP-competitive inhibitors via allosteric activation and autophosphorylation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.01.604391?rss=1">
<title>
<![CDATA[
Protein degradation shapes developmental tempo in mouse and human neural progenitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.01.604391?rss=1</link>
<description><![CDATA[
The pace of embryonic development differs markedly across mammalian species, yet the molecular mechanisms underlying these tempo differences remain largely unknown. Here, we systematically compared protein dynamics in mouse and human neural progenitors (NPs) and examined how protein stability influences developmental timing. We find that mouse NPs exhibit faster protein production and degradation than human NPs. Human NPs display broadly increased protein half-lives, independent of cellular compartment or protein function, and this difference persists in post-mitotic neurons. Consistent with this, proteasomal activity is lower in human embryonic spinal cord and stem cell-derived neural progenitors than mouse, correlating with reduced expression of proteasome-associated proteins. Functionally, accelerating the degradation of the key transcriptional repressor IRX3 in mouse NPs speeds the activation of its target gene, providing causal evidence that protein turnover modulates developmental tempo. These results reveal that species-specific regulation of protein degradation shapes the timing of neural development and suggest that evolutionary tuning of proteasomal activity contributes to differences in embryonic developmental pace.
]]></description>
<dc:creator>Nakanoh, S.</dc:creator>
<dc:creator>Stamataki, D.</dc:creator>
<dc:creator>Garcia-Perez, L.</dc:creator>
<dc:creator>Azzi, C.</dc:creator>
<dc:creator>Carr, H. L.</dc:creator>
<dc:creator>Pokhilko, A.</dc:creator>
<dc:creator>Howell, S.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Skehel, M.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Briscoe, J.</dc:creator>
<dc:creator>Rayon, T.</dc:creator>
<dc:date>2024-08-01</dc:date>
<dc:identifier>doi:10.1101/2024.08.01.604391</dc:identifier>
<dc:title><![CDATA[Protein degradation shapes developmental tempo in mouse and human neural progenitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.28.601066?rss=1">
<title>
<![CDATA[
Phospholipase Cgamma regulates lacrimal gland branching by competing with PI3K in phosphoinositide metabolism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.28.601066?rss=1</link>
<description><![CDATA[
Although the regulation of branching morphogenesis by spatially distributed cues is well established, the role of intracellular signaling in determining the branching pattern remains poorly understood. In this study, we investigated the regulation and function of phospholipase C gamma (PLC{gamma}) in Fibroblast Growth Factor (FGF) signaling in lacrimal gland development. We showed that deletion of PLC{gamma}1 in the lacrimal gland epithelium leads to ectopic branching and acinar hyperplasia, which was phenocopied by either mutating the PLC{gamma}1 binding site on Fgfr2 or disabling any of its SH2 domains. PLC{gamma}1 inactivation did not change the level of Fgfr2 or affect MAPK signaling, but instead led to sustained AKT phosphorylation due to increased PIP3 production. Consistent with this, PLC{gamma}1 mutant phenotype can be reproduced by elevation of PI3K signaling in Pten knockout and attenuated by blocking AKT signaling. This study demonstrated that PLC{gamma} modulates PI3K signaling by shifting phosphoinositide metabolism, revealing an important role of signaling dynamics in conjunction with spatial cues in shaping branching morphogenesis.
]]></description>
<dc:creator>Wang, Q.</dc:creator>
<dc:creator>Tao, C.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Anderson, K. E.</dc:creator>
<dc:creator>Hannan, A.</dc:creator>
<dc:creator>Lin, C.-s.</dc:creator>
<dc:creator>Hawkins, P. T.</dc:creator>
<dc:creator>Stephens, L.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:date>2024-07-02</dc:date>
<dc:identifier>doi:10.1101/2024.06.28.601066</dc:identifier>
<dc:title><![CDATA[Phospholipase Cgamma regulates lacrimal gland branching by competing with PI3K in phosphoinositide metabolism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.26.580534?rss=1">
<title>
<![CDATA[
A targetable PREX2/RAC1/PI3Kβ signalling axis confers resistance to clinically relevant therapeutic approaches in melanoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.26.580534?rss=1</link>
<description><![CDATA[
Metastatic melanoma remains a major clinical challenge. Large-scale genomic sequencing of melanoma has identified bona fide activating mutations in RAC1, with mutations of its upstream regulator, the RAC-GEF PREX2, also commonly detected. Crucially, RAC1 mutations are associated with resistance to BRAF-targeting therapies. Despite the role of its homologue PREX1 in melanomagenesis, and evidence that some truncating PREX2 mutations drive increased RAC1 activity, no hotspot mutations have been identified, and the impact of PREX2 mutation remains contentious. Here, we use genetically engineered mouse models and patient-derived BRAFV600E-driven melanoma cell lines to dissect the role of PREX2 in melanomagenesis and response to therapy. We show that while PREX2 is dispensable for the initiation and progression of melanoma, its loss confers sensitivity to clinically relevant therapeutics. Importantly, genetic and pharmacological targeting of the RAC1 effector kinase PI3K{beta} phenocopies PREX2 loss, sensitizing our model systems to therapy. Our data reveal a druggable PREX2/RAC1/PI3K{beta} signalling axis in BRAF-mutant melanoma that could be exploited clinically.

Statement of SignificanceMetastatic melanoma remains both a clinical problem, and an opportunity for therapeutic benefit. Co-targeting of the MAPK pathway and the PREX2/RAC1/PI3K{beta} has remarkable efficacy and outperforms monotherapy MAPK targeting in vivo.
]]></description>
<dc:creator>Ford, C. A.</dc:creator>
<dc:creator>Koludrovic, D.</dc:creator>
<dc:creator>Centeno, P. P.</dc:creator>
<dc:creator>Foth, M.</dc:creator>
<dc:creator>Tsonou, E.</dc:creator>
<dc:creator>Vlahov, N.</dc:creator>
<dc:creator>Sphyris, N.</dc:creator>
<dc:creator>Gilroy, K.</dc:creator>
<dc:creator>Bull, C.</dc:creator>
<dc:creator>Nixon, C.</dc:creator>
<dc:creator>Serrels, B.</dc:creator>
<dc:creator>Munro, A. F.</dc:creator>
<dc:creator>Dawson, J. C.</dc:creator>
<dc:creator>Carragher, N. O.</dc:creator>
<dc:creator>Pavet, V.</dc:creator>
<dc:creator>Hornigold, D. C.</dc:creator>
<dc:creator>Dunne, P. D.</dc:creator>
<dc:creator>Downward, J.</dc:creator>
<dc:creator>Welch, H. C. E.</dc:creator>
<dc:creator>Barry, S. T.</dc:creator>
<dc:creator>Sansom, O. J.</dc:creator>
<dc:creator>Campbell, A. D.</dc:creator>
<dc:date>2024-02-28</dc:date>
<dc:identifier>doi:10.1101/2024.02.26.580534</dc:identifier>
<dc:title><![CDATA[A targetable PREX2/RAC1/PI3Kβ signalling axis confers resistance to clinically relevant therapeutic approaches in melanoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.15.580302?rss=1">
<title>
<![CDATA[
Tissue-resident regulatory T cells exert dualistic anti-tumour and pro-repair function in the exocrine pancreas 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.15.580302?rss=1</link>
<description><![CDATA[
Regulatory T cells are fundamentally important for maintaining immune homeostasis, and their potent immune-suppressive roles make them attractive immunotherapeutic targets in cancer. Recent work suggests potential functions of tissue-resident Tregs (trTregs) in tissue-repair and epithelial cell homeostasis. Here, we describe a rare population of trTreg in the exocrine pancreas. We show that these cells share common features of trTregs, including expression of the IL-33 receptor ST2 and production of the epithelial growth factor Amphiregulin, and display an oligoclonal T cell receptor repertoire. Using a mouse model of acute pancreatitis, we show that pancreatic Tregs rapidly expand upon release of IL-33 by fibroblasts. Moreover, depletion of Tregs after initiation of pancreatic injury impairs the regeneration of the exocrine parenchyma. This effect is due, in part, through a direct effect of Tregs on acinar cell proliferation. Finally, we show that transient Treg depletion in established orthotopic pancreatic tumours leads to tumour rejection yet provokes long-lasting damages to surrounding exocrine parenchyma. In all, our results demonstrate the tissue-repair capacity of pancreatic Tregs, and highlight a dualistic role of these cells in the pancreatic tumour ecosystem, with their harmful immune-suppressive function in the tumour coupled to a beneficial tissue-repair function in the surrounding tissue.
]]></description>
<dc:creator>Stockis, J.</dc:creator>
<dc:creator>Yip, T.</dc:creator>
<dc:creator>Raghunathan, S.</dc:creator>
<dc:creator>Garcia, C.</dc:creator>
<dc:creator>Lee, S.</dc:creator>
<dc:creator>Simpson, C.</dc:creator>
<dc:creator>Silvain, S.</dc:creator>
<dc:creator>Schuijs, M. J.</dc:creator>
<dc:creator>Araos, J.</dc:creator>
<dc:creator>Png, S.</dc:creator>
<dc:creator>Raddi, G.</dc:creator>
<dc:creator>Bricard, O.</dc:creator>
<dc:creator>So, T. Y.</dc:creator>
<dc:creator>Mack, S.</dc:creator>
<dc:creator>Papadopoulos, P.</dc:creator>
<dc:creator>Sawle, A.</dc:creator>
<dc:creator>Jodrell, D. I.</dc:creator>
<dc:creator>McKenzie, A. N. J.</dc:creator>
<dc:creator>Thaventhiran, J.</dc:creator>
<dc:creator>Clatworthy, M.</dc:creator>
<dc:creator>Biffi, G.</dc:creator>
<dc:creator>Saeb-Parsy, K.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:creator>Halim, T. Y. F.</dc:creator>
<dc:date>2024-02-19</dc:date>
<dc:identifier>doi:10.1101/2024.02.15.580302</dc:identifier>
<dc:title><![CDATA[Tissue-resident regulatory T cells exert dualistic anti-tumour and pro-repair function in the exocrine pancreas]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.09.579641?rss=1">
<title>
<![CDATA[
Regulation of IFNgamma production by ZFP36L2 in T cells is context-dependent 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.09.579641?rss=1</link>
<description><![CDATA[
CD8+ T cells kill target cells by releasing cytotoxic molecules and pro-inflammatory cytokines, such as TNF and IFN{gamma}. The magnitude and duration of cytokine production is defined by post-transcriptional regulation, and a critical regulator herein are RNA-binding proteins (RBPs). Although the functional importance of RBPs in regulating cytokine production is established, the kinetics and mode of action through which RBPs control cytokine production is not well understood. Previously, we showed that the RBP ZFP36L2 blocks translation of pre-formed cytokine encoding mRNA in quiescent memory T cells. Here, we uncover that ZFP36L2 regulates cytokine production in a context-dependent manner. T cell-specific deletion of ZFP36L2 (CD4-cre) had no effect on T cell development, or on cytokine production during early time points (2-6h) of T cell activation. In contrast, ZFP36L2 specifically dampened the production of IFN{gamma} during prolonged T cell activation (20-48h). ZFP36L2 deficiency also resulted in increased production of IFN{gamma} production in tumour-infiltrating T cells that are chronically exposed to antigen. Mechanistically, ZFP36L2 regulates IFN{gamma} production at late time points of activation by destabilizing Ifng mRNA in an AU-rich element-dependent manner. Together, our results reveal that ZFP36L2 employs different regulatory nodules in effector and memory T cells to regulate cytokine production.
]]></description>
<dc:creator>Zandhuis, N. D.</dc:creator>
<dc:creator>Guislain, A.</dc:creator>
<dc:creator>Popalzij, A.</dc:creator>
<dc:creator>Engels, S.</dc:creator>
<dc:creator>Popovic, B.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:creator>Wolkers, M. C.</dc:creator>
<dc:date>2024-02-12</dc:date>
<dc:identifier>doi:10.1101/2024.02.09.579641</dc:identifier>
<dc:title><![CDATA[Regulation of IFNgamma production by ZFP36L2 in T cells is context-dependent]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.01.09.574858?rss=1">
<title>
<![CDATA[
p110α-dependent hepatocyte signaling is critical for liver gene expression and its rewiring in MASLD 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.01.09.574858?rss=1</link>
<description><![CDATA[
Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is dependent on PI3K. We used mice lacking p110, the catalytic subunit of PI3K, to investigate its role in the regulation of liver gene expression in health and in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). The absence of hepatocyte PI3K signaling promoted glucose intolerance in lean mice and significantly regulated liver gene expression, including insulin-sensitive genes, in ad libitum feeding. Some of the defective regulation of gene expression in response to hepatocyte-restricted insulin receptor deletion was related to PI3K signaling. In addition, though PI3K deletion in hepatocytes promoted insulin resistance, it was protective against steatotic liver disease in diet-induced obesity. In the absence of hepatocyte PI3K, the effect of diet-induced obesity on liver gene expression was significantly altered, with changes in rhythmic gene expression in liver. Altogether, this study highlights the specific role of p110 in the control of liver gene expression in physiology and in the metabolic rewiring that occurs during MASLD.
]]></description>
<dc:creator>Regnier, M.</dc:creator>
<dc:creator>Polizzi, A.</dc:creator>
<dc:creator>Fougeray, T.</dc:creator>
<dc:creator>Fougerat, A.</dc:creator>
<dc:creator>Perrier, P.</dc:creator>
<dc:creator>Anderson, K.</dc:creator>
<dc:creator>Lippi, Y.</dc:creator>
<dc:creator>Smati, S.</dc:creator>
<dc:creator>Lukowicz, C.</dc:creator>
<dc:creator>Lasserre, F.</dc:creator>
<dc:creator>Fouche, E.</dc:creator>
<dc:creator>Huillet, M.</dc:creator>
<dc:creator>Rives, C.</dc:creator>
<dc:creator>Tramunt, B.</dc:creator>
<dc:creator>Naylies, C.</dc:creator>
<dc:creator>Garcia, G.</dc:creator>
<dc:creator>Rousseau-Bacquie, E.</dc:creator>
<dc:creator>Bertrand-Michel, J.</dc:creator>
<dc:creator>Canlet, C.</dc:creator>
<dc:creator>Chevolleau-Mege, S.</dc:creator>
<dc:creator>Debrauwer, L.</dc:creator>
<dc:creator>Heymes, C.</dc:creator>
<dc:creator>Burcelin, R.</dc:creator>
<dc:creator>Levade, T.</dc:creator>
<dc:creator>Gourdy, P.</dc:creator>
<dc:creator>Wahli, W.</dc:creator>
<dc:creator>Blum, Y.</dc:creator>
<dc:creator>Gamet-Payrastre, L.</dc:creator>
<dc:creator>Ellero-Simatos, S.</dc:creator>
<dc:creator>Guillermet-Guibert, J.</dc:creator>
<dc:creator>Hawkins, P.</dc:creator>
<dc:creator>Stephens, L.</dc:creator>
<dc:creator>Montagner, A.</dc:creator>
<dc:creator>Loiseau, N.</dc:creator>
<dc:creator>Guillou, H.</dc:creator>
<dc:date>2024-01-10</dc:date>
<dc:identifier>doi:10.1101/2024.01.09.574858</dc:identifier>
<dc:title><![CDATA[p110α-dependent hepatocyte signaling is critical for liver gene expression and its rewiring in MASLD]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-01-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.19.572318?rss=1">
<title>
<![CDATA[
Single-cell analysis reveals lasting immunological consequences of influenza infection and respiratory immunisation in the pig lung 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.19.572318?rss=1</link>
<description><![CDATA[
The pig is a natural host for influenza viruses and integrally involved in virus evolution through interspecies transmissions between humans and swine. Swine have many physiological, anatomical, and immunological similarities to humans, and are an excellent model for human influenza. Here, we employed single RNA-sequencing (scRNA-seq) and flow cytometry to characterize the major leucocyte subsets in bronchoalveolar lavage (BAL), twenty-one days after H1N1pdm09 infection or respiratory immunization with an adenoviral vector vaccine expressing haemagglutinin and nucleoprotein with or without IL-1{beta}. Mapping scRNA-seq clusters from BAL onto those previously described in peripheral blood facilitated annotation and highlighted differences between tissue resident and circulating immune cells. ScRNA-seq data and functional assays revealed lasting impacts of immune challenge on BAL populations. First, mucosal administration of IL-1{beta} reduced the number of functionally active Treg. Second, influenza infection upregulated IFI6 in BAL cells, decreasing their susceptibility to virus replication in vitro. Our data provides a reference map of porcine BAL cells and reveals lasting immunological consequences of influenza infection and respiratory immunisation in a highly relevant large animal model for respiratory virus infection.

Author SummaryPigs and humans have a similar anatomy and physiology. In humans, cells from lung-washes are used to study immune responses and it was shown that these cells are crucial in protection against respiratory diseases such as influenza and COVID-19. To better understand lung immunity, we compared genes expressed in cells of pig lung-wash to white blood cells, providing an atlas for future studies of immunity in the lung. We also tested a vaccine given to the lung containing IL-1{beta}, a strong immune activator that protects mice against influenza virus infection. However, although IL-1{beta} increased pig immune responses it did not protect pigs against infection. We also showed that the number of immune cells that dampen immune responses (regulatory T cells) is reduced. In addition, we demonstrated increased expression of a protein, IFI6, 21 days after infection showing that while immune cells in the lung have common properties, the invading organisms influence them significantly. Our study elucidates why some vaccines fail despite inducing powerful immune responses, emphasizes the need for caution when applying results from small animals like mice to humans, and indicates the importance of the pig as a model to study disease in humans and livestock.
]]></description>
<dc:creator>Muir, A.</dc:creator>
<dc:creator>Paudyal, B.</dc:creator>
<dc:creator>Schmidt, S.</dc:creator>
<dc:creator>Sedaghat-Rostani, E.</dc:creator>
<dc:creator>Chakravarti, S.</dc:creator>
<dc:creator>Villanueva Hernandez, S.</dc:creator>
<dc:creator>Moffat, K.</dc:creator>
<dc:creator>Polo, N.</dc:creator>
<dc:creator>Angelopoulos, N.</dc:creator>
<dc:creator>Schmidt, A.</dc:creator>
<dc:creator>Tenbusch, M.</dc:creator>
<dc:creator>Freimanis, G.</dc:creator>
<dc:creator>Gerner, W.</dc:creator>
<dc:creator>Richard, A. C.</dc:creator>
<dc:creator>Tchilian, E.</dc:creator>
<dc:date>2023-12-19</dc:date>
<dc:identifier>doi:10.1101/2023.12.19.572318</dc:identifier>
<dc:title><![CDATA[Single-cell analysis reveals lasting immunological consequences of influenza infection and respiratory immunisation in the pig lung]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.12.571217?rss=1">
<title>
<![CDATA[
A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV (PADI4) regulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.12.571217?rss=1</link>
<description><![CDATA[
Peptidylarginine deiminase IV (PADI4) deregulation promotes the development of autoimmunity, cancer, atherosclerosis and age-related tissue fibrosis. Genetic or pharmacological PADI4 inhibition is therapeutically efficacious in mice, but no clinically relevant inhibitors currently exist. PADI4 additionally mediates immune responses and cellular reprogramming, although the full extent of its physiological roles is unexplored. Despite detailed molecular knowledge of PADI4 activation in vitro, we lack understanding of its regulation within cells, largely due to lack of appropriate systems and tools. Here, we developed and applied a set of potent and selective PADI4 modulators. Using the mRNA- display-based RaPID system, we screened >1012 cyclic peptides for high-affinity, conformation-selective binders. We report PADI4_3, an inhibitor specific for the active conformation of PADI4; PADI4_7, an inert binder, which we functionalised for the isolation and study of cellular PADI4; and PADI4_11, a first-in-class activator. Using a newly developed method for the quantification of cellular PADI4 activity, we show that PADI4_3 and PADI4_11 are effective in cells. Structural studies with PADI4_11 reveal an allosteric binding mode that may reflect the mechanism that promotes cellular PADI4 activation. This work offers new understanding of PADI4 regulation and a toolkit for the study and modulation of PADI4 across physiological and pathophysiological contexts.
]]></description>
<dc:creator>Bertran, M. T.</dc:creator>
<dc:creator>Walmsley, R.</dc:creator>
<dc:creator>Cummings, T. F. M.</dc:creator>
<dc:creator>Aramburu, I.</dc:creator>
<dc:creator>Benton, D. J.</dc:creator>
<dc:creator>Assalaarachchi, J.</dc:creator>
<dc:creator>Chasampalioti, M.</dc:creator>
<dc:creator>Swanton, T.</dc:creator>
<dc:creator>Joshi, D.</dc:creator>
<dc:creator>Federico, S.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Walker, S.</dc:creator>
<dc:creator>Papayannopoulos, V.</dc:creator>
<dc:creator>Suga, H.</dc:creator>
<dc:creator>Christophorou, M. A.</dc:creator>
<dc:creator>Walport, L. J.</dc:creator>
<dc:date>2023-12-12</dc:date>
<dc:identifier>doi:10.1101/2023.12.12.571217</dc:identifier>
<dc:title><![CDATA[A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV (PADI4) regulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.01.569004?rss=1">
<title>
<![CDATA[
Protein tyrosine phosphatase receptor kappa regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.01.569004?rss=1</link>
<description><![CDATA[
Fat accumulation, de novo lipogenesis, and glycolysis are key drivers of hepatocyte reprogramming and the consequent metabolic dysfunction-associated steatotic liver disease (MASLD). Here we report that obesity leads to dysregulated expression of hepatic protein-tyrosine phosphatases (PTPs). PTPRK was found to be increased in steatotic hepatocytes in both humans and mice, and positively correlated with PPAR{gamma}-induced lipogenic signalling. High-fat-fed PTPRK knockout mice displayed reduced weight gain and hepatic fat accumulation. Phosphoproteomic analysis in primary hepatocytes and hepatic metabolomics identified fructose-1,6-bisphosphatase 1 and glycolysis as PTPRK targets in metabolic reprogramming. Silencing PTPRK in hepatoma cell lines resulted in reduced colony-forming ability and PTPRK knockout mice developed smaller tumours after diethylnitrosamine-induced hepatocarcinogenesis. Our study defines a novel role for PTPRK in regulating hepatic glycolysis, lipid metabolism, and tumour development. PTPRK inhibition may provide therapeutic possibilities in obesity-associated liver diseases.

HighlightsO_LIHepatic receptor-type PTPs are increased in MASLD
C_LIO_LIPTPRK is expressed in hepatocytes and upregulated in obesity
C_LIO_LIPTPRK deficiency reduces body fat mass and liver steatosis in diet-induced obesity
C_LIO_LIPTPRK regulates hepatic glycolysis and lipogenesis, promoting tumorigenesis
C_LI
]]></description>
<dc:creator>Gilglioni, E. H.</dc:creator>
<dc:creator>Li, A.</dc:creator>
<dc:creator>Saint-Pierre Wijckmans, W.</dc:creator>
<dc:creator>Shen, T.-K.</dc:creator>
<dc:creator>Perez-Chavez, I.</dc:creator>
<dc:creator>Hovhannisyan, G.</dc:creator>
<dc:creator>Lisjak, M.</dc:creator>
<dc:creator>Negueruela, J.</dc:creator>
<dc:creator>Vandenbempt, V.</dc:creator>
<dc:creator>Bauza-Martinez, J.</dc:creator>
<dc:creator>Herranz, J. M.</dc:creator>
<dc:creator>Ezerina, D.</dc:creator>
<dc:creator>Demine, S.</dc:creator>
<dc:creator>Feng, Z.</dc:creator>
<dc:creator>Vignane, T.</dc:creator>
<dc:creator>Otero-Sanchez, L.</dc:creator>
<dc:creator>Lambertucci, F.</dc:creator>
<dc:creator>Prasnicka, A.</dc:creator>
<dc:creator>Deviere, J.</dc:creator>
<dc:creator>Hay, D. C.</dc:creator>
<dc:creator>Encinar, J. A. N.</dc:creator>
<dc:creator>Singh, S. P.</dc:creator>
<dc:creator>Messens, J.</dc:creator>
<dc:creator>Filipovic, M. R.</dc:creator>
<dc:creator>Sharpe, H. J.</dc:creator>
<dc:creator>Trepo, E.</dc:creator>
<dc:creator>Wu, W.</dc:creator>
<dc:creator>Gurzov, E. N.</dc:creator>
<dc:date>2023-12-01</dc:date>
<dc:identifier>doi:10.1101/2023.12.01.569004</dc:identifier>
<dc:title><![CDATA[Protein tyrosine phosphatase receptor kappa regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.29.564595?rss=1">
<title>
<![CDATA[
The N-terminal region of DNMT3A combines multiple chromatin reading motifs to guide recruitment. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.29.564595?rss=1</link>
<description><![CDATA[
DNA methyltransferase 3A (DNMT3A) plays a critical role in establishing and maintaining DNA methylation patterns. However, the mechanisms underlying DNMT3A recruitment to and function within different chromatin environments remain unclear. Using a combination of biochemical and structural approaches we find that DNMT3A interacts using multiple interfaces with chromatin; directly binding generic nucleosome features as well as site-specific post-translational histone modifications. The N-terminal region, unique to the DNMT3A1 isoform, is essential for these interactions and stabilises H3K36me2-nucleosome recruitment. Intriguingly, in the same region critical for nucleosome binding we also map a ubiquitylation-dependent recruitment motif (UDR). The UDR binds specifically to ubiquitylated H2AK119, explaining the previously observed recruitment to Polycomb-occupied heterochromatin. A cryo-EM structure of DNMT3A1-DNMT3L with a modified nucleosome reveals that the UDR interacts with the nucleosome surface including the acidic patch. Previously unexplained disease-associated mutations are present in the UDR and ablate nucleosome interactions. This leads to an increased understanding of how DNMT3A1 recruitment occurs in the genome and highlights the importance of multivalent binding of DNMT3A to histone modifications and the nucleosome.
]]></description>
<dc:creator>Wapenaar, H.</dc:creator>
<dc:creator>Clifford, G.</dc:creator>
<dc:creator>Rolls, W.</dc:creator>
<dc:creator>Burdett, H.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Deak, G.</dc:creator>
<dc:creator>Zou, J.</dc:creator>
<dc:creator>Taylor, M. R.</dc:creator>
<dc:creator>Mills, J.</dc:creator>
<dc:creator>Watson, J. A.</dc:creator>
<dc:creator>Kumar, D.</dc:creator>
<dc:creator>Das, A.</dc:creator>
<dc:creator>Valsakumar, D.</dc:creator>
<dc:creator>Bramham, J.</dc:creator>
<dc:creator>Voigt, P.</dc:creator>
<dc:creator>Wilson, M. D.</dc:creator>
<dc:date>2023-10-29</dc:date>
<dc:identifier>doi:10.1101/2023.10.29.564595</dc:identifier>
<dc:title><![CDATA[The N-terminal region of DNMT3A combines multiple chromatin reading motifs to guide recruitment.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.07.561361?rss=1">
<title>
<![CDATA[
Whole Genome Methylation Sequencing via Enzymatic Conversion (EM-seq): Protocol, Data Processing and Analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.07.561361?rss=1</link>
<description><![CDATA[
Whole genome bisulfite sequencing (WGBS) has been the gold standard technique for base resolution analysis of DNA methylation for the last 15 years. It has been, however, associated with technical biases, which lead to overall overestimation of global and regional methylation values, and significant artifacts in extreme cytosine-rich DNA sequence contexts. Enzymatic conversion of cytosine is the newest approach, set to replace entirely the use of the damaging bisulfite conversion of DNA. The EM-seq technique utilises TET2, T4-BGT and APOBEC in a two-step conversion process, where the modified cytosines are first protected by oxidation and glucosylation, followed by deamination of all unmodified cytosines to uracil. As a result, EM-seq is degradation-free and bias-free, requires low DNA input, and produces high library yields with longer reads, little batch variation, less duplication, uniform genomic coverage, accurate methylation over a larger number of captured CpGs, and no sequence-specific artifacts.
]]></description>
<dc:creator>Olova, N. N.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:date>2023-10-10</dc:date>
<dc:identifier>doi:10.1101/2023.10.07.561361</dc:identifier>
<dc:title><![CDATA[Whole Genome Methylation Sequencing via Enzymatic Conversion (EM-seq): Protocol, Data Processing and Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.09.561545?rss=1">
<title>
<![CDATA[
A maternal-effect Padi6 variant results in abnormal nuclear localization of DNMT1 and failure of epigenetic reprogramming and zygotic genome activation in mouse embryos 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.09.561545?rss=1</link>
<description><![CDATA[
PADI6 belongs to the multi-protein sub-cortical maternal complex (SCMC) that is present specifically in mammalian oocytes and early embryos. Maternal inactivation of SCMC genes generally results in early embryo lethality. In humans, variants in a subset of SCMC genes have been found in the healthy mothers of children affected by genomic imprinting disorders and characterized by multi-locus imprinting disturbances (MLID). However, how the SCMC controls the DNA methylation required to regulate imprinting remains poorly defined. To address this issue, we generated a mouse line carrying a Padi6 missense variant that had been identified in the mother of two sisters affected by Beckwith-Wiedemann syndrome and MLID. We found that if homozygous in female mice this variant resulted in interruption of embryo development at the 2-cell stage. Single-cell DNA methylation and RNA analyses demonstrated genomic hypermethylation, down-regulation of zygotic genome activation (ZGA) genes and up-regulation of maternal decay genes in 2-cell embryos from homozygous females. In addition, immunofluorescence analysis showed abnormal localization of DNMT1 and UHRF1 in mutant oocytes and zygotes. Taken together, this study demonstrates that PADI6 controls the subcellular localization of DNMT1 that is necessary for pre-implantation epigenetic reprogramming and ZGA.
]]></description>
<dc:creator>Giaccari, C.</dc:creator>
<dc:creator>Cecere, F.</dc:creator>
<dc:creator>Argenziano, L.</dc:creator>
<dc:creator>Galvao, A.</dc:creator>
<dc:creator>Acampora, D.</dc:creator>
<dc:creator>Rossi, G.</dc:creator>
<dc:creator>Hay Mele, B.</dc:creator>
<dc:creator>Cubellis, M. V.</dc:creator>
<dc:creator>Cerrato, F.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Cecconi, S.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:creator>Riccio, A.</dc:creator>
<dc:date>2023-10-10</dc:date>
<dc:identifier>doi:10.1101/2023.10.09.561545</dc:identifier>
<dc:title><![CDATA[A maternal-effect Padi6 variant results in abnormal nuclear localization of DNMT1 and failure of epigenetic reprogramming and zygotic genome activation in mouse embryos]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.29.560184?rss=1">
<title>
<![CDATA[
Stability of Genomic Imprinting and X-Chromosome Inactivation in the Aging Brain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.29.560184?rss=1</link>
<description><![CDATA[
Epigenetic drift is a hallmark of aging that contributes to the irreversible decline in organismal fitness ultimately leading to aging-related diseases. Epigenetic modifications regulate the cellular memory of the epigenetic processes of genomic imprinting and X-chromosome inactivation to ensure monoallelic expression of imprinted and X-linked genes. Whether epigenetic drift affects maintenance of genomic imprinting and X-chromosome inactivation has not been comprehensively studied. Here, we investigate the allele-specific transcriptional and epigenetic signatures of the aging brain, by comparing juvenile and old hybrid mice obtained from C57BL/6J (BL6) & CAST/EiJ (CAST) reciprocal crosses, with an emphasis on the hippocampus (HCP). We confirm that the aged HCP shows an increase of DNA hydroxymethylation, a sign of epigenetic drift, and a typical aging transcriptional signature. Genomic imprinting was found to be largely unaffected with stable parent-of-origin-specific DNA methylation in HCP, but also other brain regions such as the cerebellum (CB), nucleus accumbens, hypothalamus and prefrontal cortex. Consistently, transcriptomics analysis confirmed unaltered imprinting expression in the aged HCP. An exception are three novel non-coding transcripts (B230209E15Rik, Ube2nl and A330076H08Rik) at the Prader-Willi syndrome/Angelman syndrome (PWS/AS) imprinted locus which lose strict monoallelic expression during aging. Like imprinting, X-chromosome inactivation was remarkably stable with no signs of aging-driven skewing or relaxation of monoallelic expression of X-linked genes. Our study provides a valuable resource for evaluating monoallelic expression in the aging brain and reveals that, despite epigenetic drift during aging, genomic imprinting and X-chromosome inactivation remain predominantly stable throughout the process of physiological aging in the mouse brain.
]]></description>
<dc:creator>Mancino, S.</dc:creator>
<dc:creator>Seneviratne, J.</dc:creator>
<dc:creator>Mupo, A.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Eckersley-Maslin, M.</dc:creator>
<dc:creator>da Rocha, S. T.</dc:creator>
<dc:date>2023-09-30</dc:date>
<dc:identifier>doi:10.1101/2023.09.29.560184</dc:identifier>
<dc:title><![CDATA[Stability of Genomic Imprinting and X-Chromosome Inactivation in the Aging Brain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.14.553196?rss=1">
<title>
<![CDATA[
The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.14.553196?rss=1</link>
<description><![CDATA[
The tissues are the site of many of the most important immunological reactions, yet the immunology of the tissues has remained relatively opaque. Recent studies have identified Foxp3+ regulatory T cells (Tregs) in several non-lymphoid tissues. These tissue-resident populations have been ascribed unique characteristics based on comparisons to lymphoid Tregs. Here we performed a systematic analysis of the Treg population residing in non-lymphoid organs throughout the body, revealing shared phenotypes, transient residency and common molecular dependencies. Further, tissue Tregs from different non-lymphoid organs shared T cell receptor (TCR) sequences, with functional capacity to drive multi-tissue Treg entry. Finally, tissue Tregs extracted from non-lymphoid organs were tissue-agnostic on re-entry, without homing preference for their tissue of origin. Together these results demonstrate that the tissue-resident Treg pool in most non-lymphoid organs, other than the gut, is largely constituted by broadly self-reactive Tregs, characterised by transient multi-tissue migration and a common residency program.
]]></description>
<dc:creator>Burton, O.</dc:creator>
<dc:creator>Bricard, O.</dc:creator>
<dc:creator>Tareen, S.</dc:creator>
<dc:creator>Gergelits, V.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Roca, C. P.</dc:creator>
<dc:creator>Whyte, C.</dc:creator>
<dc:creator>Junius, S.</dc:creator>
<dc:creator>Brajic, A.</dc:creator>
<dc:creator>Pasciuto, E.</dc:creator>
<dc:creator>Ali, M.</dc:creator>
<dc:creator>Lemaitre, P.</dc:creator>
<dc:creator>Schlenner, S. M.</dc:creator>
<dc:creator>Ishigame, H.</dc:creator>
<dc:creator>Brown, B.</dc:creator>
<dc:creator>Dooley, J.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:date>2023-08-14</dc:date>
<dc:identifier>doi:10.1101/2023.08.14.553196</dc:identifier>
<dc:title><![CDATA[The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.04.551986?rss=1">
<title>
<![CDATA[
The Fork Protection Complex protects long replicons from DNA damage at the cost of genome instability induced by DNA topological stress. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.04.551986?rss=1</link>
<description><![CDATA[
Tof1/Timeless protects eukaryotic cells from DNA replication stress as part of the Fork Protection Complex (FPC). Tof1 supports rapid DNA replication, fork pausing, and resolution of DNA topological stress. Here, we show that disruption of FPC function through loss of either Tof1 or Mrc1 results in DNA damage in long replicons. Despite increasing DNA damage in long replicons, loss of either Tof1 or Mrc1 concurrently reduces DNA damage in regions prone to damage caused by DNA topological stress, indicating that the rapid replication promoted by the FPC fosters completing DNA replication at the cost of increased vulnerability to DNA topological stress. Supporting this we find that a tof1 mutation that selectively inhibits DNA topological stress resolution increases DNA damage in contexts prone to DNA topological stress. Our data indicates that the FPC balances rapid replication with recruitment of topoisomerase I to resolve the topological stress generated by increased DNA unwinding.
]]></description>
<dc:creator>Keszthelyi, A.</dc:creator>
<dc:creator>Whale, A.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:creator>Baxter, J.</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:identifier>doi:10.1101/2023.08.04.551986</dc:identifier>
<dc:title><![CDATA[The Fork Protection Complex protects long replicons from DNA damage at the cost of genome instability induced by DNA topological stress.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.31.551250?rss=1">
<title>
<![CDATA[
MiR-155 epigenetically counteracts hypoxia for mitochondrial fitness during germinal center positive selection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.31.551250?rss=1</link>
<description><![CDATA[
To increase antibody affinity against pathogens, positively selected GC-B cells initiate cell division in the light zone (LZ) of germinal centres (GCs). Among those, higher-affinity clones migrate to the dark zone (DZ) and vigorously proliferate by relying on oxidative phosphorylation (OXPHOS). However, it remains unknown how positively selected GC-B cells adapt their metabolism for cell division in the glycolysis-dominant, cell cycle arrest-inducing, hypoxic LZ microenvironment. Here, we show that microRNA (miR)-155 mediates metabolic reprogramming during positive selection to protect high-affinity clones. Transcriptome examination and mass spectrometry analysis revealed that miR-155 regulates H3K36me2 levels by directly repressing hypoxia-induced histone lysine demethylase, Kdm2a. This is indispensable for enhancing OXPHOS through optimizing the expression of vital nuclear mitochondrial genes under hypoxia. The miR-155-Kdm2a interaction is crucial to prevent excessive production of reactive oxygen species and apoptosis. Thus, miR-155-mediated epigenetic regulation promotes mitochondrial fitness in high-affinity clones, ensuring their expansion and consequently affinity maturation.
]]></description>
<dc:creator>Nakagawa, R.</dc:creator>
<dc:creator>Llorian-Sopena, M.</dc:creator>
<dc:creator>Varsani-brown, S.</dc:creator>
<dc:creator>Chakravarty, P.</dc:creator>
<dc:creator>Camarillo, J. M.</dc:creator>
<dc:creator>Barry, D.</dc:creator>
<dc:creator>George, R.</dc:creator>
<dc:creator>Blackledge, N. P.</dc:creator>
<dc:creator>Duddy, G.</dc:creator>
<dc:creator>Klose, R.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:creator>Calado, D. P.</dc:creator>
<dc:date>2023-08-02</dc:date>
<dc:identifier>doi:10.1101/2023.07.31.551250</dc:identifier>
<dc:title><![CDATA[MiR-155 epigenetically counteracts hypoxia for mitochondrial fitness during germinal center positive selection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.11.548598?rss=1">
<title>
<![CDATA[
Chromatin remodeling of histone H3 variants underlies epigenetic inheritance of DNA methylation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.11.548598?rss=1</link>
<description><![CDATA[
Epigenetic inheritance refers to the faithful replication of DNA methylation and histone modification independent of DNA sequence. Nucleosomes block access to DNA methyltransferases, unless they are remodeled by DECREASE IN DNA METHYLATION1 (DDM1Lsh/HELLS), a Snf2-like master regulator of epigenetic inheritance. We show that DDM1 activity results in replacement of the transcriptional histone variant H3.3 for the replicative variant H3.1 during the cell cycle. In ddm1 mutants, DNA methylation can be restored by loss of the H3.3 chaperone HIRA, while the H3.1 chaperone CAF-1 becomes essential. The single-particle cryo-EM structure at 3.2 [A] of DDM1 with a variant nucleosome reveals direct engagement at SHL2 with histone H3.3 at or near variant residues required for assembly, as well as with the deacetylated H4 tail. An N-terminal autoinhibitory domain binds H2A variants to allow remodeling, while a disulfide bond in the helicase domain is essential for activity in vivo and in vitro. We show that differential remodeling of H3 and H2A variants in vitro reflects preferential deposition in vivo. DDM1 co-localizes with H3.1 and H3.3 during the cell cycle, and with the DNA methyltransferase MET1Dnmt1. DDM1 localization to the chromosome is blocked by H4K16 acetylation, which accumulates at DDM1 targets in ddm1 mutants, as does the sperm cell specific H3.3 variant MGH3 in pollen, which acts as a placeholder nucleosome in the germline and contributes to epigenetic inheritance.
]]></description>
<dc:creator>Lee, S. C.</dc:creator>
<dc:creator>Adams, D. W.</dc:creator>
<dc:creator>Ipsaro, J. J.</dc:creator>
<dc:creator>Cahn, J.</dc:creator>
<dc:creator>Lynn, J.</dc:creator>
<dc:creator>Kim, H.-S.</dc:creator>
<dc:creator>Berube, B.</dc:creator>
<dc:creator>Major, V.</dc:creator>
<dc:creator>Calarco, J. P.</dc:creator>
<dc:creator>LeBlanc, C.</dc:creator>
<dc:creator>Bhattacharjee, S.</dc:creator>
<dc:creator>Ramu, U.</dc:creator>
<dc:creator>Grimanelli, D.</dc:creator>
<dc:creator>Jacob, Y.</dc:creator>
<dc:creator>Voigt, P.</dc:creator>
<dc:creator>Joshua-Tor, L.</dc:creator>
<dc:creator>Martienssen, R. A.</dc:creator>
<dc:date>2023-07-11</dc:date>
<dc:identifier>doi:10.1101/2023.07.11.548598</dc:identifier>
<dc:title><![CDATA[Chromatin remodeling of histone H3 variants underlies epigenetic inheritance of DNA methylation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.10.547212?rss=1">
<title>
<![CDATA[
Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.10.547212?rss=1</link>
<description><![CDATA[
Microbiome research has gained much attention in recent years as the importance of gut microbiota in regulating host health becomes increasingly evident. However, the impact of radiation on the microbiota in the murine bone marrow transplantation model is still poorly understood. In this paper, we present the major conclusions of our investigation into the effects of radiation and subsequent bone marrow transplantation with or without T cell depletion of the donor bone-marrow on the microbiota of the ileum and cecum. Our findings show that radiation has different effects on the microbiota of the two intestinal regions, with the cecum showing increased interindividual variation, suggesting an impaired ability of the host to regulate microbial symbionts, consistent with the Anna Karenina principle. Additionally, we observed changes in the ileum composition, including an increase in bacterial taxa that are important modulators of host health, such as Akkermansia and Faecalibaculum.

In contrast, radiation in the cecum was associated with an increased abundance of several common commensal taxa in the gut, including Lachnospiraceae and Bacteroides. Finally, we found that high doses of radiation had more substantial effects on the caecal microbiota of the T-cell-depleted group than that of the non-T-cell-depleted group. Overall, our results contribute to a better understanding of the complex relationship between radiation and the gut microbiota in the context of bone marrow transplantation and highlight the importance of considering different intestinal regions when studying microbiome responses to environmental stressors.
]]></description>
<dc:creator>Kreisinger, J.</dc:creator>
<dc:creator>Dooley, J.</dc:creator>
<dc:creator>Singh, K.</dc:creator>
<dc:creator>Cizkova, D.</dc:creator>
<dc:creator>Schmiedova, L.</dc:creator>
<dc:creator>Bendova, B.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:creator>Moudra, A.</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:identifier>doi:10.1101/2023.07.10.547212</dc:identifier>
<dc:title><![CDATA[Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.29.541316?rss=1">
<title>
<![CDATA[
Delay of human early development via in vitro diapause 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.29.541316?rss=1</link>
<description><![CDATA[
Many mammals can control the timing of gestation and birth by pausing embryonic development at the blastocyst stage. It is unknown whether the capacity to pause development is conserved, in general across mammals, and more specifically in humans. Activity of the growth regulating mTOR pathway governs developmental pausing in the mouse (1). Here we show a stage-specific capacity to delay the progression of human development via mTOR inhibition. In this context, human blastoids and pluripotent stem cells in naive and naive-like, but not primed, states can be induced to enter a dormant state, which is reversible at the functional and molecular level. Comparative analysis of mouse and human naive cells longitudinal response to mTORi revealed distinct temporal dynamics and metabolic requirements of dormancy in each species. Mouse and human blastocysts show similar tissue-specific patterns of mTOR pathway activity, suggesting that the mTOR pathway may be a conserved regulator of blastocyst development and timing in both species. Our results raise the possibility that the developmental timing of the human embryo may be controllable, with implications for reproductive therapies.
]]></description>
<dc:creator>Bulut-Karslioglu, A.</dc:creator>
<dc:creator>Iyer, D.</dc:creator>
<dc:creator>van der Weijden, V.</dc:creator>
<dc:creator>Heidari Khoei, H.</dc:creator>
<dc:creator>McCarthy, A.</dc:creator>
<dc:creator>Rayon, T.</dc:creator>
<dc:creator>Simon, C.</dc:creator>
<dc:creator>Dunkel, I.</dc:creator>
<dc:creator>Wamaitha, S.</dc:creator>
<dc:creator>Schulz, E.</dc:creator>
<dc:creator>Niakan, K.</dc:creator>
<dc:creator>Rivron, N. C.</dc:creator>
<dc:date>2023-05-29</dc:date>
<dc:identifier>doi:10.1101/2023.05.29.541316</dc:identifier>
<dc:title><![CDATA[Delay of human early development via in vitro diapause]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.18.541123?rss=1">
<title>
<![CDATA[
PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.18.541123?rss=1</link>
<description><![CDATA[
The PIP3/PI3K network is a central regulator of metabolism and is frequently activated in cancer, commonly by loss of the PIP3/PI(3,4)P2-phosphatase, PTEN. Despite huge investment, the drivers of the PI3K network in normal tissues and how they adapt to overactivation are unclear.

We find that in healthy mouse prostate PI3K activity is driven by RTK/IRS signalling and constrained by pathway-feedback. In the absence of PTEN, the network is dramatically remodelled. A poorly understood, YXXM and PIP3/PI(3,4)P2-binding PH domain-containing, adaptor, PLEKHS1, became the dominant activator and was required to sustain PIP3, AKT-phosphorylation and growth in PTEN-null prostate. This was because PLEKHS1 evaded pathway-feedback and experienced enhanced PI3K and SRC-family kinase-dependent phosphorylation of Y258XXM, eliciting PI3K activation. hPLEKHS1-mRNA and activating-Y419-phosphorylation of hSRC correlated with PI3K-pathway activity in human prostate cancers. We propose that in PTEN-null cells, receptor-independent, SRC-dependent tyrosine-phosphorylation of PLEKHS1 creates positive-feedback that escapes homeostasis, drives PIP3- signalling and supports tumour progression.
]]></description>
<dc:creator>Chessa, T. A. M.</dc:creator>
<dc:creator>Jung, P.</dc:creator>
<dc:creator>Suire, S.</dc:creator>
<dc:creator>Anwar, A.</dc:creator>
<dc:creator>Anderson, K. E.</dc:creator>
<dc:creator>Barneda, D.</dc:creator>
<dc:creator>Kielkowska, A.</dc:creator>
<dc:creator>Sadiq, B. A.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Felisbino, S.</dc:creator>
<dc:creator>Spensberger, D.</dc:creator>
<dc:creator>Segonds-Pichon, A.</dc:creator>
<dc:creator>Wilson, M.</dc:creator>
<dc:creator>Walker, S.</dc:creator>
<dc:creator>Okkenhaug, H.</dc:creator>
<dc:creator>Cosulich, S.</dc:creator>
<dc:creator>Hawkins, P. T.</dc:creator>
<dc:creator>Stephens, L. R.</dc:creator>
<dc:date>2023-05-18</dc:date>
<dc:identifier>doi:10.1101/2023.05.18.541123</dc:identifier>
<dc:title><![CDATA[PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.11.539978?rss=1">
<title>
<![CDATA[
Zfp36l1 establishes the high affinity CD8 T cell response by directly linking TCR affinity to cytokine sensing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.11.539978?rss=1</link>
<description><![CDATA[
How individual T cells compete for and respond to IL2 at the molecular level, and, as a consequence, how this shapes population dynamics and the selection of high affinity clones is still poorly understood. Here we describe how the RNA binding protein ZFP36L1, acts as a sensor of TCR affinity to promote clonal expansion of high affinity CD8 T cells. As part of an incoherent feed forward loop ZFP36L1 has a non-redundant role in suppressing negative regulators of cytokine signalling and mediating a selection mechanism based on competition for IL2. We suggest that ZFP36L1 acts as a sensor of antigen affinity and establishes dominance of high affinity T cells by installing a hierarchical response to IL2.
]]></description>
<dc:creator>Petkau, G.</dc:creator>
<dc:creator>Mitchell, T.</dc:creator>
<dc:creator>Jones Evans, M.</dc:creator>
<dc:creator>Matheson, L. S.</dc:creator>
<dc:creator>Salerno, F.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:date>2023-05-13</dc:date>
<dc:identifier>doi:10.1101/2023.05.11.539978</dc:identifier>
<dc:title><![CDATA[Zfp36l1 establishes the high affinity CD8 T cell response by directly linking TCR affinity to cytokine sensing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.24.538044?rss=1">
<title>
<![CDATA[
B cells from aged mice do not have intrinsic defects in affinity maturation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.24.538044?rss=1</link>
<description><![CDATA[
Affinity maturation, the progressive increase in serum antibody affinity after vaccination, is an essential process that contributes to an effective humoral response against vaccines and infections. Germinal centres (GCs) are key for affinity maturation, as they are where B cells undergo somatic hypermutation of their immunoglobulin genes in the dark zone, before going through positive selection in the light zone via interactions with T follicular helper cells and follicular dendritic cells. In aged mice, affinity maturation has been shown to be impaired, but whether B cell-intrinsic factors contribute to this defect remains unclear. In this study, we show that B cells from aged B cell receptor transgenic mice are able to become GC B cells, which are capable of receiving positive selection signals to a similar extent as B cells from young adult mice. Consistent with this, ageing also does not impact the ability of B cells to undergo somatic hypermutation and acquire affinity-enhancing mutations. Together, this shows that there are no B cell-intrinsic defects in affinity maturation with age when the B cell receptor repertoire is constant.
]]></description>
<dc:creator>Lee, J. L.</dc:creator>
<dc:creator>Innocentin, S.</dc:creator>
<dc:creator>Silva-Cayetano, A.</dc:creator>
<dc:creator>Guillaume, S.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:date>2023-04-25</dc:date>
<dc:identifier>doi:10.1101/2023.04.24.538044</dc:identifier>
<dc:title><![CDATA[B cells from aged mice do not have intrinsic defects in affinity maturation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.22.533754?rss=1">
<title>
<![CDATA[
Lysosome damage triggers direct ATG8 conjugation and ATG2 engagement via CASM 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.22.533754?rss=1</link>
<description><![CDATA[
Cells harness multiple pathways to maintain lysosome integrity, a central homeostatic process. Damaged lysosomes can be repaired, or targeted for degradation by lysophagy, a selective autophagy process involving ATG8/LC3. Here, we describe a parallel ATG8/LC3 response to lysosome damage, mechanistically distinct from lysophagy. Using a comprehensive series of biochemical, pharmacological and genetic approaches, we show that lysosome damage induces rapid Conjugation of ATG8s to Single Membranes (CASM). ATG8 proteins are recruited directly onto damaged membranes, independently of ATG13/WIPI2, and conjugated to PS, as well as PE, a molecular hallmark of CASM. Lysosome damage drives V-ATPase V0-V1 association, and direct recruitment of ATG16L1, dependent on K490 (WD40-domain), and sensitive to Salmonella SopF. Lysosome damage-induced CASM is associated with the formation of dynamic LC3A-positive tubules, and promotes robust LC3A engagement with ATG2, a lipid transfer protein central to lysosome repair. Together, our data identify direct ATG8 conjugation as a rapid response to lysosome damage, with important links to lipid transfer and dynamics.
]]></description>
<dc:creator>Cross, J.</dc:creator>
<dc:creator>Durgan, J.</dc:creator>
<dc:creator>McEwan, D. G.</dc:creator>
<dc:creator>Florey, O.</dc:creator>
<dc:date>2023-03-22</dc:date>
<dc:identifier>doi:10.1101/2023.03.22.533754</dc:identifier>
<dc:title><![CDATA[Lysosome damage triggers direct ATG8 conjugation and ATG2 engagement via CASM]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.13.528037?rss=1">
<title>
<![CDATA[
Ubiquitination is a novel post-translational modification of VMP1 in autophagy of human tumor cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.13.528037?rss=1</link>
<description><![CDATA[
Autophagy is a tightly regulated catabolic process involved in the degradation and re-cycling of proteins and organelles. Ubiquitination plays an important role in the regulation of autophagy. Vacuole Membrane Protein 1 (VMP1) is an essential autophagy protein. The expression of VMP1 in pancreatic cancer stem cells carrying the activated Kirsten rat sarcoma viral oncogene homolog (KRAS) triggers autophagy and enables therapy resistance. Using biochemical and cellular approaches, we identified ubiquitination as a post-translational modification of VMP1 from the initial steps in autophagosome biogenesis. VMP1 remains ubiquitinated as part of the autophagosome membrane throughout autophagic flux until autolysosome formation. However, VMP1 is not degraded by autophagy, nor by the ubiquitin-proteasomal system. Mass spectrometry and immunoprecipitation showed that the cell division cycle protein cdt2 (Cdt2), the substrate recognition subunit of the E3 ligase complex associated with cancer, cullin-RING ubiquitin ligase complex 4 (CRL4), is a novel interactor of VMP1 and is involved in VMP1 ubiquitination. VMP1 ubiquitination decreases under the CRL inhibitor MLN4924 and increases with Cdt2 overexpression. Moreover, VMP1 recruitment and autophagosome formation is significantly affected by CRL inhibition. Our results indicate that ubiquitination is a novel post-translational modification of VMP1 during autophagy in human tumor cells. VMP1 ubiquitination may be of clinical relevance in tumor cell therapy resistance.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=68 SRC="FIGDIR/small/528037v2_ufig1.gif" ALT="Figure 1">
View larger version (21K):
org.highwire.dtl.DTLVardef@1a1538dorg.highwire.dtl.DTLVardef@74580corg.highwire.dtl.DTLVardef@409ef0org.highwire.dtl.DTLVardef@82b856_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Renna, F. J.</dc:creator>
<dc:creator>Steinberg, J. H. E.</dc:creator>
<dc:creator>Manifava, M.</dc:creator>
<dc:creator>Gonzalez, C. D.</dc:creator>
<dc:creator>Tadic, M. S.</dc:creator>
<dc:creator>Orquera, T.</dc:creator>
<dc:creator>Vecino, C. V.</dc:creator>
<dc:creator>Ropolo, A.</dc:creator>
<dc:creator>Rossi, M.</dc:creator>
<dc:creator>Ktistakis, N. T.</dc:creator>
<dc:creator>Vaccaro, M. I.</dc:creator>
<dc:date>2023-02-13</dc:date>
<dc:identifier>doi:10.1101/2023.02.13.528037</dc:identifier>
<dc:title><![CDATA[Ubiquitination is a novel post-translational modification of VMP1 in autophagy of human tumor cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.03.527081?rss=1">
<title>
<![CDATA[
MICA: A multi-omics method to predict gene regulatory networks in early human embryos 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.03.527081?rss=1</link>
<description><![CDATA[
Recent advances in single-cell-omics have been transformative to characterise cell types in challenging to study biological contexts. It is technically difficult to infer transcription factor-gene regulatory interactions from these datasets, especially in contexts with limited single-cell sample number such as the early human embryo. Here we systematically assessed the application of four different linear or non-linear gene regulatory network (GRN) prediction strategies to single-cell simulated and human embryo transcriptome datasets. We also compared how gene expression normalisation methods impact on regulatory network predictions, finding that TPM (transcripts per million reads) outperformed alternative methods. We identified more reproducible GRN inferences using a non-linear method based on mutual information (MI) applied to single-cell transcriptome datasets refined with chromatin accessibility (CA) (called MICA), compared to alternative network prediction methods tested. MICA captures complex non-monotonic dependencies and feedback loops. Using MICA, we generated the first GRN inferences in early human development. MICA predicted co-localisation of the AP-1 transcription factor subunit proto-oncogene JUND and the TFAP2C transcription factor AP-2{psi} in human preimplantation embryos. These interactions were supported by previous findings in other developmental and stem cell contexts. Overall, our comparative analysis of gene regulatory network prediction methods defines a pipeline that can be applied to single-cell multi-omics datasets in especially challenging contexts to infer interactions between transcription factor expression and target gene regulation.
]]></description>
<dc:creator>Alanis-Lobato, G.</dc:creator>
<dc:creator>Bartlett, T. E.</dc:creator>
<dc:creator>Huang, Q.</dc:creator>
<dc:creator>Simon, C.</dc:creator>
<dc:creator>McCarthy, A.</dc:creator>
<dc:creator>Elder, K.</dc:creator>
<dc:creator>Snell, P.</dc:creator>
<dc:creator>Christie, L.</dc:creator>
<dc:creator>Niakan, K.</dc:creator>
<dc:date>2023-02-03</dc:date>
<dc:identifier>doi:10.1101/2023.02.03.527081</dc:identifier>
<dc:title><![CDATA[MICA: A multi-omics method to predict gene regulatory networks in early human embryos]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.30.526343?rss=1">
<title>
<![CDATA[
Single cell DNA methylation ageing in mouse blood 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.30.526343?rss=1</link>
<description><![CDATA[
Ageing is the accumulation of changes and overall decline of the function of cells, organs and organisms over time. At the molecular and cellular level, the concept of biological age has been established and biomarkers of biological age have been identified, notably epigenetic DNA-methylation based clocks. With the emergence of single-cell DNA methylation profiling methods, the possibility to study biological age of individual cells has been proposed, and a first proof-of-concept study, based on limited single cell datasets mostly from early developmental origin, indicated the feasibility and relevance of this approach to better understand organismal changes and cellular ageing heterogeneity.

Here we generated a large single-cell DNA methylation and matched transcriptome dataset from mouse peripheral blood samples, spanning a broad range of ages (10-101 weeks of age). We observed that the number of genes expressed increased at older ages, but gene specific changes were small. We next developed a robust single cell DNA methylation age predictor (scEpiAge), which can accurately predict age in a broad range of publicly available datasets, including very sparse data and it also predicts age in single cells. Interestingly, the DNA methylation age distribution is wider than technically expected in 19% of single cells, suggesting that epigenetic age heterogeneity is present in vivo and may relate to functional differences between cells. In addition, we observe differences in epigenetic ageing between the major blood cell types. Our work provides a foundation for better single-cell and sparse data epigenetic age predictors and highlights the significance of cellular heterogeneity during ageing.

Highlights- Model to estimate DNA methylation age in single cells
- Large multi-omics dataset of single cells from murine blood
- Epigenetic age deviations from chronological age are greater than technical expected from technical variability
- Number of genes expressed increases with chronological and epigenetic age
]]></description>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:creator>Clark, S.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Luo, S.</dc:creator>
<dc:creator>Agostinho de Sousa, J.</dc:creator>
<dc:creator>Hashtroud, A. M.</dc:creator>
<dc:creator>Stubbs, T. M.</dc:creator>
<dc:creator>Stark, A.-K.</dc:creator>
<dc:creator>Rulands, S.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>von Meyenn, F.</dc:creator>
<dc:date>2023-02-01</dc:date>
<dc:identifier>doi:10.1101/2023.01.30.526343</dc:identifier>
<dc:title><![CDATA[Single cell DNA methylation ageing in mouse blood]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.26.524308?rss=1">
<title>
<![CDATA[
The LCLAT1/LYCAT acyltransferase supports EGF-mediated phosphatidylinositol-3,4,5-trisphosphate and Akt signalling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.26.524308?rss=1</link>
<description><![CDATA[
Receptor tyrosine kinases such as epidermal growth factor receptor (EGFR) stimulate phosphoinositide 3-kinases (PI3Ks) to convert phosphatidylinositol-4,5-bisphosophate [PtdIns(4,5)P2] into phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P3]. PtdIns(3,4,5)P3 then remodels actin and gene expression, and boosts cell survival and proliferation. PtdIns(3,4,5)P3 partly achieves these functions by triggering activation of the kinase Akt, which phosphorylates targets like Tsc2 and GSK3{beta}. Consequently, unchecked upregulation of PtdIns(3,4,5)P3-Akt signalling promotes tumour progression. Interestingly, 50-70% of PtdIns and PtdInsPs have stearate and arachidonate at sn-1 and sn-2 positions of glycerol, respectively, forming a species known as 38:4-PtdIns/PtdInsPs. LCLAT1 and MBOAT7 acyltransferases partly enrich PtdIns in this acyl format. We previously showed that disruption of LCLAT1 lowered PtdIns(4,5)P2 levels and perturbed endocytosis and endocytic trafficking. However, the role of LCLAT1 in receptor tyrosine kinase and PtdIns(3,4,5)P3 signaling was not explored. Here, we show that LCLAT1 silencing in MDA-MB-231 and ARPE-19 cells abated the levels of PtdIns(3,4,5)P3 in response to EGF signalling. Importantly, LCLAT1-silenced cells were also impaired for EGF-driven and insulin-driven Akt activation and downstream signalling. Thus, our work provides first evidence that the LCLAT1 acyltransferase is required for receptor tyrosine kinase signalling.
]]></description>
<dc:creator>Chan, V.</dc:creator>
<dc:creator>Bone, L.</dc:creator>
<dc:creator>Anderson, K. E.</dc:creator>
<dc:creator>Zhang, K.</dc:creator>
<dc:creator>Orofiamma, L.</dc:creator>
<dc:creator>Awadeh, Y.</dc:creator>
<dc:creator>Lee, D. K. C.</dc:creator>
<dc:creator>Fu, N. J.</dc:creator>
<dc:creator>Chow, J. T. S.</dc:creator>
<dc:creator>Salmena, L.</dc:creator>
<dc:creator>Stephens, L. R.</dc:creator>
<dc:creator>Hawkins, P. T.</dc:creator>
<dc:creator>Antonescu, C. N.</dc:creator>
<dc:creator>Botelho, R. J.</dc:creator>
<dc:date>2023-01-27</dc:date>
<dc:identifier>doi:10.1101/2023.01.26.524308</dc:identifier>
<dc:title><![CDATA[The LCLAT1/LYCAT acyltransferase supports EGF-mediated phosphatidylinositol-3,4,5-trisphosphate and Akt signalling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.25.525562?rss=1">
<title>
<![CDATA[
Ageing impairs the regenerative capacity of regulatory T cells in central nervous system remyelination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.25.525562?rss=1</link>
<description><![CDATA[
Myelin regeneration (remyelination) is essential to prevent neurodegeneration in demyelinating diseases such as Multiple Sclerosis, however, its efficiency declines with age. Regulatory T cells (Treg) recently emerged as critical players in tissue regeneration, including remyelination. However, the effect of ageing on Treg-mediated regenerative processes is poorly understood. Here, we show that expansion of aged Treg does not rescue age-associated remyelination impairment due to an intrinsically diminished capacity of aged Treg to promote oligodendrocyte differentiation and myelination. This decline in regenerative Treg functions can be rescued by a young environment. We identified Melanoma Cell Adhesion Molecule 1 (MCAM1) and Integrin alpha 2 (ITGA2) as novel candidates of Treg-mediated oligodendrocyte differentiation that decrease with age. Our findings demonstrate that ageing limits the neuroregenerative capacity of Treg, likely limiting their remyelinating therapeutic potential in aged patients, and describe two novel mechanisms implicated in Treg-driven remyelination that may be targetable to overcome this limitation.
]]></description>
<dc:creator>de la Fuente, A. G.</dc:creator>
<dc:creator>Dittmer, M.</dc:creator>
<dc:creator>Heesbeen, E.</dc:creator>
<dc:creator>de la Vega-Gallardo, N.</dc:creator>
<dc:creator>White, J. A.</dc:creator>
<dc:creator>Young, A.</dc:creator>
<dc:creator>Mayne, K.</dc:creator>
<dc:creator>Falconer, J.</dc:creator>
<dc:creator>McMurran, C. E.</dc:creator>
<dc:creator>Innayatulah, M.</dc:creator>
<dc:creator>Tiwari, V.</dc:creator>
<dc:creator>Penalva, R.</dc:creator>
<dc:creator>Ingram, R. J.</dc:creator>
<dc:creator>Dombrowski, Y.</dc:creator>
<dc:creator>Fitzgerald, D. C.</dc:creator>
<dc:date>2023-01-25</dc:date>
<dc:identifier>doi:10.1101/2023.01.25.525562</dc:identifier>
<dc:title><![CDATA[Ageing impairs the regenerative capacity of regulatory T cells in central nervous system remyelination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.16.524218?rss=1">
<title>
<![CDATA[
Dbx2, an aging-related homeobox gene, inhibits the proliferation of adult neural progenitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.16.524218?rss=1</link>
<description><![CDATA[
The subventricular zone (SVZ) of the adult mouse brain contains quiescent neural stem cells, which can be activated (aNSCs) to generate transit amplifying progenitors (TAPs), neuroblasts (NBs) and newborn neurons. Neurogenesis declines during aging, as the aged SVZ niche causes transcriptomic changes that promote NSC quiescence and decrease proliferating neural/stem progenitor cells (NSPCs). The transcription factors mediating these changes, however, remain unclear. We previously found that the homeobox gene Dbx2 is upregulated in aged SVZ NSPCs and inhibits NSPC culture growth. Here, we report that Dbx2 is repressed by Epidermal Growth Factor Receptor signaling, which promotes NSPC proliferation and decreases in the aged SVZ. We show that Dbx2 inhibits NSPC proliferation by hindering the G2/M transition and elucidate the transcriptomic networks modulated by Dbx2, highlighting its role in the downregulation of the cell cycle molecular pathways. Accordingly, Dbx2 function is negatively correlated with the transcriptional signatures of proliferative NSPCs (aNSCs, TAPs and early NBs). These results point to Dbx2 as a molecular node relaying the anti-neurogenic input of the aged niche to the NSPC transcriptome.
]]></description>
<dc:creator>Giuliani, A.</dc:creator>
<dc:creator>Licursi, V.</dc:creator>
<dc:creator>Nisi, P. S.</dc:creator>
<dc:creator>Fiore, M.</dc:creator>
<dc:creator>Biagioni, S.</dc:creator>
<dc:creator>Negri, R.</dc:creator>
<dc:creator>Rugg-Gunn, P.</dc:creator>
<dc:creator>Cacci, E.</dc:creator>
<dc:creator>Lupo, G.</dc:creator>
<dc:date>2023-01-19</dc:date>
<dc:identifier>doi:10.1101/2023.01.16.524218</dc:identifier>
<dc:title><![CDATA[Dbx2, an aging-related homeobox gene, inhibits the proliferation of adult neural progenitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.11.523441?rss=1">
<title>
<![CDATA[
Dynamic DNA methylation turnover at the exit of pluripotency epigenetically primes gene regulatory elements for hematopoietic lineage specification 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.11.523441?rss=1</link>
<description><![CDATA[
Epigenetic mechanisms govern developmental cell fate decisions, but how DNA methylation coordinates with chromatin structure and three-dimensional DNA folding to enact cell-type specific gene expression programmes remains poorly understood. Here, we use mouse embryonic stem and epiblast-like cells deficient for 5-methyl cytosine or its oxidative derivatives (5-hydroxy-, 5-formyl- and 5-carboxy-cytosine) to dissect the gene regulatory mechanisms that control cell lineage specification at the exit of pluripotency. Genetic ablation of either DNA methyltransferase (Dnmt) or Ten-eleven-translocation (Tet) activity yielded largely distinct sets of dysregulated genes, revealing divergent transcriptional defects upon perturbation of individual branches of the DNA cytosine methylation cycle. Unexpectedly, we found that disrupting DNA methylation or oxidation interferes with key enhancer features, including chromatin accessibility, enhancer-characteristic histone modifications, and long-range chromatin interactions with putative target genes. In addition to affecting transcription of select genes in pluripotent stem cells, we observe impaired enhancer priming, including a loss of three-dimensional interactions, at regulatory elements associated with key lineage-specifying genes that are required later in development, as we demonstrate for the key hematopoietic genes Klf1 and Lyl1. Consistently, we observe impaired transcriptional activation of blood genes during embryoid body differentiation of knockout cells. Our findings identify a novel role for the dynamic turnover of DNA methylation at the exit of pluripotency to establish and maintain chromatin states that epigenetically prime enhancers for later activation during developmental cell diversification.

HighlightsO_LIWe perform a detailed epigenetic characterisation of the mouse embryonic stem cell (ESC) to epiblast-like cell (EpiLC) transition in wild type, Tet triple-knockout (TKO) and Dnmt TKO lines and develop a novel clustering approach to interrogate the data.
C_LIO_LITet TKO reduces H3K4me1 and H3K27ac levels across enhancer elements upon pluripotency exit whilst Dnmt TKO affects only H3K4me1 levels, suggesting a novel role for oxidative derivatives in H3K4me1 deposition.
C_LIO_LITet TKO and Dnmt TKO affect enhancer priming in EpiLCs which is associated with failure to upregulate hematopoietic genes upon differentiation.
C_LIO_LILong-range chromosomal interactions between primed enhancers and their target genes are weakened in both Dnmt and Tet TKO.
C_LI
]]></description>
<dc:creator>Parry, A. J.</dc:creator>
<dc:creator>Krueger, C.</dc:creator>
<dc:creator>Lohoff, T.</dc:creator>
<dc:creator>Wingett, S.</dc:creator>
<dc:creator>Schoenfelder, S.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2023-01-11</dc:date>
<dc:identifier>doi:10.1101/2023.01.11.523441</dc:identifier>
<dc:title><![CDATA[Dynamic DNA methylation turnover at the exit of pluripotency epigenetically primes gene regulatory elements for hematopoietic lineage specification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.28.522149?rss=1">
<title>
<![CDATA[
Dynamic protein deacetylation is a limited carbon source for acetyl-CoA-dependent metabolism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.28.522149?rss=1</link>
<description><![CDATA[
The ability of cells to store and rapidly mobilize energy reserves in response to nutrient availability is essential for survival. Breakdown of carbon stores produces acetyl-coenzyme-A (acetyl-CoA), which fuels various metabolic pathways and is also the acyl donor for protein lysine acetylation. Notably, histone acetylation is sensitive to acetyl-CoA availability and nutrient replete conditions induce a substantial accumulation of acetylation on histones. Deacetylation releases acetate, which can be recycled to acetyl-CoA, suggesting that deacetylation could be mobilized as an acetyl-CoA source to feed downstream metabolic processes under nutrient depletion. While the notion of histones as a metabolic reservoir has been frequently proposed, experimental evidence has been lacking. Therefore, to test this concept directly, we developed an experimental system to trace deacetylation-derived acetate and its incorporation into acetyl-CoA, using 13C2-acetate in ATP citrate lyase-deficient fibroblasts (Acly-/- MEFs), which are primarily dependent on acetate for protein acetylation. We find that dynamic protein deacetylation in Acly-/- MEFs contributes carbons to acetyl-CoA and proximal downstream metabolites. However, there is no significant effect on acyl-CoA pool sizes, and even at maximal acetylation, deacetylation transiently supplies approximately 9% of cellular acetyl-CoA. Together, our data reveal that although protein acetylation is dynamic and sensitive to nutrient availability, its potential for maintaining cellular acetyl-CoA-dependent metabolic pathways is limited compared to cellular demand.
]]></description>
<dc:creator>Soaita, I.</dc:creator>
<dc:creator>Megill, E.</dc:creator>
<dc:creator>Kantner, D.</dc:creator>
<dc:creator>Chatoff, A.</dc:creator>
<dc:creator>Arany, Z.</dc:creator>
<dc:creator>Snyder, N. W.</dc:creator>
<dc:creator>Wellen, K. E.</dc:creator>
<dc:creator>Trefely, S. W.</dc:creator>
<dc:date>2022-12-29</dc:date>
<dc:identifier>doi:10.1101/2022.12.28.522149</dc:identifier>
<dc:title><![CDATA[Dynamic protein deacetylation is a limited carbon source for acetyl-CoA-dependent metabolism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.22.521572?rss=1">
<title>
<![CDATA[
A quantitative and site-specific atlas of the in vivo citrullinome reveals widespread existence of citrullination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.22.521572?rss=1</link>
<description><![CDATA[
Citrullination is the conversion of peptidyl-arginine into the non-coded amino acid citrulline. Despite its importance in physiology and disease, global identification of citrullinated proteins and precise modification sites has remained challenging. Here, we employed quantitative mass spectrometry-based proteomics to generate a comprehensive atlas of citrullination sites in a physiologically relevant cell type. Collectively, we identified 14.056 citrullination sites within 4.008 proteins and quantified their regulation upon inhibition of the citrullinating enzyme PADI4. Using this rich dataset, we uncover general mechanistic and cell biological principles of citrullination function, while providing site-specific and quantitative information on thousands of PAD4 substrates within cells. Our findings include signature histone marks and numerous modifications on transcriptional regulators and chromatin-related signaling effectors. Additionally, we identify precise citrullination sites on an extensive list of known autoantigens. Collectively, we describe systems attributes of the human citrullinome and provide a resource framework for understanding citrullinaiton at the mechanistic level.
]]></description>
<dc:creator>Rebak, A.</dc:creator>
<dc:creator>Hendriks, I. A.</dc:creator>
<dc:creator>Buch-Larsen, S. C.</dc:creator>
<dc:creator>Elsborg, J. D.</dc:creator>
<dc:creator>Kirsch, R.</dc:creator>
<dc:creator>Doncheva, N. T.</dc:creator>
<dc:creator>Jensen, L. J.</dc:creator>
<dc:creator>Christophorou, M. A.</dc:creator>
<dc:creator>Nielsen, M. L.</dc:creator>
<dc:date>2022-12-22</dc:date>
<dc:identifier>doi:10.1101/2022.12.22.521572</dc:identifier>
<dc:title><![CDATA[A quantitative and site-specific atlas of the in vivo citrullinome reveals widespread existence of citrullination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.21.521417?rss=1">
<title>
<![CDATA[
Back to the Future: Unleashing your cytometers spectral potential 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.21.521417?rss=1</link>
<description><![CDATA[
With the recent growth in spectral flow cytometry many laboratories are investing in new spectral flow cytometers in order to maximise the information gathered about every cell. This study hypothesised that traditional cytometers already within many laboratories may be used as spectral cytometers and have shown using a range of different cytometers that data acquired may be unmixed after acquisition.
]]></description>
<dc:creator>Walker, R. V.</dc:creator>
<dc:creator>Hall, C.</dc:creator>
<dc:creator>Ibrahim, H.</dc:creator>
<dc:creator>Thompson, S.</dc:creator>
<dc:creator>Hobson, P.</dc:creator>
<dc:creator>Crofts, J.-A.</dc:creator>
<dc:creator>Nobes, P.</dc:creator>
<dc:creator>Lim, S.</dc:creator>
<dc:creator>Burpee, T.</dc:creator>
<dc:date>2022-12-22</dc:date>
<dc:identifier>doi:10.1101/2022.12.21.521417</dc:identifier>
<dc:title><![CDATA[Back to the Future: Unleashing your cytometers spectral potential]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.22.521580?rss=1">
<title>
<![CDATA[
An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.22.521580?rss=1</link>
<description><![CDATA[
During B cell maturation, transitional and mature B cells acquire cell-intrinsic features that determine their ability to exit quiescence and mount effective immune responses. We used label-free mass spectrometry to quantify the proteome of B cell subsets from the mouse spleen and map the differential expression of environmental sensing, transcription- and translation initiation-factors that define cellular identity and function. By comparing the full-length transcriptome and proteome within the same sample, we identified mRNAs linked to B cell activation and antibody secretion that are expressed without detectable protein. These "poised" mRNAs might enable rapid protein production through increased translation or protein stability. In addition, through interrogation of our proteomic dataset, we found that the translational repressor PDCD4 restrains the response of marginal zone B cells to a T-independent antigen. Our molecular characterization of B cell maturation is a valuable resource to further explore the mechanisms underpinning the specialised functions of B cell subsets.
]]></description>
<dc:creator>Salerno, F.</dc:creator>
<dc:creator>Howden, A. J.</dc:creator>
<dc:creator>Matheson, L. S.</dc:creator>
<dc:creator>Gizlenci, O.</dc:creator>
<dc:creator>Screen, M.</dc:creator>
<dc:creator>Lingel, H.</dc:creator>
<dc:creator>Brunner-Weinzierl, M.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:date>2022-12-22</dc:date>
<dc:identifier>doi:10.1101/2022.12.22.521580</dc:identifier>
<dc:title><![CDATA[An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.02.514842?rss=1">
<title>
<![CDATA[
Intracellular calcium elevations drive the nucleation of FIP200- and ATG13-containing pre-autophagosomal structures that become omegasomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.02.514842?rss=1</link>
<description><![CDATA[
Ca2+ modulates autophagy at multiple steps including the induction and maturation of autophagosomes, but the magnitude and spatiotemporal properties of this calcium signal and its ultimate effect on the autophagic machinery are unclear. Focusing on the induction step leading to omegasome formation, we report that low but sustained elevations in cytosolic calcium levels induce omegasome formation but treatments that only transiently elevate calcium do not. The calcium-induced structures are early intermediates that mature into omegasomes but do not constitute full autophagosomes because they are partially devoid of late autophagy proteins ATG16 and LC3. In addition to omegasomes, all four components of the ULK complex (ULK1, FIP200, ATG13, ATG101) respond to calcium modulation: they translocate to early autophagy puncta in complete medium upon calcium elevation, and are inhibited from translocation during starvation by calcium chelation with BAPTA-2 AM. The principal early step affected by calcium lies downstream of mTORC1 inactivation and upstream of VPS34 activation, coinciding biochemically with phosphorylation of ATG13 at serine 318, which is known to require ULK1 activity. However, although the calcium-mediated step requires ATG9, FIP200 and ATG13, it does not require ULK1/2, suggesting that calcium does not directly regulate ULK1 activity but rather it regulates the mechanism by which the ULK complex components ATG13 and FIP200, together with ATG9, nucleate pre-autophagosomal precursors. This calcium-induced nucleation is sufficient to drive autophagy induction up to the omegasome step, but not beyond it.
]]></description>
<dc:creator>Smith, M.</dc:creator>
<dc:creator>Schoenfelder, P.</dc:creator>
<dc:creator>Manifava, M.</dc:creator>
<dc:creator>Polson, H.</dc:creator>
<dc:creator>Tooze, S.</dc:creator>
<dc:creator>Roderick, L.</dc:creator>
<dc:creator>Ktistakis, N.</dc:creator>
<dc:date>2022-11-02</dc:date>
<dc:identifier>doi:10.1101/2022.11.02.514842</dc:identifier>
<dc:title><![CDATA[Intracellular calcium elevations drive the nucleation of FIP200- and ATG13-containing pre-autophagosomal structures that become omegasomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.19.512842?rss=1">
<title>
<![CDATA[
High-resolution promoter interaction analysis in Type 3 Innate Lymphoid Cells implicates Batten Disease gene CLN3 in Crohn's Disease aetiology 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.19.512842?rss=1</link>
<description><![CDATA[
Innate lymphoid cells (ILCs) are rare, tissue-resident innate lymphocytes that functionally mirror CD4+ T helper cell lineages but lack antigen receptors. Type 3 ILCs (ILC3s) are enriched in the gut, airways, and mucosal lymphoid tissues, where they regulate inflammation and promote barrier integrity. To define the regulatory architecture of primary human ILC3s, we map promoter-anchored chromosomal contacts using high-resolution, low-input Promoter Capture Hi-C (PCHi-C) in these cells alongside CD4+ T cells. By combining statistical detection with a PCHi-C-adapted Activity-by-Contact approach, we link promoters to distal regulatory elements, identifying hundreds of ILC3-specific contacts. We use these maps to connect genome-wide association study (GWAS) risk variants for Crohns disease to target genes using multiCOGS, a Bayesian framework that integrates PCHi-C with summary-statistic imputation and multivariate fine-mapping. This analysis highlights both known and unanticipated candidates, including CLN3, a causal gene for the neurodevelopmental Batten disease. Using a mouse ILC3-like cell line, we show that Cln3 is downregulated upon cytokine stimulation, and Cln3 overexpression alters stimulation-induced transcriptional programmes and cytokine secretion. Extending this approach, we generate a catalogue of ILC3-linked risk genes for five additional autoimmune conditions and show that they are enriched for regulators of the ILC3 inflammatory response identified in a CRISPR interference screen. Together, these findings illuminate long-range gene control in ILC3s and prioritise known and newly implicated autoimmune risk genes with potential roles in this clinically important cell type.
]]></description>
<dc:creator>Malysheva, V.</dc:creator>
<dc:creator>Ray-Jones, H.</dc:creator>
<dc:creator>Cazares, T. A.</dc:creator>
<dc:creator>Clay, O.</dc:creator>
<dc:creator>Ohayon, D.</dc:creator>
<dc:creator>Artemov, P.</dc:creator>
<dc:creator>Wayman, J. A.</dc:creator>
<dc:creator>Della Rosa, M.</dc:creator>
<dc:creator>Petitjean, C.</dc:creator>
<dc:creator>Ellaway, J. I. J.</dc:creator>
<dc:creator>Orchard, W.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Parameswaran, S.</dc:creator>
<dc:creator>Nagano, T.</dc:creator>
<dc:creator>Fraser, P.</dc:creator>
<dc:creator>Schoenfelder, S.</dc:creator>
<dc:creator>Weirauch, M.</dc:creator>
<dc:creator>Kottyan, L. C.</dc:creator>
<dc:creator>Smith, D. F.</dc:creator>
<dc:creator>Powell, N.</dc:creator>
<dc:creator>Weimer, J.</dc:creator>
<dc:creator>Wallace, C.</dc:creator>
<dc:creator>Miraldi, E. R.</dc:creator>
<dc:creator>Waggoner, S.</dc:creator>
<dc:creator>Spivakov, M.</dc:creator>
<dc:date>2022-10-21</dc:date>
<dc:identifier>doi:10.1101/2022.10.19.512842</dc:identifier>
<dc:title><![CDATA[High-resolution promoter interaction analysis in Type 3 Innate Lymphoid Cells implicates Batten Disease gene CLN3 in Crohn's Disease aetiology]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.27.509783?rss=1">
<title>
<![CDATA[
Inter-gastruloid heterogeneity revealed by single cell transcriptomics time course: implications for organoid based perturbation studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.27.509783?rss=1</link>
<description><![CDATA[
Recent advances in organoid and genome editing technologies are allowing for perturbation experiments at an unprecedented scale. However, before doing such experiments it is important to understand the gene expression profile in each of the organoids cells, as well as how much heterogeneity there is between individual organoids. Here we characterise an organoid model of mouse gastrulation called gastruloids using single cell RNA-sequencing of individual organoids at half-day intervals between day 3 and day 5 of differentiation (roughly corresponding to E6.5-E8.75 in vivo). Our study reveals multiple differentiation trajectories that have hitherto not been characterised in gastruloids. Intriguingly, we observe that individual gastruloids displayed a strong bias towards producing either mesodermal (largely somitic) or ectodermal (specifically neural) cell types. This bifurcation is already seen at the earliest sampled time point, and is characterised by increased activity of WNT-associated pathways in mesodermally-biased gastruloids as compared to neurally-biased gastruloids. Notably, at day 5, mesodermal gastruloids show an increase in the proportion of neural cells, while neural gastruloids do not produce notably more mesodermal cells. This is in line with previous studies on how the balance between these cell types is regulated. We demonstrate using in silico simulations that without proper understanding of the inter-organoid heterogeneity, perturbation experiments have either very high false positive or negative rates, depending on the statistical model used. Thus in future studies, modelling of inter-organoid heterogeneity will be crucial when designing organoid-based perturbation studies.

HighlightsO_LIA single cell RNA-sequencing time course of day 3 to day 5 mouse gastruloids reveals multiple mesodermal and neural differentiation trajectories hitherto uncharacterised in gastruloids
C_LIO_LISingle gastruloid, single cell RNA-sequencing of mouse gastruloids reveals that gastruloids are either mesodermally- or neurally-biased
C_LIO_LIThe two classes of gastruloid arise from differences in response strength to the WNT-agonist chiron
C_LIO_LIAt day 5, mesodermal gastruloids start making more neural cells, while neural gastruloids do not make more mesodermal cells, aligning with previously studied in vivo feedback loops
C_LIO_LIWe show using simulations that understanding interorganoid heterogeneity is a crucial consideration in the design and analysis of well-powered organoid-based perturbation studies
C_LI
]]></description>
<dc:creator>Rosen, L. U.</dc:creator>
<dc:creator>Stapel, L. C.</dc:creator>
<dc:creator>Argelaguet, R.</dc:creator>
<dc:creator>Barker, C. G.</dc:creator>
<dc:creator>Yang, A.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Marioni, J. C.</dc:creator>
<dc:date>2022-09-28</dc:date>
<dc:identifier>doi:10.1101/2022.09.27.509783</dc:identifier>
<dc:title><![CDATA[Inter-gastruloid heterogeneity revealed by single cell transcriptomics time course: implications for organoid based perturbation studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.18.504441?rss=1">
<title>
<![CDATA[
NANOGP1, a tandem duplicate of NANOG, exhibits partial functional conservation in human naive pluripotent stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.18.504441?rss=1</link>
<description><![CDATA[
Gene duplication events are important drivers of evolution by providing genetic material for new gene functions. They also create opportunities for diverse developmental strategies to emerge between species. To study the contribution of duplicated genes to human early development, we examined the evolution and function of NANOGP1, a tandem duplicate of the key transcription factor NANOG. We found that NANOGP1 and NANOG have overlapping but distinct expression profiles, with high NANOGP1 expression restricted to early epiblast cells and naive-state pluripotent stem cells. Sequence analysis and epitope-tagging of the endogenous locus revealed that NANOGP1 is protein-coding with an intact homeobox domain. NANOGP1 has been retained only in great apes, whereas Old World monkeys have disabled the gene in different ways including point mutations in the homeodomain. NANOGP1 is a strong inducer of naive pluripotency; however, unlike NANOG, it is not required to maintain the undifferentiated status of human naive pluripotent cells. By retaining expression, sequence and partial functional conservation with its ancestral copy, NANOGP1 exemplifies how gene duplication and subfunctionalisation can contribute to transcription factor activity in human pluripotency and development.

Summary statementEstablishing that NANOGP1 has retained partial functional conservation with its ancestral copy NANOG sheds light on the role of gene duplication and subfunctionalisation in human pluripotency and development.
]]></description>
<dc:creator>Maskalenka, K.</dc:creator>
<dc:creator>Alagoz, G.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Wright, J.</dc:creator>
<dc:creator>Rostovskaya, M.</dc:creator>
<dc:creator>Nakhuda, A.</dc:creator>
<dc:creator>Bendall, A.</dc:creator>
<dc:creator>Krueger, C.</dc:creator>
<dc:creator>Walker, S.</dc:creator>
<dc:creator>Scally, A.</dc:creator>
<dc:creator>Rugg-Gunn, P.</dc:creator>
<dc:date>2022-08-19</dc:date>
<dc:identifier>doi:10.1101/2022.08.18.504441</dc:identifier>
<dc:title><![CDATA[NANOGP1, a tandem duplicate of NANOG, exhibits partial functional conservation in human naive pluripotent stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.19.500645?rss=1">
<title>
<![CDATA[
Dietary change without caloric restriction maintains a youthful profile in ageing yeast 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.19.500645?rss=1</link>
<description><![CDATA[
Caloric restriction increases lifespan and improves ageing health, but it is unknown whether these outcomes can be separated or achieved through less severe interventions. Here we show that an unrestricted galactose diet in early life minimises change during replicative ageing in budding yeast, irrespective of diet later in life. Lifespan and average mother cell division rate are comparable between glucose and galactose diets, but markers of senescence and the progressive dysregulation of gene expression observed on glucose are minimal on galactose, showing these to be associated rather than intrinsic aspects of the replicative ageing process. Respiration on galactose is critical for minimising hallmarks of ageing, and forced respiration during ageing on glucose by over-expression of the mitochondrial biogenesis factor Hap4 also has the same effect though only in a fraction of cells. This fraction maintains Hap4 activity to advanced age with low senescence and a youthful gene expression profile, whereas other cells in the same population lose Hap4 activity, undergo dramatic dysregulation of gene expression and accumulate fragments of chromosome XII (ChrXIIr), which are tightly associated with senescence. Our findings support the existence of two separable ageing trajectories in yeast. We propose that a complete shift to the healthy ageing mode can be achieved in wild-type cells through dietary change in early life without restriction.
]]></description>
<dc:creator>Horkai, D.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:date>2022-07-20</dc:date>
<dc:identifier>doi:10.1101/2022.07.19.500645</dc:identifier>
<dc:title><![CDATA[Dietary change without caloric restriction maintains a youthful profile in ageing yeast]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.14.500009?rss=1">
<title>
<![CDATA[
Senescence in yeast is associated with chromosome XII cleavage rather than ribosomal DNA circle accumulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.14.500009?rss=1</link>
<description><![CDATA[
The massive accumulation of extrachromosomal ribosomal DNA circles (ERCs) in yeast mother cells has been long cited as the primary driver of replicative ageing. ERCs arise through ribosomal DNA (rDNA) recombination and a wealth of genetic data connects rDNA instability events giving rise to ERCs with shortened lifespan and other ageing pathologies. However, we understand little about the molecular effects of ERC accumulation. Here we studied ageing in the presence and absence of ERCs, and unexpectedly found no evidence of gene expression differences that might indicate stress responses or metabolic feedback caused by ERCs. Neither did we observe any global change in the widespread disruption of gene expression that accompanies yeast ageing, altogether suggesting that ERCs are largely inert. Much of the differential gene expression that accompanies ageing in yeast was actually associated with markers of the Senescence Entry Point (SEP), showing that senescence rather than age underlies these changes. Cells passed the SEP irrespective of ERCs, but we found the SEP to be associated with copy number amplification of a region of chromosome XII between the rDNA and the telomere (ChrXIIr), which arises in aged cells due to rDNA instability but through a different mechanism to ERCs. Therefore, although rDNA copy number increases dramatically with age due to ERC accumulation, our findings implicate ChrXIIr, rather than ERCs, as the primary driver of senescence during budding yeast ageing.
]]></description>
<dc:creator>Zylstra, A.</dc:creator>
<dc:creator>Horkai, D.</dc:creator>
<dc:creator>Hadj-Moussa, H.</dc:creator>
<dc:creator>Piguet, B.</dc:creator>
<dc:creator>Houseley, J.</dc:creator>
<dc:date>2022-07-14</dc:date>
<dc:identifier>doi:10.1101/2022.07.14.500009</dc:identifier>
<dc:title><![CDATA[Senescence in yeast is associated with chromosome XII cleavage rather than ribosomal DNA circle accumulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.04.498412?rss=1">
<title>
<![CDATA[
FOXA2 controls the antioxidant response in FH-deficient cells independent of NRF2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.04.498412?rss=1</link>
<description><![CDATA[
Hereditary Leiomyomatosis and renal cell cancer (HLRCC) is a cancer syndrome caused by inactivating germline mutations in fumarate hydratase (FH) and subsequent accumulation of fumarate. Fumarate accumulation leads to the activation of an anti-oxidant response via nuclear translocation of the transcription factor NRF2. The activation of the anti-oxidant response is key for cellular survival in FH-deficient cells, yet the extent to which chromatin remodelling shapes the anti-oxidant response is currently unknown. Here, we explored the global effects of FH loss on the chromatin landscape to identify transcription factor networks involved in the highly remodelled chromatin landscape of FH-deficient cells. We identify FOXA2 as a key transcription factor which directly regulates anti-oxidant response genes and subsequent metabolic rewiring. Moreover, we also find that FOXA2 regulates anti-oxidant genes independent of the canonical anti-oxidant regulator NRF2. The identification of FOXA2 as an anti-oxidant regulator provides new insights into the molecular mechanisms behind cell responses to fumarate accumulation, and potentially provides new avenues for therapeutic intervention for HLRCC.
]]></description>
<dc:creator>Rogerson, C.</dc:creator>
<dc:creator>Sciacovelli, M.</dc:creator>
<dc:creator>Maddalena, L. A.</dc:creator>
<dc:creator>Valcarcel-Jimenez, L.</dc:creator>
<dc:creator>Schmidt, C.</dc:creator>
<dc:creator>Yang, M.</dc:creator>
<dc:creator>Ivanova, E.</dc:creator>
<dc:creator>Kent, J.</dc:creator>
<dc:creator>Cheeseman, D.</dc:creator>
<dc:creator>Carroll, J. S.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:creator>Frezza, C.</dc:creator>
<dc:date>2022-07-04</dc:date>
<dc:identifier>doi:10.1101/2022.07.04.498412</dc:identifier>
<dc:title><![CDATA[FOXA2 controls the antioxidant response in FH-deficient cells independent of NRF2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.23.497309?rss=1">
<title>
<![CDATA[
Structural determinants of homophilic adhesion by receptor tyrosine phosphatases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.23.497309?rss=1</link>
<description><![CDATA[
The type IIB receptor protein tyrosine phosphatases (R2B RPTPs) are cell surface transmembrane proteins that engage in cell adhesion via their extracellular domains (ECDs) and cell signaling via their cytoplasmic phosphatase domains. The ECDs of R2B RPTPs form stable, homophilic, trans interactions between adjacent cell membranes. Previous work has demonstrated how one family member, PTPRM, forms homodimers; however, the determinants of homophilic specificity remain unknown. We have solved the X-ray crystal structure of the membrane-distal, N-terminal domains of PTPRK that form a head-to-tail dimer consistent with intermembrane adhesion. Comparison with the PTPRM structure demonstrates inter-domain conformational differences that may define homophilic specificity. Using small-angle X-ray scattering we determined the solution structures of the full-length ECDs of PTPRM and PTPRK, identifying that both are rigid, extended molecules that differ in their overall long-range conformation. Furthermore, we identify one residue, W351, within the interaction interface that differs between PTPRM and PTPRK and show that mutation to glycine, the equivalent residue in PTPRM, abolishes PTPRK dimer formation in vitro. This comparison of two members of the receptor tyrosine phosphatase family suggest that homophilic specificity is driven by a combination of shape complementarity and specific but limited sequence differences.

SIGNIFICANCE STATEMENTCell-cell contacts are dynamically regulated, in part, by the actions of tyrosine kinases and phosphatases. The R2B family of receptor tyrosine phosphatases combine an adhesive extracellular domain with intracellular catalytic domains that bind and dephosphorylate key cell adhesion and polarity proteins. Previous work demonstrated that the extracellular domains form head-to-tail homodimers but, as the interface was composed of residues conserved across the family, homophilic specificity determinants remained unclear. We have used a range of structural techniques including X-ray crystallography, small angle X-ray scattering and AlphaFold modelling to demonstrate that, despite their similarity, two members of the R2B family possess significant differences in their overall shape. Our results support that a combination of subtle shape and sequence variations may determine homophilic binding.
]]></description>
<dc:creator>Hay, I. M.</dc:creator>
<dc:creator>Shamin, M.</dc:creator>
<dc:creator>Caroe, E. R.</dc:creator>
<dc:creator>Mohammed, A. S. A.</dc:creator>
<dc:creator>Svergun, D. I.</dc:creator>
<dc:creator>Jeffries, C. M.</dc:creator>
<dc:creator>Graham, S. C.</dc:creator>
<dc:creator>Sharpe, H. J.</dc:creator>
<dc:creator>Deane, J. E.</dc:creator>
<dc:date>2022-06-23</dc:date>
<dc:identifier>doi:10.1101/2022.06.23.497309</dc:identifier>
<dc:title><![CDATA[Structural determinants of homophilic adhesion by receptor tyrosine phosphatases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.15.496239?rss=1">
<title>
<![CDATA[
Decoding gene regulation in the mouse embryo using single-cell multi-omics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.15.496239?rss=1</link>
<description><![CDATA[
Following gastrulation, the three primary germ layers develop into the major organs in a process known as organogenesis. Single-cell RNA sequencing has enabled the profiling of the gene expression dynamics of these cell fate decisions, yet a comprehensive map of the interplay between transcription factors and cis-regulatory elements is lacking, as are the underlying gene regulatory networks. Here we generate a multi-omics atlas of mouse early organogenesis by simultaneously profiling gene expression and chromatin accessibility from tens of thousands of single cells. We develop a computational method to leverage the multimodal readouts to predict transcription factor binding events in cis-regulatory elements, which we then use to infer gene regulatory networks that underpin lineage commitment events. Finally, we show that these models can be used to generate in silico predictions of the effect of transcription factor perturbations. We validate this experimentally by showing that Brachyury is essential for the differentiation of neuromesodermal progenitors to somitic mesoderm fate by priming cis-regulatory elements. The data set can be interactively explored at https://www.bioinformatics.babraham.ac.uk/shiny/shiny_multiome_organogenesis/
]]></description>
<dc:creator>Argelaguet, R.</dc:creator>
<dc:creator>Lohoff, T.</dc:creator>
<dc:creator>Li, J. G.</dc:creator>
<dc:creator>Nakhuda, A.</dc:creator>
<dc:creator>Drage, D.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Velten, L.</dc:creator>
<dc:creator>Clark, S. J.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2022-06-15</dc:date>
<dc:identifier>doi:10.1101/2022.06.15.496239</dc:identifier>
<dc:title><![CDATA[Decoding gene regulation in the mouse embryo using single-cell multi-omics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.23.492985?rss=1">
<title>
<![CDATA[
Native size exclusion chromatography-based mass spectrometry (SEC-MS) identifies novel components of the Heat Shock Protein 90-dependent proteome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.23.492985?rss=1</link>
<description><![CDATA[
The molecular chaperone heat shock protein 90 (HSP90) works in concert with co-chaperones to stabilize its client proteins, which include multiple drivers of oncogenesis and malignant progression. Pharmacologic inhibitors of HSP90 have been observed to exert a wide range of effects on the proteome, including depletion of client proteins, induction of heat shock proteins, dissociation of co-chaperones from HSP90, disruption of client protein signaling networks, and recruitment of the protein ubiquitylation and degradation machinery--suggesting widespread remodeling of cellular protein complexes. However, proteomics studies to date have focused on inhibitor-induced changes in total protein levels, often overlooking protein complex alterations. Here, we use size-exclusion chromatography in combination with mass spectrometry (SEC-MS) to characterize the changes in native protein complexes following treatment with the HSP90 inhibitor tanespimycin (17-AAG) in the HT29 colon adenocarcinoma cell line. After confirming the signature cellular response to HSP90 inhibition (e.g., induction of heat shock proteins, decreased total levels of client proteins), we were surprised to find only modest perturbations to the global distribution of protein elution profiles in inhibitor-treated cells. Similarly, co-chaperones that co-eluted with HSP90 displayed no clear difference between control and treated conditions. However, two distinct analysis strategies identified multiple inhibitor-induced changes, including several known components of the HSP90 proteome, as well as numerous proteins and protein complexes with no previous links to HSP90. We present this dataset as a resource for the HSP90, proteostasis, and cancer communities (https://www.bioinformatics.babraham.ac.uk/shiny/HSP90/SEC-MS/), laying the groundwork for future mechanistic and therapeutic studies related to HSP90 pharmacology. Data are available via ProteomeXchange with identifier PXD033459.
]]></description>
<dc:creator>Samant, R. S.</dc:creator>
<dc:creator>Batista, S.</dc:creator>
<dc:creator>Larance, M.</dc:creator>
<dc:creator>Ozer, B.</dc:creator>
<dc:creator>Milton, C. I.</dc:creator>
<dc:creator>Bludau, I.</dc:creator>
<dc:creator>Biggins, L.</dc:creator>
<dc:creator>Andrews, S.</dc:creator>
<dc:creator>Hervieu, A.</dc:creator>
<dc:creator>Johnston, H. E.</dc:creator>
<dc:creator>Al-Lazikhani, B.</dc:creator>
<dc:creator>Lamond, A. I.</dc:creator>
<dc:creator>Clarke, P. A.</dc:creator>
<dc:creator>Workman, P.</dc:creator>
<dc:date>2022-05-23</dc:date>
<dc:identifier>doi:10.1101/2022.05.23.492985</dc:identifier>
<dc:title><![CDATA[Native size exclusion chromatography-based mass spectrometry (SEC-MS) identifies novel components of the Heat Shock Protein 90-dependent proteome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.26.489502?rss=1">
<title>
<![CDATA[
Widespread allele-specific topological domains in the human genome are not confined to imprinted gene clusters. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.26.489502?rss=1</link>
<description><![CDATA[
BackgroundThere is widespread interest in the three-dimensional chromatin conformation of the genome and its impact on gene expression. However, these studies frequently do not consider parent-of-origin differences, such as genomic imprinting, which result in monoallelic expression. In addition, genome-wide allele-specific chromatin conformation associations have not been extensively explored. There are few accessible bioinformatic workflows for investigating allelic conformation differences and these require pre-phased haplotypes which are not widely available.

ResultsWe assembled a bioinformatic pipeline, "HiCFlow", which performs haplotype assembly and visualisation of parental chromatin architecture. We benchmarked the pipeline using prototype haplotype phased Hi-C data from GM12878 cells at three disease associated imprinted gene clusters. Using RC-HiC (Region Capture Hi-C) and Hi-C data from further human cell lines (1-7HB2, IMR-90, and H1-hESCs) we were able to robustly identify the known stable allele-specific interactions at the H19/IGF2 locus. Other imprinted loci (DLK1 and SNRPN) were more variable and there was no "canonical imprinted 3D structure", but we could detect allele-specific differences in A/B compartmentalisation. Genome-wide, when TADs were unbiasedly ranked according to their allele-specific contact frequencies, a set of "allele-specific TADs" (ASTADs) could be defined. These occurred in genomic regions of high sequence variation. In addition to imprinted genes, ASTADs were also enriched for allele-specific expressed (ASE) genes. We found loci in ASTADs that have not previously been identified as ASE such as the bitter taste receptors (TAS2Rs).

ConclusionsThis study highlights the widespread differences in chromatin conformation between heterozygous loci and provides a new framework for understanding ASE.
]]></description>
<dc:creator>Richer, S.</dc:creator>
<dc:creator>Yuan, T.</dc:creator>
<dc:creator>Schoenfelder, S.</dc:creator>
<dc:creator>Hurst, L.</dc:creator>
<dc:creator>Murrell, A.</dc:creator>
<dc:creator>Pisignano, G.</dc:creator>
<dc:date>2022-04-27</dc:date>
<dc:identifier>doi:10.1101/2022.04.26.489502</dc:identifier>
<dc:title><![CDATA[Widespread allele-specific topological domains in the human genome are not confined to imprinted gene clusters.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.27.489754?rss=1">
<title>
<![CDATA[
Molecular mechanism of Afadin substrate recruitment to the receptor phosphatase PTPRK via its pseudophosphatase domain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.27.489754?rss=1</link>
<description><![CDATA[
Protein tyrosine phosphatase receptor-type kappa (PTPRK) is a transmembrane receptor that links extracellular homophilic interactions to intracellular catalytic activity. Previously we showed that PTPRK promotes cell-cell adhesion by selectively dephosphorylating several cell junction regulators including the protein Afadin (Fearnley et al., 2019). Here we demonstrate that Afadin is recruited for dephosphorylation by directly binding to the PTPRK D2 pseudophosphatase domain. We mapped this interaction to a putative coiled coil (CC) domain in Afadin that is separated by more than 100 amino acids from the substrate pTyr residue. We identify the residues that define PTP specificity, explaining how Afadin is selectively dephosphorylated by PTPRK yet not by the closely-related receptor tyrosine phosphatase PTPRM. Our work demonstrates that PTP substrate specificity can be determined by protein-protein interactions distal to the active site. This explains how PTPRK and other PTPs achieve substrate specificity despite a lack of specific sequence context at the substrate pTyr. Furthermore, by demonstrating that these interactions are phosphorylation-independent and mediated via binding to a non-catalytic domain, we highlight how receptor PTPs could function as intracellular scaffolds in addition to catalyzing protein dephosphorylation.
]]></description>
<dc:creator>Hay, I. M.</dc:creator>
<dc:creator>Mulholland, K. E.</dc:creator>
<dc:creator>Graham, S. C.</dc:creator>
<dc:creator>Sharpe, H.</dc:creator>
<dc:creator>Deane, J. E.</dc:creator>
<dc:date>2022-04-27</dc:date>
<dc:identifier>doi:10.1101/2022.04.27.489754</dc:identifier>
<dc:title><![CDATA[Molecular mechanism of Afadin substrate recruitment to the receptor phosphatase PTPRK via its pseudophosphatase domain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.07.487453?rss=1">
<title>
<![CDATA[
Chemical conversion of human conventional Pluripotent Stem Cells to Trophoblast Stem Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.07.487453?rss=1</link>
<description><![CDATA[
In human embryos, naive pluripotent cells of the inner cell mass generate epiblast, primitive endoderm and Trophectoderm (TE) lineage, whence trophoblast cells derive. In vitro, naive pluripotent stem cells (PSCs) retain this potential and can generate trophoblast stem cells (TSCs), while conventional PSCs form amnion-like cells and lack the competence to generate TSCs. Transient histone deacetylase and MEK inhibitions with LIF stimulation can be used to chemically reset conventional to naive PSCs. Here we report that chemical resetting induced expression of both naive and TSC markers and of placental imprinted genes. A modified chemical resetting protocol allowed for the fast and efficient conversion of conventional PSCs into TSCs, entailing shutdown of pluripotency genes and full activation of the trophoblast master regulators, without induction of amnion markers. Chemical resetting generates a responsive intermediate state, in which conventional PSCs rapidly acquire competence to form TSCs without the need of stabilisation and expansion in a naive state. The efficiency and rapidity of our system will be useful for the study of cell fate transitions, and to generate models of placental disorders.
]]></description>
<dc:creator>Zorzan, I.</dc:creator>
<dc:creator>Betto, R. M.</dc:creator>
<dc:creator>Rossignoli, G.</dc:creator>
<dc:creator>Arboit, M.</dc:creator>
<dc:creator>Drusin, A.</dc:creator>
<dc:creator>Martini, P.</dc:creator>
<dc:creator>Martello, G.</dc:creator>
<dc:date>2022-04-08</dc:date>
<dc:identifier>doi:10.1101/2022.04.07.487453</dc:identifier>
<dc:title><![CDATA[Chemical conversion of human conventional Pluripotent Stem Cells to Trophoblast Stem Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.11.483903?rss=1">
<title>
<![CDATA[
The AppNL-G-F mouse model of Alzheimer's disease is refractory to regulatory T cell treatment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.11.483903?rss=1</link>
<description><![CDATA[
BackgroundAlzheimers Disease is a neurodegenerative disease with a neuroinflammatory component. Due to the multifunctional capacity of regulatory T cells to prevent and reverse inflammation, regulatory T cells have been proposed as a potential therapeutic in Alzheimers Disease, either as a direct cell therapy or through the use of IL2 as a biologic to expand the endogenous population.

MethodsHere we characterize the longitudinal immunological changes occurring in T cells in the AppNL-G-F mouse model of Alzheimers disease.

ResultsAge-dependent immunological changes, in both the brain and periphery, occurred in parallel in both AppNL-G-F mice and control AppNL mice. As the endogenous IL2 axis was disturbed with age, we sought to determine the effect of IL2 supplementation on disease progression. Using a genetic model of IL2 provision in the periphery or in the brain, we found that expanding regulatory T cells in either location was unable to alter the progression of key pathological events or behavioral changes.

ConclusionThese results suggest that either the AppNL-G-F mouse model does not recapitulate key regulatory T cell-dependent process of Alzheimers disease, or that regulatory T cell therapy is not a promising candidate for APP-mutation-driven Alzheimers disease.
]]></description>
<dc:creator>Yshii, L.</dc:creator>
<dc:creator>Mascali, L.</dc:creator>
<dc:creator>Kouser, L.</dc:creator>
<dc:creator>Lemaitre, P.</dc:creator>
<dc:creator>Marino, M.</dc:creator>
<dc:creator>Dooley, J.</dc:creator>
<dc:creator>Burton, O.</dc:creator>
<dc:creator>Haughton, J.</dc:creator>
<dc:creator>Callaerts-Vegh, Z.</dc:creator>
<dc:creator>de Strooper, B.</dc:creator>
<dc:creator>Holt, M.</dc:creator>
<dc:creator>Pasciuto, E.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:date>2022-03-14</dc:date>
<dc:identifier>doi:10.1101/2022.03.11.483903</dc:identifier>
<dc:title><![CDATA[The AppNL-G-F mouse model of Alzheimer's disease is refractory to regulatory T cell treatment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.03.482829?rss=1">
<title>
<![CDATA[
Polypyrimidine Tract Binding Protein 1 regulates the activation of mouse CD8 T cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.03.482829?rss=1</link>
<description><![CDATA[
We show that the RNA-binding protein Polypyrimidine Tract Binding Protein 1 (PTBP1) is dispensable for the development of naive mouse CD8 T cells, but is necessary for the optimal expansion and production of effector molecules by antigen-specific CD8 T cells in vivo. PTBP1 has an essential role in regulating the early events following activation of the naive CD8 T cell leading to IL-2 and TNF production. It is also required to protect activated CD8 T cells from apoptosis. PTBP1 controls alternative splicing of over 400 genes in naive CD8 T cells in addition to regulating the abundance of [~]200 mRNAs. PTBP1 is required for the nuclear accumulation of c-Fos, NFATc2 and NFATc3, but not NFATc1. This selective effect on NFAT proteins correlates with PTBP1-promoted expression of the shorter A{beta}1 isoform and exon 13 skipped A{beta}2 isoform of the catalytic A-subunit of calcineurin phosphatase. These findings reveal a crucial role for PTBP1 in regulating CD8 T cell activation.
]]></description>
<dc:creator>D'Angeli, V.</dc:creator>
<dc:creator>Monzon-Casanova, E.</dc:creator>
<dc:creator>Matheson, L. S.</dc:creator>
<dc:creator>Gizlenci, O.</dc:creator>
<dc:creator>Petkau, G.</dc:creator>
<dc:creator>Gooding, C.</dc:creator>
<dc:creator>Berrens, R. V.</dc:creator>
<dc:creator>Smith, C. W. J.</dc:creator>
<dc:creator>Turner, M.</dc:creator>
<dc:date>2022-03-04</dc:date>
<dc:identifier>doi:10.1101/2022.03.03.482829</dc:identifier>
<dc:title><![CDATA[Polypyrimidine Tract Binding Protein 1 regulates the activation of mouse CD8 T cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.01.482519?rss=1">
<title>
<![CDATA[
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.01.482519?rss=1</link>
<description><![CDATA[
Cognitive decline is a common pathological outcome during aging, with an ill-defined cellular or molecular basis. Among the cellular changes observed with age are alterations to neuronal plasticity, changes in the glial compartment and the decline of the neurogenic niche. In the recent years, the concept of inflammaging, defined as a low-grade inflammation increasing with age, has emerged as a nexus for age-related diseases. This increase of basal inflammation is also observed in the central nervous system. While not classically considered a neurological cell type, infiltrating T cells increase in the brain with age, and may be responsible for amplification of inflammatory cascades and disruptions to the neurogenic niche. Recently, a small resident population of regulatory T cells has been identified in the brain, and the capacity of IL2-mediated expansion of this population to counter neuroinflammatory disease has been demonstrated. Here we test a brain-specific IL2 delivery system for the prevention of neurological decline in aging mice. We identify the molecular hallmarks of aging in the brain glial compartments, and identify partial restoration of this signature through IL2 treatment. At a behavioral level, brain IL2 delivery prevented the age-induced defect in spatial learning, without improving the general decline in motor skill or arousal. These results identify immune modulation as a potential path to preserving cognitive function for healthy ageing.
]]></description>
<dc:creator>Lemaitre, P.</dc:creator>
<dc:creator>Tareen, S.</dc:creator>
<dc:creator>Pasciuto, E.</dc:creator>
<dc:creator>Mascali, L.</dc:creator>
<dc:creator>Martirosyan, A.</dc:creator>
<dc:creator>Callaerts-Vegh, Z.</dc:creator>
<dc:creator>Dooley, J.</dc:creator>
<dc:creator>Holt, M.</dc:creator>
<dc:creator>Yshii, L.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:date>2022-03-04</dc:date>
<dc:identifier>doi:10.1101/2022.03.01.482519</dc:identifier>
<dc:title><![CDATA[Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.28.482297?rss=1">
<title>
<![CDATA[
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.28.482297?rss=1</link>
<description><![CDATA[
The ability of immune-modulating biologics to prevent and reverse pathology has transformed recent clinical practice. Full utility in the neuroinflammation space, however, requires identification of both effective targets for local immune-modulation and a delivery system capable of crossing the blood-brain-barrier. The recent identification and characterization of a small population of regulatory T cells (Tregs) resident in the brain presents one such potential therapeutic target. Here we identified brain IL2 levels as a limiting factor for brain-resident Tregs. We developed a gene-delivery approach for astrocytes, with a small-molecule on-switch to allow temporal control, and enhanced production in reactive astrocytes to spatially-direct delivery to inflammatory sites. Mice with brain-specific IL2 delivery were protected from traumatic brain injury, stroke and multiple sclerosis models, without impacting the peripheral immune system. These results validate brain-specific IL2 gene-delivery as effective protection against neuroinflammation, and provide a versatile platform for delivery of diverse biologics to neuroinflammatory patients.
]]></description>
<dc:creator>Yshii, L.</dc:creator>
<dc:creator>Pasciuto, E.</dc:creator>
<dc:creator>Bielefeld, P.</dc:creator>
<dc:creator>Mascali, L.</dc:creator>
<dc:creator>Lemaitre, P.</dc:creator>
<dc:creator>Marino, M.</dc:creator>
<dc:creator>Dooley, J.</dc:creator>
<dc:creator>Kouser, L.</dc:creator>
<dc:creator>Verschoren, S.</dc:creator>
<dc:creator>Lagou, V.</dc:creator>
<dc:creator>Kemps, H.</dc:creator>
<dc:creator>Gervois, P.</dc:creator>
<dc:creator>de Boer, A.</dc:creator>
<dc:creator>Burton, O.</dc:creator>
<dc:creator>Wahis, J.</dc:creator>
<dc:creator>Tareen, S.</dc:creator>
<dc:creator>Roca, C.</dc:creator>
<dc:creator>Singh, K.</dc:creator>
<dc:creator>Whyte, C.</dc:creator>
<dc:creator>Kerstens, A.</dc:creator>
<dc:creator>Callaerts-Vegh, Z.</dc:creator>
<dc:creator>Poovathingal, S.</dc:creator>
<dc:creator>Prezzemolo, T.</dc:creator>
<dc:creator>Wierda, K.</dc:creator>
<dc:creator>Dashwood, A.</dc:creator>
<dc:creator>Xie, J.</dc:creator>
<dc:creator>Van Wonterghem, E.</dc:creator>
<dc:creator>Creemers, E.</dc:creator>
<dc:creator>Aloulou, M.</dc:creator>
<dc:creator>Gsell, W.</dc:creator>
<dc:creator>Abiega, O.</dc:creator>
<dc:creator>Munck, S.</dc:creator>
<dc:creator>Vandenbroucke, R.</dc:creator>
<dc:creator>Lemmens, R.</dc:creator>
<dc:creator>De Strooper, B.</dc:creator>
<dc:creator>Van Den Bosch, L.</dc:creator>
<dc:creator>Himmelreich, U.</dc:creator>
<dc:creator>Fitzsimons, C. P.</dc:creator>
<dc:creator>Holt, M.</dc:creator>
<dc:creator>Liston, A.</dc:creator>
<dc:date>2022-03-02</dc:date>
<dc:identifier>doi:10.1101/2022.02.28.482297</dc:identifier>
<dc:title><![CDATA[Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.20.477063?rss=1">
<title>
<![CDATA[
Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.20.477063?rss=1</link>
<description><![CDATA[
The expression of the pluripotency factors OCT4, SOX2, KLF4 and MYC (OSKM) can convert somatic differentiated cells into pluripotent stem cells in a process known as reprogramming. Notably, cycles of brief OSKM expression do not change cell identity but can reverse markers of aging in cells and extend longevity in progeroid mice. However, little is known about the mechanisms involved. Here, we have studied changes in the DNA methylome, transcriptome and metabolome in naturally aged mice subject to a single period of transient OSKM expression. We found that this is sufficient to reverse DNA methylation changes that occur upon aging in the pancreas, liver, spleen and blood. Similarly, we observed reversion of transcriptional changes, especially regarding biological processes known to change during aging. Finally, some serum metabolites altered with aging were also restored to young levels upon transient reprogramming. These observations indicate that a single period of OSKM expression can drive epigenetic, transcriptomic and metabolomic changes towards a younger configuration in multiple tissues and in the serum.
]]></description>
<dc:creator>Chondronasiou, D.</dc:creator>
<dc:creator>Gill, D.</dc:creator>
<dc:creator>Mosteiro, L.</dc:creator>
<dc:creator>Urdinguio, R. G.</dc:creator>
<dc:creator>Berenguer, A.</dc:creator>
<dc:creator>Aguilera, M.</dc:creator>
<dc:creator>Durand, S.</dc:creator>
<dc:creator>Aprahamian, F.</dc:creator>
<dc:creator>Nirmalathasan, N.</dc:creator>
<dc:creator>Abad, M.</dc:creator>
<dc:creator>Martin-Herranz, D. E.</dc:creator>
<dc:creator>Stephan-Otto Attolini, C.</dc:creator>
<dc:creator>Prats, N.</dc:creator>
<dc:creator>Kroemer, G.</dc:creator>
<dc:creator>Fraga, M. F.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Serrano, M.</dc:creator>
<dc:date>2022-01-21</dc:date>
<dc:identifier>doi:10.1101/2022.01.20.477063</dc:identifier>
<dc:title><![CDATA[Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.14.476154?rss=1">
<title>
<![CDATA[
Plasma cell maintenance and antibody secretion are under the control of Sec22b-mediated regulation of organelle dynamics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.14.476154?rss=1</link>
<description><![CDATA[
Despite the essential role of plasma cells in health and disease, the cellular mechanisms controlling their survival and secretory capacity are still poorly understood. Here, we identified the SNARE Sec22b as a unique and critical regulator of plasma cell maintenance and function. In absence of Sec22b, plasma cells were barely detectable and serum antibody titres were dramatically reduced. Accordingly, Sec22b deficient mice fail to mount a protective immune response. At the mechanistic level, we demonstrated that Sec22b is indispensable for efficient antibody secretion but also for plasma cell fitness through the regulation of the morphology of the endoplasmic reticulum and mitochondria. Altogether, our results unveil a critical role for Sec22b-mediated regulation of plasma cell biology through the control of organelle dynamics.
]]></description>
<dc:creator>Bonaud, A.</dc:creator>
<dc:creator>Gargowitsch, L.</dc:creator>
<dc:creator>Gilbert, S.</dc:creator>
<dc:creator>Rajan, E.</dc:creator>
<dc:creator>Canales-Herrerias, P.</dc:creator>
<dc:creator>Stockholm, D.</dc:creator>
<dc:creator>Rahman, N.</dc:creator>
<dc:creator>Collins, M.</dc:creator>
<dc:creator>Hill, D. L.</dc:creator>
<dc:creator>Alloatti, A.</dc:creator>
<dc:creator>Alouche, N.</dc:creator>
<dc:creator>Balor, S.</dc:creator>
<dc:creator>Soldan, V.</dc:creator>
<dc:creator>Gillet, D.</dc:creator>
<dc:creator>Barbier, J.</dc:creator>
<dc:creator>Bachelerie, F.</dc:creator>
<dc:creator>Smith, K. G. C.</dc:creator>
<dc:creator>Bruhns, P.</dc:creator>
<dc:creator>Amigorena, S.</dc:creator>
<dc:creator>Balabanian, K.</dc:creator>
<dc:creator>Linterman, M. A.</dc:creator>
<dc:creator>Peden, A.</dc:creator>
<dc:creator>Espeli, M.</dc:creator>
<dc:date>2022-01-15</dc:date>
<dc:identifier>doi:10.1101/2022.01.14.476154</dc:identifier>
<dc:title><![CDATA[Plasma cell maintenance and antibody secretion are under the control of Sec22b-mediated regulation of organelle dynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.29.474486?rss=1">
<title>
<![CDATA[
Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.29.474486?rss=1</link>
<description><![CDATA[
TET (ten-eleven translocation) enzymes catalyze the oxidation of 5-methylcytosine bases in DNA, thus driving active and passive DNA demethylation. Here, we report that the catalytic cores of mammalian TET enzymes favor CpGs embedded within bHLH and bZIP transcription factor binding sites, with 250-fold preference in vitro. Crystal structures and molecular dynamics calculations show that sequence preference is caused by intra-substrate interactions and CpG flanking sequence indirectly affecting enzyme conformation. TET sequence preferences are physiologically relevant as they explain the rates of DNA demethylation in TET-rescue experiments in culture and in vivo within the zygote and germline. Most and least favorable TET motifs represent DNA sites that are bound by methylation-sensitive immediate-early transcription factors and OCT4, respectively, illuminating TET function in transcriptional responses and pluripotency support.

One-Sentence SummaryThe catalytic domains of the enzymes that facilitate passive and drive active DNA demethylation have intrinsic sequence preferences that target DNA demethylation to bHLH and bZIP transcription factor binding sites.
]]></description>
<dc:creator>Ravichandran, M.</dc:creator>
<dc:creator>Rafalski, D.</dc:creator>
<dc:creator>Ortega-Recalde, O.</dc:creator>
<dc:creator>Davies, C. I.</dc:creator>
<dc:creator>Glanfield, C. R.</dc:creator>
<dc:creator>Kotter, A.</dc:creator>
<dc:creator>Misztal, K.</dc:creator>
<dc:creator>Wang, A. H.</dc:creator>
<dc:creator>Wojciechowski, M.</dc:creator>
<dc:creator>Razew, M.</dc:creator>
<dc:creator>Mayyas, I. M.</dc:creator>
<dc:creator>Kardailsky, O.</dc:creator>
<dc:creator>Schwarz, U.</dc:creator>
<dc:creator>Zembrzycki, K.</dc:creator>
<dc:creator>Morison, I. M.</dc:creator>
<dc:creator>Helm, M.</dc:creator>
<dc:creator>Weichenhan, D.</dc:creator>
<dc:creator>Jurkowska, R. Z.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Plass, C.</dc:creator>
<dc:creator>Zacharias, M.</dc:creator>
<dc:creator>Hore, T. A.</dc:creator>
<dc:creator>Bochtler, M.</dc:creator>
<dc:creator>Jurkowski, T. P.</dc:creator>
<dc:date>2021-12-30</dc:date>
<dc:identifier>doi:10.1101/2021.12.29.474486</dc:identifier>
<dc:title><![CDATA[Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.20.473460?rss=1">
<title>
<![CDATA[
GLP is critical for oogenesis exhibiting a G9A-independent role in transcriptional repression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.20.473460?rss=1</link>
<description><![CDATA[
GLP (EHMT1) is a multifunctional protein, best known for its role as an H3K9me1 and H3K9me2 methyltransferase through its reportedly obligatory dimerization with G9A (EHMT2). Here, we investigate the role of GLP in the oocyte in comparison to G9A using oocyte-specific conditional knockout mouse models (G9a cKO, Glp cKO, G9a-Glp cDKO). Loss of GLP in Glp cKO and G9a-Glp cDKO oocytes re-capitulated meiotic defects observed in the G9a cKO; however, there was a significant impairment in oocyte maturation and developmental competence in Glp cKO and G9a-Glp cDKO oocytes beyond that observed in the G9a cKO. Consequently, loss of GLP in oogenesis results upon fertilisation in mid-gestation embryonic lethality. To assess the molecular functions of GLP and G9A, we applied a multi-omics approach, supported by immunofluorescence, to identify changes in epigenomic, transcriptomic and proteomic signatures in cKO oocytes. H3K9me2 was equally depleted in all cKO oocytes, whereas H3K9me1 was decreased only upon loss of GLP. The transcriptome, DNA methylome and proteome were markedly more affected in G9a-Glp cDKO than G9a cKO oocytes, with transcriptional de-repression associated with increased protein abundance and gains in genic DNA methylation in G9a-Glp cDKO oocytes. Together, our findings suggest that GLP contributes to transcriptional repression in the oocyte, independent of G9A, and is critical for oogenesis and oocyte developmental competence.
]]></description>
<dc:creator>Demond, H.</dc:creator>
<dc:creator>Hanna, C. W.</dc:creator>
<dc:creator>Castillo-Fernandez, J.</dc:creator>
<dc:creator>Santos, F.</dc:creator>
<dc:creator>Papachristou, E. K.</dc:creator>
<dc:creator>Segonds-Pichon, A.</dc:creator>
<dc:creator>Kishore, K.</dc:creator>
<dc:creator>D'Santos, C. S.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:date>2021-12-21</dc:date>
<dc:identifier>doi:10.1101/2021.12.20.473460</dc:identifier>
<dc:title><![CDATA[GLP is critical for oogenesis exhibiting a G9A-independent role in transcriptional repression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.20.473453?rss=1">
<title>
<![CDATA[
Single-Cell Atlas of Common Variable Immunodeficiency reveals germinal center-associated epigenetic dysregulation in B cell responses 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.20.473453?rss=1</link>
<description><![CDATA[
Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, is characterized by impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and a wide range of phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. We used single-cell epigenomics and transcriptomics to create a cell census of naive-to-memory B cell differentiation in a pair of CVID-discordant MZ twins. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B cells that mirror defective cell-cell communication defects following activation. These findings were validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naive-to-memory B-cell transition in CVID and reveal links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, paves the way for future diagnosis and treatments of CVID patients.
]]></description>
<dc:creator>Rodriguez-Ubreva, J.</dc:creator>
<dc:creator>Arutyunyan, A.</dc:creator>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:creator>Del Pino-Molina, L.</dc:creator>
<dc:creator>Clark, S.</dc:creator>
<dc:creator>de la Calle-Fabregat, C.</dc:creator>
<dc:creator>Garcia-Alonso, L.</dc:creator>
<dc:creator>Handfield, L.-F.</dc:creator>
<dc:creator>Ciudad, L.</dc:creator>
<dc:creator>Andres-Leon, E.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Catala-Moll, F.</dc:creator>
<dc:creator>Rodriguez-Cortez, V. C.</dc:creator>
<dc:creator>Polanski, K.</dc:creator>
<dc:creator>Mamanova, L.</dc:creator>
<dc:creator>van Dongen, S.</dc:creator>
<dc:creator>Kiselev, V. Y.</dc:creator>
<dc:creator>Martinez-Saavedra, M. T.</dc:creator>
<dc:creator>Heyn, H.</dc:creator>
<dc:creator>Martin, J.</dc:creator>
<dc:creator>Warnatz, K.</dc:creator>
<dc:creator>Lopez-Granados, E.</dc:creator>
<dc:creator>Rodriguez-Gallego, C.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Kelsey, G. D.</dc:creator>
<dc:creator>Vento-Tormo, R.</dc:creator>
<dc:creator>Ballestar, E.</dc:creator>
<dc:date>2021-12-21</dc:date>
<dc:identifier>doi:10.1101/2021.12.20.473453</dc:identifier>
<dc:title><![CDATA[Single-Cell Atlas of Common Variable Immunodeficiency reveals germinal center-associated epigenetic dysregulation in B cell responses]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.18.469000?rss=1">
<title>
<![CDATA[
The distinct effects of MEK and GSK3 inhibition upon the methylome and transcriptome of mouse embryonic stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.18.469000?rss=1</link>
<description><![CDATA[
Mouse embryonic stem cells (mESCs) were first cultured in vitro in serum-containing medium with leukaemia inhibitory factor, in which they exhibit heterogeneous expression of both pluripotency and some early differentiation markers. Over the last decade, however, it has become commonplace to grow mESCs with inhibitors of MEK and GSK3 signalling, which together elicit a more homogeneously  naive state of pluripotency. Whilst 2i/L-cultured mESCs have been shown to be globally hypomethylated, a comprehensive understanding of the distinct effects of these signalling inhibitors upon the DNA methylome is still lacking. Here we carried out whole genome bisulphite and RNA sequencing of mESCs grown with MEK or GSK3 inhibition alone, including different time points and concentrations of MEK inhibitor treatment. This demonstrated that MEK inhibition causes a dose-dependent impairment of maintenance methylation via loss of UHRF1 protein, as well as rapid impairment of de novo methylation. In contrast, GSK3 inhibition triggers impairment of de novo methylation alone, and consequent hypomethylation is enriched at enhancers with a 2i/L-specific chromatin signature and coincides with upregulation of nearby genes. Our study provides detailed insights into the epigenetic and transcriptional impacts of inhibiting MEK or GSK3 signalling in mouse pluripotent cells.

HighlightsO_LIMEK inhibition causes dose-dependent impairment of maintenance methylation via loss of UHRF1 protein, as well as impairment of de novo methylation.
C_LIO_LIGSK3 inhibition triggers impairment of de novo methylation alone, which results in hypomethylation of enhancers and non-CGI promoters.
C_LIO_LIEnhancers that are hypomethylated following GSK3 inhibition are enriched for 2i/L-specific pluripotency factor binding, TET2 and H3K4me1.
C_LIO_LIEnhancer hypomethylation coincides with increased expression of nearby and Capture Hi-C linked genes.
C_LI
]]></description>
<dc:creator>Spindel, J.</dc:creator>
<dc:creator>Krueger, C.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Papachristou, E. K.</dc:creator>
<dc:creator>Kishore, K.</dc:creator>
<dc:creator>D'Santos, C. S.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2021-11-18</dc:date>
<dc:identifier>doi:10.1101/2021.11.18.469000</dc:identifier>
<dc:title><![CDATA[The distinct effects of MEK and GSK3 inhibition upon the methylome and transcriptome of mouse embryonic stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.03.467112?rss=1">
<title>
<![CDATA[
Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.03.467112?rss=1</link>
<description><![CDATA[
Potent T cell responses against infections and malignancies depend on the release of effector molecules, such as pro-inflammatory cytokines. Because effector molecules can be toxic, their production is tightly regulated through post-transcriptional events at 3 Untranslated Regions (3UTRs). RNA binding proteins (RBPs) were shown to be key regulators herein. With an RNA aptamer-based capture assay from human T cells, we identified >130 RBPs interacting with the IFNG, TNF and IL2 3UTRs in human T cells. T cell activation altered RBP-RNA interactions, revealing that RBP-target mRNA interactions rapidly respond to stimulation. Furthermore, we uncovered the intricate and time-dependent regulation of cytokine production by RBPs: whereas HuR supports early cytokine production, ZFP36L1, ATXN2L and ZC3HAV1 dampen and shorten the production duration, each at different time points. Strikingly, even though ZFP36L1 deletion did not phenotypically rescue T cell dysfunction in tumors, the increased production of cytokines and cytotoxic molecules resulted in superior anti-tumoral T cell responses in vivo. Our findings thus show that identifying RBP-RNA interactions reveals key modulators of T cell responses in health and disease.
]]></description>
<dc:creator>Popovic, B.</dc:creator>
<dc:creator>Guislain, A.</dc:creator>
<dc:creator>Engels, S.</dc:creator>
<dc:creator>Nicolet, B.</dc:creator>
<dc:creator>Jurgens, A. P.</dc:creator>
<dc:creator>Paravinja, N.</dc:creator>
<dc:creator>Freen-van Heeren, J. J.</dc:creator>
<dc:creator>van Alphen, F. P.</dc:creator>
<dc:creator>van den Biggelaar, M.</dc:creator>
<dc:creator>Salerno, F.</dc:creator>
<dc:creator>Wolkers, M.</dc:creator>
<dc:date>2021-11-03</dc:date>
<dc:identifier>doi:10.1101/2021.11.03.467112</dc:identifier>
<dc:title><![CDATA[Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.28.466259?rss=1">
<title>
<![CDATA[
Modelling human zygotic genome activation in 8C-like cells in vitro 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.28.466259?rss=1</link>
<description><![CDATA[
The remodelling of the epigenome and transcriptome of the fertilised oocyte to establish totipotency in the zygote and developing embryo is one of the most critical processes in mammalian embryogenesis. Zygotic or embryonic genome activation (ZGA, EGA) in the 2-cell embryo in mouse, and the 8-cell embryo in humans, constitutes the first major wave of transcription. Failure to initiate ZGA leads to developmental defects, and contributes to the high attrition rates of human pre-implantation embryos. Due to limitations in cell numbers and experimental tractability, the mechanisms that regulate human embryonic genome activation in the totipotent embryo remain poorly understood. Here we report the discovery of human 8-cell like cells (8CLCs) specifically among naive embryonic stem cells, but not primed pluripotent cells. 8CLCs express ZGA marker genes such as ZSCAN4, LEUTX and DUXA and their transcriptome closely resembles that of the 8-cell human embryo. 8-cell like cells reactivate 8-cell stage specific transposable elements such as HERVL and MLT2A1 and are characterized by upregulation of the DNA methylation regulator DPPA3. 8CLCs show reduced SOX2 protein, and can be identified based on expression of the novel ZGA-associated protein markers TPRX1 and H3.Y in vitro. Overexpression of the transcription factor DUX4. as well as spliceosome inhibition increase ZGA-like transcription and enhance TPRX1+ 8CLCs formation. Excitingly, the in vitro identified 8CLC marker proteins TPRX1 and H3.Y are also expressed in 8-cell human embryos at the time of genome activation and may thus be relevant in vivo. The discovery of 8CLCs provides a unique opportunity to model and manipulate human ZGA-like transcriptional programs in vitro, and might provide critical functional insights into one of the earliest events in human embryogenesis in vivo.

HighlightsO_LIZGA markers and transposable elements are expressed in 8CLCs among naive human stem cells
C_LIO_LIThe transcription factor DUX4 and spliceosome inhibition induce ZGA-like transcription
C_LIO_LI8CLC marker proteins TPRX1 and H3.Y are expressed in nuclei of 8-cell human embryos
C_LIO_LI8CLCs serve as a novel in vitro model for human ZGA
C_LI
]]></description>
<dc:creator>Taubenschmid-Stowers, J.</dc:creator>
<dc:creator>Rostovskaya, M.</dc:creator>
<dc:creator>Santos, F.</dc:creator>
<dc:creator>Ljung, S.</dc:creator>
<dc:creator>Argelaguet, R.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Nichols, J.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2021-10-29</dc:date>
<dc:identifier>doi:10.1101/2021.10.28.466259</dc:identifier>
<dc:title><![CDATA[Modelling human zygotic genome activation in 8C-like cells in vitro]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.24.461247?rss=1">
<title>
<![CDATA[
Solvent Precipitation SP3 (SP4) enhances recovery for proteomics sample preparation without magnetic beads 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.24.461247?rss=1</link>
<description><![CDATA[
Complete, reproducible extraction of protein material is essential for comprehensive and unbiased proteome analyses. A current gold standard is single-pot, solid-phase-enhanced sample preparation (SP3), in which organic solvent and magnetic beads are used to denature and capture proteins, with subsequently washes allowing contaminant removal. However, SP3 is dependent on effective protein immobilisation onto beads, risks losses during wash steps, and experiences a drop-off in protein recovery at higher protein inputs. Magnetic beads may also contaminate samples and instruments, and become costly for larger scale protein preparations. Here, we propose solvent precipitation SP3 (SP4) as an alternative to SP3, omitting magnetic beads and employing brief centrifugation--either with or without low-cost inert glass beads--as the means of aggregated protein capture. SP4 recovered equivalent or greater protein yields for 1-5000 {micro}g preparations and improved reproducibility (median protein R2 0.99 (SP4) vs. 0.97 (SP3)). Deep proteome profiling (n = 9,076) also demonstrated improved recovery by SP4 and a significant enrichment of membrane and low-solubility proteins vs. SP3. The effectiveness of SP4 was verified in three other labs, each confirming equivalent or improved proteome characterisation over SP3. This work suggests that protein precipitation is the primary mechanism of SP3, and reliance on magnetic beads presents protein losses, especially at higher concentrations and amongst hydrophobic proteins. SP4 represents an efficient and effective alternative to SP3, provides the option to omit beads entirely, and offers virtually unlimited scalability of input and volume--all whilst retaining the speed and universality of SP3.

BRIEFSolvent precipitation SP3 (SP4) captures aggregated protein for proteomics sample clean-up by omitting magnetic beads, instead employing brief centrifugation--with or without low-cost inert glass beads. SP4 offers improvements to protein yields, higher reproducibility, and greater recovery of membrane proteins, with verifications from three labs. Protein precipitation appears to be the primary mechanism of SP3, with reliance on magnetic beads presenting protein losses, especially at higher concentrations. SP4 presents an effective alternative to SP3 with improved scalability and equal speed and universality.

GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/461247v1_ufig1.gif" ALT="Figure 1">
View larger version (49K):
org.highwire.dtl.DTLVardef@1ba615corg.highwire.dtl.DTLVardef@14df25dorg.highwire.dtl.DTLVardef@62f0c1org.highwire.dtl.DTLVardef@1ac436a_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Johnston, H. E.</dc:creator>
<dc:creator>Yadav, K.</dc:creator>
<dc:creator>Kirkpatrick, J. M.</dc:creator>
<dc:creator>Biggs, G. S.</dc:creator>
<dc:creator>Oxley, D.</dc:creator>
<dc:creator>Kramer, H. B.</dc:creator>
<dc:creator>Samant, R. S.</dc:creator>
<dc:date>2021-09-24</dc:date>
<dc:identifier>doi:10.1101/2021.09.24.461247</dc:identifier>
<dc:title><![CDATA[Solvent Precipitation SP3 (SP4) enhances recovery for proteomics sample preparation without magnetic beads]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.13.460183?rss=1">
<title>
<![CDATA[
Maternal Dppa2 and Dppa4 are dispensable for zygotic genome activation but important for offspring survival 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.13.460183?rss=1</link>
<description><![CDATA[
Zygotic Genome Activation (ZGA) represents the initiation of transcription following fertilisation. Despite its importance in shifting developmental control from primarily maternal stores in the oocyte to the embryo proper, we know little of the molecular events that initiate ZGA in vivo. Recent in vitro studies in mouse embryonic stem cells (ESCs) have revealed Developmental Pluripotency Associated 2 and 4 (Dppa2/4) as key regulators of ZGA-associated transcription. However, their roles in initiating ZGA in vivo remain unexplored. We reveal Dppa2/4 proteins are present in the nucleus at all stages of preimplantation development and associate with mitotic chromatin. We generated single and double maternal knockout mouse models to deplete maternal stores of Dppa2/4. Importantly, while fertile, Dppa2/4 maternal knockout mice had reduced litter sizes, indicating decreased offspring survival. Immunofluorescence and transcriptome analyses of 2-cell embryos revealed while ZGA took place there were subtle defects in embryos lacking maternal Dppa2/4. Strikingly, heterozygous offspring that inherited the null allele maternally had higher preweaning lethality than those that inherited the null allele paternally. Together our results show that while Dppa2/4 are dispensable for ZGA transcription, maternal stores have an important role in offspring survival, potentially via epigenetic priming of developmental genes.
]]></description>
<dc:creator>Kubinyecz, O.</dc:creator>
<dc:creator>Santos, F.</dc:creator>
<dc:creator>Drage, D.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Eckersley-Maslin, M. A.</dc:creator>
<dc:date>2021-09-14</dc:date>
<dc:identifier>doi:10.1101/2021.09.13.460183</dc:identifier>
<dc:title><![CDATA[Maternal Dppa2 and Dppa4 are dispensable for zygotic genome activation but important for offspring survival]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-14</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
